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Aims and scope of the thesis 
 
Homeostasis, derived from the Greek word ‘homoios’, meaning of the 
same kind, and ‘stasis’, meaning condition, is a very important feature of all 
biological organisms. Equilibrium is required for many biophysical functions, 
amongst which the regulation of body temperature, cardiac frequency, blood 
pressure, and water- and electrolyte balance. Water constitutes the major 
component of the body, and thus its regulation is of vital importance for all living 
organisms. 
In the general introduction of this thesis (Chapter 2), an overview is given 
of water homeostasis and its regulation, including the integration of water intake 
and water excretion, the mechanism of urine concentration, and the regulation and 
action of vasopressin (VP)  and aquaporin-2 (AQP2). Polyuria and polydipsia 
(PUPD) represent an important disorder of water homeostasis, and are frequently 
encountered in the dog. Current knowledge of the pathogenesis of the different 
forms of canine polyuria is reviewed, in addition to the diagnostic approaches to 
PUPD. 
Urine specific gravity and urine osmolality are used to assess the ability of 
the renal tubules to concentrate or dilute the glomerular filtrate and are therefore 
important variables for the documentation of PUPD. It has been stated that there is 
a high degree of individual biological variability in urine concentration. Although 
reference ranges can be found in many textbooks, these are only scarcely 
substantiated by investigatory data. To gain further insight into this topic, the intra- 
and interindividual variation in urine osmolality and urine specific gravity was 
studied in healthy dogs, together with the influence of age and gender on these 
variables (Chapter 3). 
In dogs, secondary polycythaemia is associated with PUPD, but the 
underlying mechanism is not yet known. It was hypothesised that the 
hyperviscosity and increased blood volume occurring in secondary polycythaemia 
may affect VP release, resulting in PUPD. To test this hypothesis, the 
osmoregulation of VP release was studied in dogs with secondary polycythaemia 
due to renal neoplasm by investigating the VP response to hypertonic saline 
infusion (Chapter 4). 
In all but one of the causes for PUPD, polyuria is the primary problem, and 
is compensated for by secondary polydipsia. In contrast, in primary polydipsia the 
polyuria is secondary to the increase in water intake. In dogs, primary polydipsia 
has been described as a behavioural problem. Results of indirect approaches not 
involving VP measurements suggest the presence of a normal hypothalamic-
neurohypophyseal system, although an impaired osmoregulation of VP release has 
also been reported in dogs with primary polydipsia. Chapter 5 describes VP 
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release during both water deprivation and hypertonic saline infusion in dogs with 
primary polydipsia identified by criteria not involving VP measurements. 
Young dogs with polyuria form a separate category among dogs presented 
with PUPD. After exclusion of other causes of PUPD, the main diagnostic 
dilemma is to differentiate between central diabetes insipidus, primary polydipsia, 
and nephrogenic abnormalities. In Chapter 6 eighteen young dogs presented with 
polyuria, in most cases since puppyhood, are described. The dogs were categorised 
according to their VP response to hypertonic saline infusion, which is regarded as 
the most powerful diagnostic tool for differentiation of polyuric conditions.  
Unexpectedly high plasma VP concentrations have been found during 
hypertonic saline infusion in some dogs with polyuria. In these dogs it was not 
clear whether these high VP values should be regarded as pathological or as the 
result of a physiological pulsatile secretion pattern of VP. To determine whether 
VP is secreted in a pulsatile fashion in the dog, and whether stimulation of VP 
release changes the secretion pattern of VP, plasma VP concentrations were 
measured by frequent sampling under basal conditions, after water deprivation, and 
during osmotic stimulation with hypertonic saline in healthy dogs (Chapter 7). 
Aquaporin-2 has been characterised as the VP-regulated water channel, 
localised in the apical membrane and the intracellular vesicles of the kidney 
collecting duct cells. Urinary AQP2 (U-AQP2) excretion closely parallels changes 
in VP action, and has been proposed as a marker for collecting duct responsiveness 
to VP. The immunohistochemical localisation of AQP2 in the canine kidney is 
described in Chapter 8. In addition, a radioimmunoassay was developed for the 
measurement of U-AQP2 excretion in dogs. To validate the assay, U-AQP2 
excretion was measured in healthy dogs under basal conditions, after water 
loading, during hypertonic saline infusion, and after desmopressin administration.  
 In Chapter 9 the results of the studies are summarised and discussed.
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General introduction on water homeostasis and 
polyuria/polydipsia 
 
1. Water homeostasis 
 
1.1 Integration of water intake and water excretion 
In healthy individuals, water homeostasis is accurately controlled, so that 
plasma osmolality (Posm) and its principal determinant, plasma sodium (Na), are 
maintained within a narrow range. This control is achieved by the close integration 
of water excretion and water intake (Robertson 1984, McKenna and Thompson 
1998). Water intake is governed by the sensation of thirst, which is mainly 
regulated by osmosensitive neurons located in the anterior hypothalamus (Thrasher 
1985, Robertson 1991). Studies in humans indicate that the thirst osmoreceptors 
possess an osmotic threshold, above which the sensation of thirst increases rapidly 
in direct proportion with Posm (Robertson 1984). In addition, hypovolaemia and 
hypotension detected by atrial and arterial baroreceptors are strong stimuli for 
water ingestion (Thrasher et al. 1982, Berl and Robertson 2000) (Figure 1). 
Oropharyngeal receptors play an important role in thirst regulation, as stimulation 
of these receptors by the ingestion of water leads to an early satiation of thirst 
before Posm or plasma volume change (Thrasher et al. 1981, Geelen et al. 1984, 
Salata et al. 1987, Appelgren et al. 1991).  
Water excretion depends on the ability of the hypothalamic osmoreceptors 
to respond to changes in Posm, the ability of the atrial and carotid bifurcation 
baroreceptors to respond to changes in blood pressure or blood volume, and the 
subsequent release of the antidiuretic hormone, vasopressin (VP), via the 
hypothalamic-neurohypophyseal axis. In addition, renal medullary hypertonicity 
must be generated and maintained, and there must be an adequate number of 
functional nephrons with an appropriate response to VP (Chew and DiBartola 
1989, Reeves and Andreoli 1992). The control of VP secretion and thirst sensation 
are partially interwoven, in that drinking not only leads to satiation of thirst but 
also to cessation of VP secretion (Thrasher et al. 1981, Geelen et al. 1984, Salata et 
al. 1987, Appelgren et al. 1991). Both thirst and VP release are influenced by 
similar stimuli, i.e. changes in Posm and pressure/volume status (Johnson and 
Cunningham 1987, Zimmerman et al. 1987) (Figure 1). In addition, osmoreceptors 
regulating VP secretion appear to be located in identical areas in the anterior 
hypothalamus as the thirst osmoreceptors (Robertson 1984, Thrasher 1985), 
although other studies indicate partial anatomic dissociation of thirst and VP 
regulatory areas (Andersson et al. 1967, Johnson and Cunningham 1987). The 
osmotic threshold for VP secretion is slightly lower than that for thirst perception, 
which permits maximum use of the antidiuretic mechanism to preserve water 
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balance, and a lower dependence on the thirst mechanism and a constant supply of 
water (Baylis and Robertson 1980, Robertson 1984). Despite the obvious vital 
importance of thirst during pathological situations of hyperosmolality and 
hypovolaemia, under normal circumstances water balance is accomplished more by 
free water excretion, regulated by VP, than by water intake, regulated by thirst 
(Robinson and Verbalis 2003). 
 
Thirst VP
osmoreceptor osmoreceptor
Thirst
Water
intake
Thirst VP neurons
t r 
i t k
Kidneys:
water excretion
Plasma osmolality
VP release
Arterial pressure
Carotid sinus
Atrial receptors
Circulating 
volume
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Figure 1. Schematic representation of the pathways influencing water intake and water 
excretion (VP = vasopressin, OPR = oropharyngeal reflex). In addition to these pathways, 
an increase in circulating volume will lead to central suppression of both thirst and VP 
secretion through the release of atrial natriuretic peptide (Gutkowska et al. 1997, McCann 
et al. 2003). On the other hand, stimulation of the juxtaglomerular apparatus and 
subsequent formation of angiotensin II in response to a decrease in circulating volume will 
stimulate both thirst and VP release, probably by a direct effect of angiotensin II on 
receptors in the circumventricular organs (Johnson and Cunningham 1987, Zimmerman et 
al. 1987, Giebisch and Windhager 2003a).  
 
 
1.2 Mechanism of urine concentration 
The kidney is an organ of both conservation and excretion: it conserves 
solutes and water needed by the body and simultaneously excretes excess solutes 
and metabolic wastes (Unwin and Capasso 2000). The functional unit of the kidney 
is the nephron, which is composed of a glomerulus, proximal tubule, loop of Henle, 
distal tubule, and collecting duct (Evans and Christensen 1993). In each nephron, 
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urine is formed by three basic processes: glomerular filtration, tubular reabsorption, 
and tubular secretion. The kidneys of the dog receive 10% to 20% of cardiac 
output, and about one fourth to one third of the blood plasma flowing through the 
glomerular capillaries becomes filtrate (approximately 3.7 l/kg body weight/day 
primary urine) (Finco 1995). The walls of the glomerular capillaries are porous to 
water and small-molecular-weight molecules, such as electrolytes, glucose, and 
amino acids. Blood cells and most plasma proteins are retained in the glomerular 
capillary lumen and leave the glomerular capillaries via the efferent arteriole. The 
tubular reabsorption of many substances, such as sodium, glucose, and amino 
acids, and the tubular secretion of organic ions, potassium, and protons, eventually 
determine the composition of urine (Rose 1994, Unwin and Capasso 2000).  
 
 
 
The absorption of approximately 75% of filtered water occurs passively in 
the proximal tubule along osmotic gradients established by the active transport of 
Figure 2. Schematic 
overview of water and 
sodium chloride (NaCl) 
movement in the nephron. 
The numbers indicate 
osmolalities and the cortico-
medullary osmotic gradient. 
(Modified after Unwin RJ, 
Capasso G. Essential renal 
anatomy and physiology. 
Renal physiology. In: 
Johnson RJ, Fehally J, eds. 
Comprehensive Clinical 
Nephrology. Mosby: 
London; 2000: 2.1-2.11.) 
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solutes such as sodium, potassium, bicarbonate, amino acids, and glucose (Ganong 
1989) (Figure 2). Obligatory water reabsorption occurs in the proximal tubule 
regardless of the body’s actual need for water. Isotonic fluid leaves the proximal 
tubule to enter the descending loop of Henle. The cells of the thin descending limb 
are highly permeable to water, but have a limited permeability to other small 
molecules, such as sodium and urea. Thus, tubular fluid becomes increasingly 
concentrated in the descending limb, as water is extracted from the tubule lumen by 
the high interstitial osmolality (Unwin and Capasso 2000). The entire ascending 
limb of the loop of Henle is impermeable to water. Passive diffusion of sodium into 
the interstitium takes place in the thin portion of the ascending limb, while active 
transport of chloride and sodium occurs in the thick ascending limb. The result of 
the outward movement of solutes and the restricted movement of water is a 
decrease in the osmolality of the fluid entering the distal tubule (Verlander 1997, 
Giebisch and Windhager 2003b). 
The primary role of the loop of Henle is to provide a hyperosmotic 
medullary interstitium with which urine equilibrates during its passage through the 
collecting duct (Unwin and Capasso 2000) (Figure 2). Medullary hypertonicity is 
generated and maintained by the above-described sodium chloride pump in the 
thick ascending limb, passive sodium chloride transport out of the thin ascending 
limb, and urea transport from the inner medullary collecting duct. In the proximal 
part of the distal tubule sodium, chloride and water are reabsorbed independently 
of the VP concentration. The adjustment of water reabsorption needed to maintain 
the body water balance occurs in the latter parts of the distal tubule and in the 
collecting duct, and depends on the release and action of the hormones aldosterone 
and VP. Aldosterone, as part of the renin-angiotensin system, stimulates sodium 
and water reabsorption, and potassium secretion (Unwin and Capasso 2000, Rose 
1994). Vasopressin facilitates the diffusion of water into the interstitium, as well as 
the diffusion of urea in the inner medullary collecting duct. Thus, the final 
concentration of urine is determined by the permeability of the collecting duct to 
water (Koeppen and Stanton 2000, Giebisch and Windhager 2003b). 
 
1.3 Vasopressin regulation and secretion 
The antidiuretic hormone VP is a nonapeptide produced in the 
neurosecretory neurons of the supraoptic, paraventricular, and suprachiasmatic 
nuclei of the hypothalamus, from which axons extend through the pituitary stalk to 
the posterior pituitary (Berl and Robertson 2000, Robinson and Verbalis 2003) 
(Figure 3). Vasopressin is synthesised as part of a large precursor molecule that is 
composed of a signal peptide, the hormone, a carrier protein termed neurophysin, 
and a glycopeptide known as copeptin (Robinson and Verbalis 2003). Like other 
peptide hormones destined for secretion, the protein precursor of VP is translocated 
into the endoplasmic reticulum, where the signal peptide is removed by a peptidase 
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and the prohormone folds and oligomerises, and moves from the Golgi apparatus 
into the neurosecretory granules (Robertson 2001). Binding of the N-terminus of 
the VP moiety into a pocket formed by the N-terminal domain of the neurophysin 
moiety facilitates proper folding of the prohormone, and is thought to play an 
important role in the production and trafficking of the hormone (Robertson 2001, 
Acher et al. 2002). As the granules move down the axons towards the axon 
terminal, the prohormone is further cleaved by endo- and exopeptidases, releasing 
VP, its neurophysin, and copeptin. In response to appropriate stimuli, the secretory 
granules fuse with the axon membranes and VP, neurophysin, and copeptin are 
released into the bloodstream, where they circulate independently of each other 
(Robertson 2001).  
The secretion of VP is primarily controlled by osmoreceptors located in the 
organum vasculosum of the lamina terminalis and in areas of the adjacent anterior 
hypothalamus near the anterior wall of the third cerebral ventricle (Ramsay 1985, 
Robertson 1985, Wang and Goetz 1985, Wells 1998). In addition, baroreceptors 
situated in the atria, aortic arch, and carotid arteries may mediate haemodynamic 
influences to the neurohypophyseal system (Thrasher 1994). The afferent signals 
from these receptors are carried from the chest to the nucleus of the tractus 
solitarius and the magnocellular neurons through cranial nerves IX and X 
(Robinson and Verbalis 2003). Functionally, the two control systems are integrated 
in such a way that osmoregulation is altered but not disrupted by haemodynamic 
influences (Goetz and Wang 1985, Robertson and Ganguly 1986) (Figure 4). As 
little as a 1% increase in Posm may increase plasma VP, whereas blood volume 
and pressure need to decrease by 10% to 15% to stimulate VP release (Robinson 
and Verbalis 2003) (Figure 5). Although the action of VP in the kidney to retain 
water helps to restore the circulatory volume, the major hormonal regulation to 
Figure 3. Schematic view of the 
hypothalamus and the pituitary gland. 
Vasopressin (VP) is produced in the 
hypothalamic magnocellular neurons 
and is released into the bloodstream in 
the posterior lobe (PL) of the pituitary 
gland (AL = anterior lobe; IL = 
intermediate lobe). (Modified after 
Rijnberk A. Hypothalamus-pituitary 
system. In: Rijnberk A, ed. Clinical 
Endocrinology of Dogs and Cats. 
Kluwer Academic Publishers: 
Dordrecht; 1996a: 11-34.) 
Chapter 2 
 
20 
control volume actually involves the renin-angiotensin system (Robinson and 
Verbalis 2003).  
 
  
 
Figure 4. The effect of changes in blood volume or arterial pressure on the relation 
between plasma osmolality and plasma vasopressin activity. (Modified after Robertson GL, 
Athar S. The interaction of blood osmolality and blood volume in regulating plasma 
vasopressin in man. J Clin Endocrinol Metab 1976; 42: 613-620.)  
 
 
 
 
 
Figure 5. Comparison in humans of 
the sensitivity of vasopressin release 
to changes in plasma osmolality 
(increase), blood pressure, and 
blood volume (decrease). (Modified 
after Berl T, Robertson GL. 
Pathophysiology of water 
metabolism. In: Brenner BM, ed. 
Brenner and Rector’s The Kidney, 
6th ed. Saunders: Philadelphia; 2000: 
866-925.) 
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Other important stimuli of VP release are nausea (Rowe et al. 1979), 
hypoglycaemia (Baylis and Heath 1977, Ellis et al. 1990), hypoxia/hypercapnia 
(Raff et al. 1983), pain (Kendler et al. 1978), and stress (Jørgensen et al. 2002). 
Apart from impairment of VP release, atrial natriuretic peptide also inhibits the 
renal responsiveness to VP (Dillingham and Anderson 1986, Iitake et al. 1986). In 
addition, a large number of drugs and hormones, amongst which glucocorticoids 
(inhibitory effect), angiotensin II, and corticotrophin-releasing factor (stimulatory 
effect), have been shown to influence VP secretion (Berl and Robertson 2000). 
 
 
1.4 Vasopressin action 
The biological effects of VP are mediated by three receptor subtypes: V1 
receptors on blood vessels, V2 receptors on renal collecting duct epithelia, and V3 
receptors (also termed V1b) responsible for the stimulation of adrenocorticotrophic 
hormone (ACTH) secretion from the anterior pituitary (Birnbaumer 2000, 
Robinson and Verbalis 2003). Although the term “vasopressin” was originally 
chosen because of the increase in blood pressure observed after administration of 
the hormone – a V1 receptor response – higher concentrations of the peptide are 
required to elicit these effects than for the antidiuretic action (Birnbaumer 2000). 
Apart from the antidiuretic effect, V2 receptors also regulate the stimulation of 
factor VIII production by VP (Robinson and Verbalis 2003). 
Binding of VP to its V2-receptor in the basolateral membrane of the 
collecting duct cells initiates a signal transduction cascade consisting of activation 
of adenylate cyclase by the receptor-coupled Gs-GTP binding protein, acceleration 
of the production of cyclic adenosine monophosphate (cAMP) from adenosine 
triphosphate (ATP), and activation of the catalytic subunit of protein kinase A 
(PKA) (Knepper 1997, Deen et al. 2000) (Figure 6). Subsequent phosphorylation 
of the water channel protein aquaporin-2 (AQP2) by PKA initiates the docking and 
fusion of AQP2-containing vesicles with the otherwise watertight apical membrane 
of collecting duct cells (Christensen et al. 2000, Deen et al. 2000). In the presence 
of these water-selective channels, water can move passively along an osmotic 
gradient, i.e., from the distal and collecting duct tubules to the hypertonic renal 
medulla. After VP withdrawal, AQP2 is redistributed into the cell by endocytosis, 
and water permeability decreases (Nielsen et al. 1995). 
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Figure 6. Regulation of aquaporin-2 (AQP2) trafficking and expression in kidney 
collecting duct cells. AC = adenylate cyclase, ATP = adenosine triphosphate, cAMP = 
cyclic adenosine monophosphate, VP = vasopressin (Modified after Nielsen S, Kwon T-H, 
Christensen BM, Promeneur D, Frøkiær J, Marples D. Physiology and pathophysiology of 
renal aquaporins. J Am Soc Nephrol 1999; 10: 647-663.) 
 
 
1.5 Aquaporin-2 regulation and action 
Diffusion-mediated water transport occurs through all biological 
membranes at a relatively low velocity. In the plasma membranes of highly water-
permeable cells, aquaporins (AQPs), a family of integral membrane proteins, 
function as water-selective channels (Nielsen et al. 1995, Deen et al. 2000, Agre et 
al. 2002). At least 11 mammalian AQPs have been identified, and more than 200 
members of this family have been found in plants, microbes, invertebrates, and 
other vertebrates (Agre et al. 2002, Ishibashi et al. 2002). The expression of AQPs 
in secretory and resorptive epithelia indicates that these proteins are involved in 
processes such as renal osmoregulation and water conservation, fluid secretion and 
absorption by epithelia of the gastrointestinal, respiratory, and reproductive tracts, 
and the formation of cerebrospinal fluid, amniotic fluid, and sweat (Deen et al. 
2000, King and Yasui 2002). Members of the AQP family have six transmembrane 
domains which are connected by five loops (A-E), with the N- and C-termini 
located intracellularly (Fushimi et al. 1993, Jung et al. 1994, Sasaki et al. 1994) 
(Figure 7). Jung et al. (1994) proposed an hourglass model with the highly 
conserved asparagine-proline-alanine (NPA) sequence in loops B and E forming 
the aperture of the very tight structural water channel. Aquaporins are believed to 
be continuously open, and transmembrane water permeability is thought to be 
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regulated by the presence or absence of AQPs in the membrane (Deen et al. 2002). 
The single-channel water permeability of different AQPs varies greatly. 
Aquaporin-1, AQP2 and AQP4 have a high permeability, whereas AQP0 and 
AQP3 have a much lower permeability. Furthermore, some AQPs, including AQP3 
and AQP9, also allow the passage of other molecules, including urea and glycerol 
(aquaglyceroporins) (Brown and Nielsen 2000). 
 
 
 
Figure 7. Schematic representation of the structural organisation of members of the 
aquaporin family. Aquaporins have six membrane-spanning domains connected by five 
loops, and both the amino- and carboxy-termini are cytoplasmic. The polypeptide is folded 
within the membrane bilayer, resulting in an hourglass-like structure, with the central necks 
of loops B and E including the highly conserved asparagine-proline-alanine (NPA) motifs 
forming the aperture of the water channel. (Modified after Jung JS, Preston GM, Smith BL, 
Guggino WB, Agre P. Molecular structure of the water channel through aquaporin CHIP. 
The hourglass model. J Biol Chem 1994; 269: 14648-14654.) 
 
 
Seven different renal AQPs (AQP1-4, 6-8) have been defined thus far, 
correlating with well-defined segmental permeabilities in the nephron (King and 
Yasui 2002). Aquaporin-3 and AQP4 are localised in the basolateral membrane of 
the kidney collecting duct, and facilitate water transport from the cell to the 
interstitium (King and Yasui 2002, Schrier and Cadnapaphornchai 2003). 
Aquaporin-2 has been characterised as the major VP-regulated water channel and 
is predominantly localised in the apical membrane and the intracellular vesicles of 
collecting duct principal cells (Nielsen et al. 1993). Aquaporin-2 was first cloned 
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from rat kidney collecting duct and characterised as a functional water channel by 
Fushimi et al. (1993). In 1994, Sasaki et al. cloned human AQP2, a 271-amino acid 
protein with 91% homology with rat AQP2. Chromosomal mapping of the AQP2 
gene assigned its location to chromosome 12q13 (Sasaki et al. 1994, Uchida et al. 
1994).  
Vasopressin-mediated regulation of collecting duct water permeability 
involves both short- and long-term regulation. Within a time frame of a few 
minutes, VP increases the water permeability of the kidney collecting duct by 
stimulating the translocation of AQP2 from an intracellular reservoir to the apical 
plasma membrane (Nielsen et al. 1993, 1995, Marples et al. 1995). Chronic VP 
exposure (>24 h) is associated with an increased maximal water permeability of the 
collecting duct epithelium and an increased expression of AQP2 (Nielsen et al. 
1993, DiGiovanni et al. 1994, Kishore et al. 1996) as a result of increased 
transcription of the AQP2 gene (Hozawa et al. 1996) (Figure 6). During VP 
stimulation, 3% of total kidney AQP2, in part associated with small vesicles and 
larger membrane fragments, is excreted into the urine by a selective apical pathway 
(Rai et al. 1997, Wen et al. 1999) (Figure 6). Urinary excretion of AQP2 closely 
parallels changes in VP exposure, and has been proposed as a reliable marker for 
collecting duct responsiveness to VP in various physiological states of water 
homeostasis as well as disorders of water homeostasis in humans (Pedersen et al. 
2001, Saito et al. 2001).  
 
 
2. Polyuria and polydipsia (PUPD) 
 
In companion animal medicine, polyuria is generally defined as a daily 
urine output of >50 ml/kg body weight per day, and polydipsia as a fluid intake 
exceeding 100 ml/kg body weight per day (Dunn 1990, Feldman and Nelson 1996, 
Taylor 2000). In general, there are two main causes of polyuria: osmotic diuresis 
and water diuresis. When the concentration of a solute present in the glomerular 
filtrate exceeds the proximal tubular capacity for reabsorption, passive water 
reabsorption is impaired. Even in the presence of VP, urine cannot be concentrated, 
resulting in osmotic diuresis. The permeability of the distal tubule and collecting 
duct depends on the presence of VP. Both a decreased release of VP and a 
decreased response to the hormone lead to a decrease in water permeability and 
water diuresis (Giebisch and Windhager 2003b).  
The differential diagnosis of polyuria represents one of the classic 
problems of clinical medicine (Zerbe and Robertson 1981). Much more so than in 
other species, polyuria occurs frequently in dogs. This is illustrated by a relatively 
long list of conditions in which polyuria is a clinical feature. The conditions, well-
known to be associated with polyuria, will be described below in brief sections. 
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2.1 Primary polydipsia 
Primary polydipsia is the only disorder of water homeostasis in which the 
polydipsia is primary, and the polyuria is a compensatory response. In humans, 
primary polydipsia may result from a defect in the thirst center (dipsogenic 
polydipsia) or may be associated with mental illness (psychogenic polydipsia) 
(Robertson 1987, Robertson 1988). In dogs, primary polydipsia has been described 
as a behavioural problem and has also been called a psychological disorder 
occurring in young hyperactive dogs (Nichols 1992, Feldman and Nelson 1996). 
Nevertheless, VP release is impaired in some dogs with primary polydipsia 
(Biewenga et al. 1987).  
 
2.2 Glucosuria 
Glucose is filtered into the primary urine in the same concentration as in 
plasma. Normally, the resorption of all glucose takes place in the proximal tubule 
by active transport. In diabetes mellitus, the elevated glucose concentrations in 
plasma exceed the renal threshold of about 10 mmol/l, leading to glucosuria. The 
resulting osmotic diuresis causes polyuria and electrolyte loss. Both exogenous 
progestagens (used in estrus prevention) and endogenous progestagens (metestrus) 
may cause diabetes mellitus through growth hormone hypersecretion of mammary 
origin and peripheral insulin resistance (Selman et al. 1994). The classic picture is 
that of the middle-aged bitch presented in late metestrus with PUPD and weight 
loss despite a good appetite (Rijnberk 1996b).  
Although glucosuria reflects hyperglycaemia in more than 95% of cases, 
primary renal glucosuria must also be taken into consideration. Dysfunction of the 
proximal tubule, such as in the Fanconi syndrome, may result in glucosuria and 
polyuria despite normoglycaemia (Meric et al. 1995).  
 
2.3 Renal failure 
Regardless of the primary cause of nephron loss, in chronic renal 
insufficiency some nephrons usually survive and subsequently adapt by enlarging 
and increasing the clearance per nephron. Initially, this adaptation process has a 
beneficial effect, maintaining whole kidney glomerular filtration rate and solute 
excretion. Ultimately, however, the glomerular hypertrophy and the increase in 
single-nephron glomerular filtration rate lead to focal glomerulosclerosis and 
further nephron loss. The osmotic diuresis in the remaining adapted nephrons 
impairs sodium and water conservation, resulting in a decreased renal 
concentrating ability. Besides PUPD, clinical manifestations may include anorexia, 
vomiting, weight loss, and anaemia (Luke 2000). 
 Acute pyelonephritis may produce a transiently decreased ability to 
concentrate urine but rarely leads to permanent renal damage. Chronic 
pyelonephritis refers to chronic interstitial nephritis resulting from infection of the 
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upper urinary tract. Many non-infectious diseases also cause an interstitial nephritis 
that is pathologically indistinguishable from chronic pyelonephritis. With persistent 
infection, chronic pyelonephritis may result in end-stage renal failure. Early signs 
of pyelonephritis may include fever, renal pain, and leukocytosis, but the renal 
problem is often occult (Stamm and Turck 1991, Kunin 2000).  
 
2.4 Hyperadrenocorticism 
The dominant clinical manifestations of canine hyperadrenocorticism are 
centripetal obesity, atrophy of muscles and skin, polyphagia, and PUPD. Many of 
these symptoms can be related to the increased gluconeogenesis and lipogenesis at 
the expense of protein caused by the glucocorticoids (Rijnberk 1996c). The 
polyuria associated with hypercortisolism is caused by an impaired osmoregulation 
of VP release affecting both the threshold and the sensitivity of the secretory 
system. A direct effect of glucocorticoids acting on the glucocorticoid receptors in 
the VP-producing magnocellular neurons seems likely (Biewenga et al. 1991). In 
addition, glucocorticoids interfere with the action of VP at the level of the kidney 
(Biewenga et al. 1991). 
 
2.5 Pyometra 
In the dog, pyometra may develop during the luteal phase of the estrus 
cycle, when cystic endometrial hyperplasia caused by repeated exposure of the 
endometrium to progesterone concurs with secondary bacterial infection. Clinical 
features may include anorexia, weight loss, vomiting, vaginal discharge, and PUPD 
(Schaefers-Okkens 1996, Johnston et al. 2001). The mechanism underlying the 
polyuria associated with pyometra is not well understood. From early studies by 
Åsheim (1963a, 1963b) it was concluded that an insufficiency of the 
neurosecretory system could not adequately explain the occurrence of polyuria in 
pyometra. According to Watts et al. (2001), endotoxinaemia in pyometra may 
cause increased plasma concentrations of prostaglandin F2α, which lead to 
polyuria, perhaps mediated by the in vivo antagonism between VP and 
prostaglandins (Anderson et al. 1975). Nevertheless, polyuria may also occur in 
dogs with pyometra which are negative for E. Coli endotoxin (Okano et al. 1998, 
Stone et al. 1998). A recent study by Heiene et al. (2003) provides evidence for the 
downregulation of kidney VP receptors in dogs with pyometra. 
 
2.6 Hepatic failure 
Polyuria in combination with failure to grow, cachexia, episodic central 
nervous system disturbances, and gastrointestinal problems may point to 
hepatoencephalopathy (HE). Rothuizen et al. (1987, 1995) have found that HE may 
be associated with hyperadrenocorticism. Hence, interference with the release and 
action of VP may play an important role in the polyuria associated with HE. It has 
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been postulated that an abnormal metabolism of amino acids in HE may give rise 
to ‘false’ dopaminergic neurotransmitters, which may increase ACTH secretion, 
and consequently cause hyperadrenocorticism. In addition to the hypercortisolism, 
an increased tonus of the gamma-amino butyric acid (GABA) neurotransmitter 
system may also result in a disturbed osmoregulation of VP release in HE 
(Rothuizen et al. 1995). 
 
2.7 Hyperthyroidism 
Most canine thyroid tumours are discovered as a painless mass in the 
midcervical or ventrocervical region, that with increasing size may give rise to 
dysphagia, hoarseness, and tracheal obstruction. In approximately 10% of cases the 
thyroid tumour may give rise to hypersecretion of thyroid hormone. Clinical 
manifestations of hyperthyroidism include weight loss despite good appetite, 
weakness, panting, and PUPD (Rijnberk 1996d). High levels of atrial natriuretic 
peptide may be involved in the polyuria of hyperthyroidism (Weissel et al. 1986). 
 
2.8 Hypercalcaemia 
Hypercalcaemia may be due to primary hyperparathyroidism (parathyroid 
adenoma, carcinoma, or hyperplasia) or to hypercalcaemia of malignancy 
(malignant lymphoma, mammary carcinoma, adenocarcinoma of the apocrine 
glands of the anal sac) (Rijnberk and Hazewinkel 1996). Clinical features include 
PUPD, anorexia, weakness, and weight loss. Hypercalcaemia has been postulated 
to impair the renal response to VP (Taylor 2000), which may be explained by 
downregulation of AQP2 (Wang et al. 2002). In humans, a raised serum calcium 
concentration prompts reciprocal changes in the secretion and action of VP. On the 
one hand, high calcium concentrations diminish the sensitivity of the antidiuretic 
response to VP, and on the other they increase the sensitivity of the VP secretory 
response to osmotic stimulation (Weiss and Robertson 1985). 
 
2.9 Hyperaldosteronism 
Primary hyperaldosteronism may lead to hypokalaemia, 
hypophosphataemia, alkalosis, and PUPD (Rijnberk et al. 2001). An elevated 
plasma aldosterone concentration and a low plasma renin activity are suggestive of 
primary hyperaldosteronism, which may be caused by an aldosterone-producing 
adrenal adenoma or idiopathic adrenocortical hyperplasia. In the dog, both VP 
resistance and an increased osmotic threshold of VP release may play a role in the 
development of polyuria, similar to the situation in glucocorticoid excess (Rijnberk 
et al. 2001). In experimental animals, hypokalaemia leads to a form of acquired 
nephrogenic diabetes insipidus due to downregulation of renal AQP2 (Marples et 
al. 1996, Amlal et al. 2000). Aquaporin-2 downregulation may play a role in the 
VP resistance seen in primary hyperaldosteronism in the dog. 
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2.10 Polycythaemia 
Polycythaemia is characterised by an increase in the packed cell volume, 
and can be classified into secondary polycythaemia and polycythaemia vera. 
Polycythaemia vera is a myeloproliferative disorder which results from the 
proliferation of pluripotential stem cells in the bone marrow, leading to an 
increased red cell mass and variable increases in granulocytes and platelets (De 
Wolf et al. 1992). Secondary polycythaemia is the consequence of excessive 
production of erythropoietin, which in companion animals is most often associated 
with renal lesions (Campbell 1990). The clinical signs may include erythema of 
mucous membranes, bleeding diatheses, disturbances of the central nervous 
system, and PUPD (Peterson and Randolph 1983). Many of these clinical 
manifestations may be related to the increased red blood cell mass, which causes 
hyperviscosity of the blood and an increased blood volume, but the exact 
mechanism leading to polyuria is as yet unclear (Peterson and Randolph 1983, 
Campbell 1990). 
 
2.11 Syndrome of inappropriate VP release (SIADH) 
In this rare syndrome, the high VP secretion is considered inappropriate 
because it occurs in the presence of plasma hypo-osmolality (Zerbe et al. 1980). 
The hypotonicity leads to generalised cellular edema, and potentially hypotonic 
encephalopathy. In humans, water excretion is impaired in SIADH, and urine 
osmolality (Uosm) is inappropriately high for the concomitant Posm. Similar 
findings have been reported in dogs with SIADH (Fleeman et al. 2000, Brofman et 
al. 2003), although others have reported a somewhat paradoxical PUPD as an 
important clinical feature of SIADH (Rijnberk et al. 1988). This polyuria can be 
explained by downregulation of renal receptors due to chronic exposure of the 
kidney to increased VP levels (Rijnberk et al. 1988, Rijnberk 1996a). 
 
2.12 Central diabetes insipidus 
Diabetes insipidus refers to the passage of large quantities of dilute urine, 
and is synonymous with polyuria. In central diabetes insipidus, polyuria results 
from a complete or partial deficiency in VP synthesis or secretion. Besides an 
idiopathic form, possible causes include primary or metastatic neoplasia involving 
the hypothalamus or the posterior pituitary gland, trauma to the skull, and pituitary 
surgery (Taylor 2000). In humans at least 30 different mutations in the gene 
encoding for the hypothalamic precursor protein (prepro-VP-neurophysin) have 
been described to cause a familial form of central diabetes insipidus (Calvo et al. 
1999, Siggaard et al. 1999). The major manifestations of central diabetes insipidus 
are insatiable polydipsia and voluminous polyuria, besides symptoms due to the 
underlying cause (Rijnberk 1996a). 
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2.13 Nephrogenic diabetes insipidus 
Nephrogenic diabetes insipidus is a disorder in which the kidney tubules 
are insensitive to VP. Many of the above-mentioned causes of polyuria, such as 
hyperadrenocorticism and hypercalcaemia, seem to be characterised by secondary 
nephrogenic diabetes insipidus, also termed acquired nephrogenic diabetes 
insipidus. Primary or congenital nephrogenic diabetes insipidus is a rare condition 
in dogs (Takemura 1998), and may be due to a mutation affecting the affinity of the 
renal V2-receptor (Luzius et al. 1992). In humans, besides mutations in the VP 
receptor gene (Pasel et al. 2000), primary nephrogenic diabetes insipidus may also 
be caused by mutations in the AQP2 gene, leading to impaired routing of the water 
channel and its subsequent degradation (Deen et al. 1994, Marr et al. 2002). 
 
 
3. Diagnostic approaches 
 
Several causes of PUPD, such as glucosuria, hypercalcaemia, and renal 
failure, may be detected by a thorough medical history and physical examination, 
followed by blood and urine examination. Depending on these results, more 
specific examinations, such as diagnostic imaging (uterus, adrenal glands, liver, 
kidneys), thyroid scintigraphy, and/or measurements of urinary corticoid/creatinine 
ratios, may be necessary to establish the final diagnosis.  
When physical and laboratory examinations do not identify a definite cause 
for polyuria, the next diagnostic step is the modified water deprivation test. In this 
indirect test for VP secretory capacity, Posm is increased by water deprivation to 
stimulate VP release. The effect is measured indirectly, by measurements of Uosm 
during the test. At the end of the water deprivation test, exogenous VP is 
administered and its effect on Uosm is determined (Mulnix et al. 1976). Although 
it may be possible to distinguish complete central diabetes insipidus, complete 
nephrogenic diabetes insipidus, and primary polydipsia, the result of the water 
deprivation test is not always conclusive (Biewenga et al. 1987).  
 Measurement of plasma VP concentration during osmotic stimulation with 
hypertonic saline constitutes a direct method to assess VP release (Biewenga et al. 
1987). In humans, this test is considered the “gold standard” for the diagnostic 
interpretation of polyuria (Diederich et al. 2001). Especially differentiation 
between partial forms of central diabetes insipidus, nephrogenic diabetes insipidus, 
and SIADH may be possible during hypertonic saline infusion. However, chronic 
dehydration and overhydration may alter the VP response to hypertonicity (Moses 
and Clayton 1993, Moses and Scheinman 1993), and this effect must be taken into 
account when interpreting the results of the hypertonic saline infusion test. 
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Abstract 
 
Urine specific gravity (Usg) and urine osmolality (Uosm) are used 
routinely to assess renal concentrating ability, but limited data on these variables 
are available for healthy dogs. Consequently, we studied the intra- and 
interindividual variations in Usg and Uosm in healthy dogs as well as the influence 
of age and gender on these variables. 
Dogs were selected for health and anestrus in females through the use of a 
detailed questionnaire. Eighty-nine owners collected morning and evening urine 
samples from their dogs on 2 consecutive days. In 8 dogs in which the Uosm of 
different samples varied more than 50%, owners collected urine for 24 hours at 2-
hour intervals during the day and at 4-hour intervals at night. The possible effect of 
changes in adrenocortical function with age was assessed by measurements of 
urinary corticoid/creatinine ratios. 
Among all samples, Uosm ranged from 161 to 2830 mOsm/kg and Usg 
from 1.006 to >1.050. In the morning, Uosm (1541 ± 527 mOsm/kg, range 273 – 
2620 mOsm/kg) and Usg (1.035 ± 0.010, range 1.009 - >1.050) were higher than in 
the evening (Uosm: 1400 ± 586 mOsm/kg, range 161 – 2830 mOsm/kg; Usg: 1.031 
± 0.012, range 1.006 - >1.050). The interindividual coefficient of variation in 
Uosm was 34.2% for morning urine samples and 41.9% for evening samples. In 8 
dogs with large differences in urine concentration, there were 2- to 3-fold increases 
or decreases in Uosm during the day, and the intraindividual coefficient of 
variation was 33.0%. There was no relation between gender and urine 
concentration. Urine concentration in both the morning and evening samples 
decreased with age. Urinary corticoid/creatinine ratios did not change with age. 
It can be concluded that Uosm and Usg vary widely among healthy dogs. 
Urine concentration is generally lower in the evening than in the morning and is 
not related to gender. Urine concentration decreases with age, and this cannot be 
ascribed to an associated increase in endogenous corticoids. 
In some dogs, Uosm varies widely during the day, with an intraindividual 
coefficient of variation approaching the interindividual coefficient of variation. 
This may be regarded as biologic variation but also could represent an early 
undiagnosed clinical abnormality. 
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Introduction 
 
Urinary concentrating capacity depends on the ability of the hypothalamic 
osmoreceptors to respond to changes in plasma osmolality, the ability of the atrial 
and carotid bifurcation baroreceptors to respond to changes in blood pressure or 
blood volume, and the release of the antidiuretic hormone vasopressin (VP) from 
the neurohypophysis. In addition, medullary hypertonicity must be generated and 
maintained, and there must be an adequate number of functional nephrons with an 
appropriate response to VP (Chew and DiBartola 1989, Reeves and Andreoli 
1992). 
In the healthy dog, urine osmolality (Uosm) values as low as 50 mOsm/kg 
are reached after infusion of large quantities of water, i.e., in the absence of VP 
(Schrier and Berl 1972, Schrier et al. 1972, Anderson et al. 1974, 
Cadnapaphornchai et al. 1974). In states of dehydration, urine specific gravity 
(Usg) and Uosm are increased to as much as 1.076 and 2738 mOsm/kg, 
respectively (Hardy and Osborne 1979). 
Urine specific gravity and Uosm are used to assess the ability of the renal 
tubules to concentrate or dilute glomerular filtrate (Stevens and Osborne 1974). 
Randomly collected urine samples from normally hydrated dogs are reported to 
have Usg values ranging from 1.015 to 1.045, whereas Uosm values usually vary 
between 500 and 1200 mOsm/kg (Bloom 1960, Doxey 1971, Osborne et al. 1972, 
Coles 1974, Stevens and Osborne 1974, Bush 1975, Bovee 1984). 
There appears to be a high degree of individual biologic variability in Usg 
or Uosm values of urine samples obtained at different times of the day from the 
same dog (Bovee 1969, Chew and Dibartola 1989). Therefore, a single urine 
sample may be misleading, and a second sample or a series of samples should be 
obtained to confirm any abnormality (Doxey 1971, Bush 1975, Bovee 1984). A 
Usg value of 1.025 or more has been considered evidence of adequate renal 
concentrating ability (Hardy and Osborne 1979, Finco 1989). 
Over the years, these statements, which have appeared in textbooks and 
which are based on clinical experience and not substantiated by investigatory data, 
have been used as guides for the assessment of urinary concentrating ability. 
Except for one report of 20 dogs (Hardy and Osborne 1979), there has been no 
systematic study of Uosm and Usg in healthy pet dogs. Also, the effects of gender 
and age on Usg and Uosm values have not been investigated in normal pet dogs. 
This study was designed to investigate the influence of age and gender on 
Uosm and Usg and the fluctuation of these variables during the day in healthy pet 
dogs. Aged dogs have an elevated basal hypothalamic-pituitary-adrenocortical 
activity characterised by increased concentrations of adrenocorticotrophic hormone 
(ACTH) and cortisol in plasma and increased urinary corticoid excretion 
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(Rothuizen et al. 1993). Consequently, we also measured urinary 
corticoid/creatinine (C/C) ratios in the dogs in this study to evaluate the possible 
effect of increased corticoid production on renal concentrating ability (Joles et al. 
1980, Biewenga et al. 1991). 
 
 
Materials and Methods 
 
Animals 
Thirty-four male (5 castrated) and 55 female (27 spayed) dogs, ranging in 
age from 6 months to 15.4 years, were investigated. The sample population 
consisted of 21 mongrel dogs and 68 pure-bred dogs comprising 31 different 
breeds. Among the breeds represented were 8 Labrador Retrievers, 5 Golden 
Retrievers, 5 Bouviers des Flandres, and 5 Border Collies. Other breeds were 
represented by 4 or fewer dogs. 
The dogs were judged to be healthy according to the information provided 
by their owners in a detailed questionnaire. Dogs were included when there had 
been no signs of polyuria, polydipsia, or urinary incontinence during the past 3 
months and when there had been no signs of illness or any treatment that could 
influence urinary concentrating ability. Furthermore, only anestrous female dogs 
were included. The questionnaire also provided information on the availability of 
food during the day and the composition of the food. 
 
Urine collection 
On 2 consecutive days, owners collected 4 urine samples by free catch: 2 in 
the morning during the first walk and 2 in the evening during the last walk, 
resulting in 4 urine samples per dog. In 8 dogs with variations in Uosm values of 
>50%, the owners collected urine at 2-hour intervals during the day and at 4-hour 
intervals at night for a period of 24 hours. 
 
Methods 
In all urine samples, Usg was measured in duplicate by refractometry 
(Clinical table refractometer, Atago, Tokyo, Japan). Urine osmolality was 
determined in duplicate by freezing point depression (Cryostatic osmometer 030, 
Gonotec GmbH, Berlin, Germany). One urine sample from each dog was examined 
for the presence of glucose by a dipstick method (TES-TAPE, Eli Lilly and Co, 
Indianapolis, USA). In 176 morning urine samples and in the urine samples 
collected during 24 hours in 4 dogs, C/C ratios were determined as described 
previously (Stolp et al. 1983, Rijnberk et al. 1988). 
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Statistical analysis 
Values are expressed as mean ± SD. The significance of changes in Uosm, 
Usg and C/C ratio with age was examined by linear regression analysis. The 
interindividual variation in Uosm of morning and evening urine samples and the 
intraindividual variation in Uosm of urine samples collected during 24 hours were 
expressed by coefficients of variation. Inter- and intraindividual differences were 
tested with unpaired and paired, two-tailed Student's t-tests, respectively. A P value 
<0.05 was considered significant. In 27 dogs, Usg of one or more samples 
exceeded the upper scale limit of the refractometer (1.050), and Usg values of these 
samples were not used for further analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Relation between age and urine osmolality (Uosm) in 89 healthy pet dogs, in 
which Uosm was measured on 2 consecutive days in morning samples (left panel) and 
evening samples (right panel). Regression lines ± 2SD are shown: 
Y = 1809 - 50.0X, r=0.36 (P<0.001), n=178 (left panel) 
Y = 1764 - 67.8X, r=0.44 (P<0.001), n=178 (right panel) 
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Results 
 
The Uosm of morning samples ranged from 273 to 2620 mOsm/kg, 
whereas the Uosm values of evening samples ranged from 161 to 2830 mOsm/kg. 
The Uosm of morning samples (1541 ± 527 mOsm/kg) was significantly higher 
than that of evening samples (1400 ± 586 mOsm/kg) (P<0.001). Neither the Uosm 
of morning samples of 2 consecutive days nor the Uosm of 2 evening samples 
differed significantly. The interindividual coefficients of variation for Uosm of 
morning and evening samples were 34.2% and 41.9%, respectively. The Uosm of 
both morning and evening samples decreased significantly with age (P<0.001, 
Figure 1). 
The morning Uosm of male (1522 ± 427 mOsm/kg) and female (1553 ± 
539 mOsm/kg) dogs did not differ significantly. Also, the Uosm values of evening 
samples of male (1309 ± 531 mOsm/kg) and female (1456 ± 562 mOsm/kg) dogs 
were not significantly different. 
The Usg of morning samples of all dogs ranged between 1.009 and >1.050 
and that of the evening samples between 1.006 and >1.050. The 27 dogs in which 
Usg of one or more samples was >1.050 were significantly younger than the 
remaining 62 dogs (P<0.001). After excluding the samples of these 27 dogs, 
analysis of data from the remaining 62 dogs showed a significant decrease in Usg 
of the evening samples with age (P<0.001, Figure 2), but no relationship was found 
between age and Usg of morning samples. In these 62 dogs, the Usg of the 
morning samples (1.035 ± 0.010) was significantly higher than the Usg of the 
evening samples (1.031 ± 0.012) (P<0.001). Neither the Usg of the 2 morning 
samples nor the Usg of the 2 evening samples differed significantly. 
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Figure 2. Relation between age and 
urine specific gravity (Usg) in 62 
healthy pet dogs, in which Usg was 
measured in evening samples on 2 
consecutive days. The regression line ± 
2SD is shown: 
Y = 1.037-0.0009X, r=0.31 
(P<0.001), n=124 
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In the 8 dogs that were sampled frequently because of the large variation in 
Uosm of different samples, 2- to 3-fold increases or decreases in Uosm often 
occurred within 2 hours (Figures 3 and 4). After a meal, Uosm decreased as often 
Figure 3. Fluctuation of urine osmolality 
(Uosm, upper panel) and the urinary
corticoid/creatinine ratio (C/C ratio, lower 
panel) during the day in a 9.5-year-old 
castrated male schnauzer (closed circle, 
dotted arrow) and a 7.5-year-old female 
Belgian shepherd (open square, 
uninterrupted arrow). Arrows indicate 
feeding times. 
Figure 4. Fluctuation of urine osmolality 
(Uosm, upper panel) and the urinary 
corticoid/creatinine ratio (C/C ratio, lower 
panel) during the day in a 2.5-year-old 
male Border collie (closed circle, dotted 
arrow) and a 12.5-year-old castrated 
female longhaired German pointer (open 
square, uninterrupted arrow). Arrows 
indicate feeding times. 
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as it increased. The mean intraindividual coefficient of variation for Uosm was 
33.0%. 
The C/C ratios measured in the morning samples of 88 dogs ranged 
between 0.3 x 10-6 and 8.3 x 10-6, with a mean of 2.9 x 10-6 (± 1.4 x 10-6). The 
mean of the C/C ratios measured in the 2 morning samples did not change 
significantly with age (Figure 5). In the dogs with large intraindividual variations 
in Uosm in which measurements were made frequently during 24 hours, the C/C 
ratios varied with Uosm in some, whereas in others the ratios changed very little 
(Figures 3 and 4). Glucose was not found in any of the urine samples examined. 
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Discussion 
 
In 1775, De Beaumarchais (French author, 1732-1799) stated, "Boire sans 
soif ... c'est ce qui distingue l'homme des autres animaux." (Drinking without thirst 
... is what distinguishes man from other animals.) Similar statements have been 
made by Adolph (1939, 1947, 1950) and Guyton (1991). Adolph (1939, 1947, 
1950) demonstrated that after water deprivation, dogs do not drink an amount 
greater than the measured deficit: "In no instance is water ingested voluntarily in an 
excess sufficient to give rise to water diuresis, and in no instance is water excreted 
in a diuresis that gives rise to water drinking" (Adolph 1950). 
In contrast to these statements and reports, we found large intra- and 
interindividual variations in Uosm and Usg in healthy pet dogs. The ranges of Usg 
(1.006 - >1.050) and Uosm (161 - 2830 mOsm/kg) found among the 89 dogs 
Figure 5. Relation between age 
and the mean urinary 
corticoid/creatinine (C/C) ratio in 
2 consecutive morning samples 
from 88 healthy pet dogs. 
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examined are also considerably larger than those reported in current veterinary 
textbooks for normally hydrated dogs (Bloom 1960, Doxey 1971, Osborne et al. 
1972, Coles 1974, Stevens and Osborne 1974, Bush 1975, Bovee 1984). 
There are very few publications addressing Uosm as a measure of renal 
concentrating ability (Bovee 1969). Hardy and Osborne (1979) found Uosm values 
ranging from 976 to 2546 mOsm/kg and Usg values ranging from 1.023 to 1.064 in 
20 healthy experimental dogs with free access to water. Our results exceed these 
values at both ends of the range. 
The differences in Uosm and Usg between morning and evening samples 
were significant, whereas those between the morning or evening samples of 2 
consecutive days were not. The lower values in the evening urine samples could 
reflect differences in water intake between day and night. 
A significant decrease in Uosm and in evening Usg occurred with aging. It 
has been reported that Usg and Uosm have excellent correlation (Hendriks et al. 
1978, Van Vonderen et al. 1995), so a significant decrease in morning Usg with 
age also would have been expected. The absence of such a decrease may have 
resulted from the fact that Usg values in 27 younger dogs could not be used in the 
analysis because they exceeded the upper scale limit of the refractometer (1.050). 
Because Usg was higher in the morning than in the evening, omission of these high 
Usg values presumably had a great effect on the mean morning Usg, causing the 
decrease of morning Usg with age to be insignificant. 
Rothuizen et al. (1993) described an elevated basal hypothalamic-pituitary-
adrenocortical activity in aged dogs, characterised by increased concentrations of 
ACTH and cortisol in plasma and increased urinary corticoid excretion. In the 
present study, no effect of age on the C/C ratio was observed. A possible 
explanation for this discrepancy could be the fact that in the study by Rothuizen et 
al. (1993), samples were not collected at home but in the clinic (i.e., under stressful 
circumstances). In addition, the dogs used in the study by Rothuizen et al. (1993) 
were all relatively old (11 - 15 years). Our results agree with the range of C/C 
ratios in healthy dogs reported by Stolp et al. (1983). Thus, in the age range studied 
there was no evidence of increased adrenocortical function and, as a consequence, 
the decrease in urinary concentrating ability cannot be ascribed to increased 
corticoid production. 
Urinary concentrating ability decreases in senescent humans (Lindeman et 
al. 1966) and rats (Bengele et al. 1981, Beck et al. 1982). Apart from basal renal 
concentrating ability, maximum Uosm after water deprivation and that obtained 
after VP administration have been shown to decrease with advancing age in the rat 
(Miller 1985, Corman and Michel 1987, Geelen and Corman 1992). Furthermore, 
there is an increase in VP secretion with age in the rat (Frolkis et al. 1982, Fliers 
and Swaab 1983). These findings provide evidence that impaired renal 
Chapter 3 
 
51 
concentrating ability during aging in the rat is not a consequence of decreased VP 
release from the neurohypophysis, but rather a result of an age-associated reduction 
in renal responsiveness to VP (Bengele et al. 1981, Miller 1985, Geelen and 
Corman 1992). Increased secretion of VP in the aging rat could also be a 
consequence of impaired renal concentrating ability, with water loss and resultant 
hypovolaemia leading to stimulation of VP release (Miller 1985). Conversely, it is 
possible that increased VP secretion is a primary event, resulting from aging effects 
on the central nervous system and hypothalamus, leading to downregulation of 
renal membrane receptors for VP (Miller 1985). 
Although VP secretion also increases with aging in humans (Kirkland et al. 
1984, Lucassen et al. 1994), impaired renal concentrating ability has not been 
reported to be caused by a decrease in the renal response to VP, but rather by a 
decrease in glomerular filtration rate (GFR) and renal blood flow (RBF) during 
aging (Lewis and Alving 1938, Lindeman et al. 1960). It is indeed well established 
that GFR and RBF decrease with age in humans (Hollenberg et al. 1974). 
Furthermore, it has been demonstrated in dogs (Levinsky et al. 1959) as well as in 
humans (Levitt et al. 1958, Gullick and Raisz 1960) that a decline in GFR leads to 
a decrease in urine concentration. 
In some dogs, a large intraindividual variation in urine concentration was 
found. Two- to 3-fold increases or decreases in Uosm often occurred within 2 
hours. In these dogs, there was no relationship between urinary corticoid excretion 
and Uosm. A possible explanation for fluctuation in Uosm during the day could be 
the effect of activity on drinking behaviour. During the day drinking is associated 
with the activity of dogs, and water intake is larger in active dogs than in quiet 
dogs (O’Connor 1975, Golob et al. 1977), although drinking stops before the 
ingestion of enough water to cause a water diuresis (O’Connor 1975). 
Another factor responsible for the fluctuation in Uosm during the day 
could be the effect of feeding on drinking behaviour. Some researchers have found 
a very close temporal relationship between eating and drinking (Adolph 1939, 
Ardisson et al. 1975, Fitzsimons 1979). At least 70% of the total intake of water is 
consumed just before, during, and immediately after meals (Fitzsimons 1979). 
Golob et al. (1977) reported that the amount of protein and carbohydrate in the 
meal is the major factor determining the postprandial water intake. Other reports 
indicate, however, that feeding and drinking evolve according to independent 
circadian rhythms (Ardisson et al. 1975, Fitzsimons 1979). In our dogs, Uosm 
decreased as often as it increased after a meal, so that it is unlikely that the 
fluctuation in Uosm during the day can be explained solely by the effect of feeding 
on drinking behaviour. 
In dogs, an early satiation of thirst occurs during drinking before any 
changes are detected in plasma osmolality, plasma volume, or blood pressure as a 
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result of absorption of water (Adolph 1939, 1950, Thrasher et al. 1981). This 
anticipatory response protects the dog from drinking an amount of water that would 
exceed its physiological need (Salata et al. 1987). Furthermore, plasma VP 
concentration decreases significantly in dogs within 6 minutes after drinking, in the 
absence of changes in plasma composition (Thrasher et al. 1981, 1987). Similar 
findings have been reported in humans (Salata et al. 1987, Geelen et al. 1984). 
Stimulation of oropharyngeal receptors by the ingestion of water probably leads 
both to the initial inhibition of VP secretion and the temporary satiety after 
drinking (Thrasher et al. 1981, Geelen et al. 1984, Salata et al. 1987, Thrasher et 
al. 1987). Nevertheless, our observations indicate that these mechanisms do not 
prevent all dogs from drinking excessive amounts of water. In some dogs, drinking 
behaviour led to large fluctuations in Uosm, although apparently not to such a 
degree that the owners perceived the dogs to be polydipsic or polyuric. It may very 
well be that in more pronounced cases the iatrotropic threshold is surpassed, and 
the animals are presented to the veterinarian because of polyuria and polydipsia. 
It does not seem appropriate to present reference values for Uosm and Usg 
in dogs, because the range found in healthy dogs is extremely wide. A low Usg in 
one urine sample does not exclude the possibility of finding a high Usg in another 
sample. Therefore, a low Usg does not automatically indicate polyuria and 
polydipsia of pathological origin. Whenever the suspicion of polyuria and 
polydipsia arises, urine samples should be collected every 2 hours to measure 
Uosm. Also in humans it is now recognised that Uosm should be established by 
repeated measurements, and that this approach may prevent further clinical 
evaluation (Mevorach et al. 1995). 
It can be concluded that Uosm and Usg vary widely among dogs. In 
general, Uosm is lower at night than in the morning. In some dogs, Uosm varies 
widely during the day, with an intraindividual coefficient of variation approaching 
the interindividual coefficient of variation. There are no differences in Uosm values 
related to gender. The decrease in Uosm with age cannot be ascribed to an 
associated increase in corticoid production. 
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Abstract 
 
In dogs, secondary polycythaemia (SP) may be associated with polyuria 
and polydipsia (PUPD). The pathogenesis of this PUPD has not yet been explained. 
We hypothesised that hyperviscosity and increased blood volume in SP might 
affect vasopressin (VP) release, resulting in PUPD. This hypothesis was tested in 
two dogs with SP caused by renal neoplasia, PUPD being the main presenting 
problem. Osmoregulation of VP release was studied by a water deprivation test and 
by investigating the VP response to hypertonic saline infusion. 
Water deprivation test results were consistent with an inability to produce 
concentrated urine despite increasing plasma osmolality. During hypertonic saline 
infusion, the osmotic threshold of VP release was markedly increased in both dogs, 
resulting in a delayed VP response to increasing plasma osmolality. The sensitivity 
of VP release was low normal in both dogs. We conclude that blood hyperviscosity 
and increased blood volume led to impaired VP release and polyuria. 
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Introduction 
 
Polycythaemia is characterised by an increase in packed cell volume 
(PCV), red blood cell (RBC) count, and hemoglobin concentration (Brodsky 1980, 
Peterson and Randolph 1983). Based on its pathogenesis, polycythaemia can be 
classified as relative polycythaemia (RP), secondary polycythaemia (SP), or 
polycythaemia vera (PV). 
Relative polycythaemia is the result of severe dehydration and disappears 
after correction of the fluid imbalance (Jain 1986, Drazner 1989, Giger 1992). 
Polycythaemia vera is a myeloproliferative disorder that results from proliferation 
of pluripotential stem cells in the bone marrow, leading to an increased red cell 
mass and variable increases in granulocytes and platelets (De Wolf et al. 1992). 
Secondary polycythaemia is the consequence of excessive production of 
erythropoietin (Epo) or other erythroid-stimulatory substances, such as androgens 
and adrenal steroids (Campbell 1990). Erythropoietin is produced primarily in the 
kidney, probably in interstitial or capillary endothelial cells. Increased production 
of Epo can be physiologically appropriate (i.e., the result of poor tissue 
oxygenation), or it can be physiologically inappropriate (Brodsky 1980, Peterson 
and Randolph 1983). Poor systemic tissue oxygenation may be caused by 
circulatory or respiratory diseases or hemoglobinopathies (Jain 1986, Drazner 
1989). The most common cause of inappropriate SP in companion animal practice 
is the presence of space-occupying renal lesions such as cysts (Peterson and 
Randolph 1983, Drazner 1989), hydronephrotic lesions (Peterson and Randolph 
1983, Drazner 1989), chronic pyelonephritis (Waters and Prueter 1988), or renal 
neoplasia (Scott and Patnaik 1972, Peterson and Zanjani 1981, Nelson et al. 1983, 
Gorse 1988, Waters and Prueter 1988, Crow et al. 1995). Renal tumours associated 
with SP in the dog include adenocarcinoma (Scott and Patnaik 1972, Peterson and 
Zanjani 1981, Waters and Prueter 1988, Crow et al. 1995), lymphosarcoma 
(Nelson et al. 1983), and fibrosarcoma (Gorse 1988). The space-occupying lesion 
causes local changes in renal blood flow, leading to a decrease in renal tissue 
oxygenation (Berk 1992, Cowgill 1992, Swinney et al. 1992). In addition, 
unregulated secretion of Epo may occur from a neoplasm (Berk 1992, Cowgill 
1992, Swinney et al. 1992). In humans, polycythaemia also has been found to be 
associated with many non-renal tumours, including adrenal carcinoma, hepatoma, 
cerebellar hemangioblastoma, pheochromocytoma, and uterine leiomyoma (Golde 
et al. 1981, Conley 1987). In the dog, a nasal fibrosarcoma has been associated 
with SP (Couto et al. 1989). 
In the veterinary literature, Epo assays have been reported to differentiate 
PV from SP (Jain 1986, Drazner 1989, Campbell 1990). The increased PCV and 
plasma Epo concentrations in dogs with SP due to renal neoplasia have decreased 
after removal of the neoplasm (Peterson and Zanjani 1981, Waters and Prueter 
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1988). In humans (Erslev and Caro 1984, Conley 1987, De Wolf et al. 1992) and 
dogs (Cook and Lothrop 1994), there is considerable overlap of Epo concentrations 
among patients with SP and PV, and thus Epo assays have limited diagnostic value 
(De Wolf et al. 1992, Cook and Lothrop 1994). 
The clinical signs of PV and SP include erythema of mucous membranes, 
bleeding diatheses, and disturbances of the central nervous system (seizures, 
paraparesis, lethargy) (Gorse 1988, Crow et al. 1995). Many of these clinical 
manifestations are related to the increased RBC mass, which increases blood 
viscosity and expands blood volume (Peterson and Randolph 1983, Conley 1987). 
Hyperviscosity slows blood flow and expanded blood volume distends capillaries 
and small vessels, resulting in an increased risk of hypoxia, thrombosis, and 
rupture of these vessels (Peterson and Randolph 1983, Conley 1987). Another 
clinical sign reported in association with SP is polyuria/polydipsia (PUPD) (Scott 
and Patnaik 1972, Peterson and Zanjani 1981, Waters and Prueter 1988). It has 
been suggested that SP interferes with the ability of the kidneys to concentrate 
urine (Waters and Prueter 1988). 
As hyperviscosity and expansion of blood volume may have consequences 
for the release of vasopressin (VP), we investigated the osmoregulation of VP 
release in two dogs with SP due to renal neoplasia by measuring the VP response 
to hypertonic saline infusion. 
 
 
Materials and methods 
 
The VP response to hypertonic saline was investigated by intravenous 
infusion of 20% NaCl for 2 hours at a rate of 0.03 ml/kg body weight/min. Samples 
for measurement of plasma VP concentration, collected in EDTA-coated tubes 
placed in ice, and for plasma osmolality (Posm) were obtained from the jugular 
vein at 20-min intervals. Plasma osmolality was measured by freezing point 
depression immediately after collection of the samples. Plasma for measurement of 
VP was separated by centrifugation at 4°C and stored at -20°C until assayed for VP 
by radioimmunoassay (Biewenga et al. 1991). Nomograms for the relation between 
Posm and plasma VP have been described (Biewenga et al. 1987). The slope of the 
regression line was used to describe the sensitivity of the osmoregulatory system 
and the intercept with the 5 pmol/l line provided a measure of its threshold value 
(Biewenga et al. 1987). 
A water deprivation test was performed as described by Mulnix et al. 
(1976). Glomerular filtration rate (GFR) was determined from the plasma clearance 
of 99mtechnetium-diethylenetriaminepenta-acetate (99mTc-DTPA) (Van den Brom 
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and Biewenga 1981). Renography was performed for 20 minutes after intravenous 
injection of 99mTc-DTPA (Biewenga and Van den Brom 1985). Red cell mass 
(ml/kg body weight) was computed from the dilution of radioactivity, measured in 
a sample taken 1 hour after intravenous injection of 51Cr-labelled autologous 
erythrocytes (Sisson 1978).  
 
 
Case reports 
 
Dog 1 
A 9½-year-old, castrated male Old English sheepdog weighing 43 kg was 
referred to the Department of Clinical Sciences of Companion Animals of Utrecht 
University because of PUPD which began suddenly 2½ months before and exercise 
intolerance for 6 months. According to the owner, the dog was less active and had 
signs of caudal weakness.  
On physical examination the mucous membranes were noted to be brick 
red. No other abnormalities were observed. Laboratory findings included increased 
PCV, and slightly decreased plasma albumin concentration (Table 1). Urine 
specific gravity was 1.009. The diagnosis of absolute polycythaemia was 
confirmed by the finding of an increased red cell mass of 57 ml/kg (reference range 
25-50 ml/kg). The glomerular filtration rate was normal. On ultrasonography of the 
abdomen, there was a hypoechoic mass approximately 15 mm in diameter in the 
caudal pole of the right kidney and a much larger hyperechoic mass in the cranial 
pole. Cytologic examination of the ultrasonography-guided biopsies of the mass in 
the cranial pole of the right kidney revealed poorly differentiated malignant cells, 
possibly of neuro-epithelial origin. There was no evidence of pulmonary metastasis 
on thoracic radiography. 
During the water deprivation test, urine osmolality increased, but did not 
reach the level of normal concentrating capacity despite a marked loss of body 
weight (5%) and increase in Posm (from 310 to 320 mOsm/kg) (Figure 1). The VP 
response to hypertonic saline infusion was abnormal (Figure 2): The threshold 
value was 352 mOsm/kg (reference values 276-309 mOsm/kg), and the sensitivity 
of the VP response was 0.28 pmol/l per mOsm/kg (reference values 0.24-2.47 
pmol/l per mOsm/kg). Euthanasia was performed at the owners request, but 
necropsy was not permitted. 
 
Dog 2 
A 9-year-old castrated male Labrador retriever weighing 37.5 kg was presented 
because   of   PUPD,   lethargy,   and   weight   loss  for  four  weeks.  The  mucous 
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Table 1. Laboratory values of a 9.5-year-old Old English Sheepdog (dog 1), and 
a 9-year-old Labrador retriever (dog 2) on admission. 
 
Unit Reference ranges Dog 1 Dog 2
Packed cell volume l/l 0.42 - 0.57 0.77 0.79
Leucocytes 109/l 5.9 - 13.8 7.4 7.8
Platelets 109/l 150 - 400 256 228
Urea mmol/l 3.0 - 12.5 6.5 10.4
Creatinine µmol/l <60 + 1.2xBW 94 127
Glucose mmol/l 3.9 - 5.0 ND 3.9
Sodium mmol/l 141 - 149 145 147
Potassium mmol/l 3.6 - 5.0 4.5 4.3
Calcium mmol/l 2.2 - 3.0 2.70 2.47
Alkaline phosphatase U/l 25 - 117 21 29
Bile acids µmol/l <8 ND <8
Total protein g/l 54 - 70 69 49
Albumin g/l 25 - 37 23 16
Plasma osmolality mOsm/kg 295 - 320 316 ND
Urinary total protein g/l 0 - 0.56 0.12 2.01
Urinary corticoid/ x 10-6 <10 3.7 3.1
creatinine ratio
λo 0.0162 - 0.0238 0.0213 0.0214
ND=not done; BW=body weight; λo=rate constant of fractional turnover of
99mTc-DTPA (99mtechnetium-diethylenetriaminepenta-acetate)  
 
membranes and skin were hyperemic and the abdomen was tense. Laboratory 
findings included increased PCV, decreased plasma albumin concentration, and 
slightly increased plasma creatinine concentration (Table 1). Urine specific gravity 
was 1.008 and proteinuria was present. Ultrasonography of the abdomen disclosed 
a mass in the caudal pole of the right kidney. There was no evidence of pulmonary 
lesions on thoracic radiography. 
The animal was hospitalised for additional studies. Initial treatment 
consisted of reduction of the PCV to 51 % by three phlebotomies and replacement 
of 1365 ml of blood by lactated Ringer's solution. During the following days, the 
PCV increased again to 64 %. There were no signs of dehydration and Posm and 
plasma concentrations of creatinine, sodium, and potassium were within the 
reference range. Urine specific gravity was 1.005 and urine osmolality was 142 
mOsm/kg. The VP response to a hypertonic saline infusion was abnormal (Figure 
2): The threshold value was 336 mOsm/kg and the sensitivity of the response was 
0.28 pmol/l per mOsm/kg. Plasma clearance of 99mTc-DTPA was slightly 
decreased, but the fractional turnover of 99mTc-DTPA was normal indicating 
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normal GFR. The renogram revealed equal excretion of 99mTc-DTPA by both 
kidneys.  
After removal of the right kidney the dog recovered without complications. 
The tumour mass consisted of white lobulated, solid tissue and was well defined. A 
renal cell carcinoma with tubular, solid, and papillary growth patterns was 
observed on histological examination. By the day after surgery, the PCV had 
decreased to 53 % and remained at this level until the dog was discharged from the 
clinic one week later. Eight months postoperatively, the dog continued to do well 
without evidence of recurrence of the renal tumour or associated polycythaemia 
and PUPD. 
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Figure 1. Urine osmolality (Uosm) 
during a 12-hour water deprivation test 
in a 9.5-year-old castrated male Old 
English sheepdog with polyuria and 
polydipsia and secondary poly-
cythaemia due to a renal neoplasm. 
Figure 2. Relation between plasma 
vasopressin (VP) concentration and 
osmolality (Posm) in a 9-year-old 
castrated male Labrador retriever 
(dotted line) and a 9.5-year-old castrated 
male Old English sheepdog 
(uninterrupted line) with polyuria and 
polydipsia and secondary poly-
cythaemia due to renal neoplasia. The 
outlined area represents the range of 
responses to infusion of hypertonic 
saline in 11 healthy dogs (Biewenga et 
al. 1987). 
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Discussion 
 
This paper describes two dogs with SP due to renal neoplasia. In both 
dogs, PUPD was the main reason for the owners to seek veterinary help. In 
addition, there was loss of endurance. Only the condition of dog 2 required 
phlebotomy. Nevertheless, three days later when the additional studies were done 
the PCV was again abnormally high. In dog 2 red cell mass was not measured, but 
RP was considered unlikely because of the absence of clinical signs and laboratory 
features of dehydration. The remission of polycythaemia after nephrectomy 
provided evidence that the polycythaemia was caused by the neoplasm. 
In several dogs with SP due to renal cell carcinoma or chronic 
pyelonephritis, the disease was associated with PUPD (Scott and Patnaik 1972, 
Peterson and Zanjani 1981, Waters and Prueter 1988). Although PUPD may be a 
clinical feature in renal adenocarcinoma not associated with polycythaemia 
(Goldschmidt 1984), it also has been reported as a consequence of PV in the dog 
(Meyer et al. 1993) and the cat (Swinney et al. 1992). Therefore, it is likely that 
polycythaemia per se causes PUPD. 
In the water deprivation test performed in dog 1, the inability to produce 
concentrated urine provided indirect evidence for impaired osmoregulation of VP 
release and/or resistance at the level of the kidney. During hypertonic saline 
infusion, the osmotic threshold of VP release was markedly increased in both dogs, 
resulting in a delayed VP response to increasing Posm. The sensitivity of the VP 
response was just above the lower limit of the reference range in both dogs. 
The hallmarks of polycythaemia are blood volume expansion and 
hyperviscosity (Conley 1987). Increased blood volume may lead to atrial stretch 
and increased release of atrial natriuretic peptide (ANP) (Stokhof et al. 1994), 
which has been observed in two dogs with PV in our Department (unpublished 
data). This may result in PUPD, because ANP inhibits the water permeability 
response to VP in the renal collecting ducts (Dillingham and Anderson 1986). 
Furthermore, ANP inhibits basal as well as KCl-stimulated VP release (Obana et 
al. 1985, Iitake et al. 1986, Lee et al. 1987), which may explain the impaired VP 
release during hypertonic saline infusion in our dogs. 
Vasopressin release is controlled mainly by hypothalamic osmoreceptors 
and atrial and carotid bifurcation baroreceptors in order to maintain osmotic and 
fluid balance (Reeves and Andreoli 1992). The PUPD in the two dogs described 
here was very likely a consequence of delayed VP release, resulting in a decrease 
in permeability of the renal collecting ducts to water. Hyperviscosity and increased 
blood volume may have stimulated baroreceptors which consequently caused the 
delay in VP release. In humans (Robertson and Athar 1976) as well as in dogs 
(Quillen and Cowley 1983), hypervolaemia impairs the VP response to hypertonic 
saline infusion. In dogs with experimentally induced hypervolaemia the threshold 
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of VP release is increased and the sensitivity of the response is decreased (Quillen 
and Cowley 1983), similar to what was observed in the two dogs with SP described 
here. In conclusion, our observations in two dogs with SP indicate that the 
associated polyuria was at least partially the result of impaired VP release. 
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Abstract 
 
Primary polydipsia is characterised by a marked increase in water intake 
and secondary polyuria, and in dogs often is described as a behavioural problem or 
a psychological disorder. We describe 4 dogs with primary polydipsia, diagnosed 
on the basis of a water deprivation test, in which further examination included 
serial measurements of urine osmolality (Uosm) and plasma vasopressin (VP) 
measurements during water deprivation and hypertonic saline infusion. 
The dogs, ranging in age from 4 months to 4 years, all were presented for 
evaluation of polyuria and polydipsia. Physical examination, routine blood 
chemistry and urinalysis disclosed no specific cause for the polyuria. During serial 
measurements Uosm spontaneously reached high concentrations in 2 dogs, whereas 
in the other 2 dogs Uosm also fluctuated but on no occasion exceeded 1000 
mOsm/kg. Primary polydipsia was diagnosed when (1) Uosm exceeded 1000 
mOsm/kg at the end of the water deprivation test and (2) plasma osmolality did not 
exceed the upper limit of the reference range during testing. During water 
deprivation, plasma VP concentrations remained relatively low. The VP response 
to hypertonic saline infusion was abnormal, with an increased threshold value in 3 
dogs, an increased sensitivity in 2 dogs, and an exaggerated response in 1 dog. 
It is concluded that some dogs fulfilling current criteria for primary 
polydipsia produce concentrated urine spontaneously throughout the day in a 
pattern similar to what has been observed in healthy pet dogs. This finding can be 
regarded as diagnostic and precludes the need for a water deprivation test. During 
water deprivation, all 4 dogs produced highly concentrated urine in the face of low 
basal plasma VP concentrations. The observed abnormal VP release in response to 
hypertonic stimulation may be interpreted as a primary disturbance in the 
regulation of VP secretion, although it might also be the result of overhydration 
caused by a primary abnormality in drinking behaviour. 
Chapter 5 
 
74 
Introduction 
 
Polyuria and polydipsia (PUPD) are associated with a wide variety of 
endocrine and metabolic disturbances (Nichols 1992). In companion animal 
medicine, polyuria generally is defined as daily urine output of >50 ml/kg body 
weight per day, and polydipsia as fluid intake exceeding 100 ml/kg body weight 
per day (Dunn 1990, Meric 1995, Feldman and Nelson 1996). 
Water diuresis is expected when there is a disturbance in urine 
concentration. Urinary concentrating capacity depends on the ability of 
hypothalamic osmoreceptors to respond to changes in plasma osmolality (Posm), 
the ability of the atrial and carotid bifurcation baroreceptors to respond to changes 
in blood pressure or blood volume, and the release of the antidiuretic hormone 
vasopressin (VP) via the hypothalamic-neurohypophyseal axis. In addition, 
medullary hypertonicity must be generated and maintained, and there must be an 
adequate number of functional nephrons with an appropriate response to VP (Chew 
and DiBartola 1989, Reeves and Andreoli 1992). When one or more of these 
conditions is not fulfilled, polyuria ensues and is compensated by secondary 
polydipsia.  
On the other hand, it is possible that the polyuria is secondary to 
compulsive water drinking. Primary polydipsia has been defined as a marked 
increase in water intake which cannot be explained as a compensatory mechanism 
for excessive fluid loss (Dunn 1990). The resulting decrease in Posm causes 
suppression of endogenous VP release, and consequently secondary polyuria 
(Finco et al. 1979). The results of physical examination and routine blood and 
urine examinations are usually unremarkable, except for a marginally low Posm 
and hypostenuria (Bovee et al. 1987, Feldman and Nelson 1996). According to 
descriptions of primary polydipsia in textbooks, definitive diagnosis is based on a 
water deprivation test in which the patient is shown to have urinary concentrating 
ability comparable to that of healthy subjects (Hardy and Osborne 1980, Bush 
1988, Dunn 1990, Nichols 1992, Meric 1995, Feldman and Nelson 1996).  
In humans, primary polydipsia may result from a defect in the thirst center 
(dipsogenic polydipsia) or may be associated with mental illness (psychogenic 
polydipsia) (Robertson 1987, 1988). In dogs, primary polydipsia has been 
described both as a psychological disorder and a behavioural problem (Feldman 
and Nelson 1989, Nichols 1992, Meric 1995). Despite numerous descriptions in 
textbooks of primary polydipsia in dogs, there are only 2 reports of documented 
cases (Mulnix et al. 1976, Biewenga et al. 1987).  
In 1959, Barlow and De Wardener suggested that humans with primary 
polydipsia may have a defect in neurohypophyseal function causing impaired VP 
release. This suggestion was supported by Díes et al. (1961) who reported that 
some cases of primary polydipsia may represent a reversible type of diabetes 
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insipidus. Zerbe and Robertson (1981) found subnormal VP release during both 
water deprivation and hypertonic stimulation in several human patients with 
primary polydipsia. They concluded that these patients suffered from partial 
diabetes insipidus. Downward resetting of the osmoreceptors (Goldman et al. 
1988), downregulation of VP release in response to hypertonicity (Moses and 
Clayton 1993), impaired VP secretion to non-osmotic stimulation (Baylis et al. 
1981), and abnormal osmotic and non-osmotic thirst regulation (Thompson et al. 
1991) also have been claimed to be present in humans with primary polydipsia. 
Reports on VP secretion in dogs with primary polydipsia are somewhat 
contradictory. Feldman and Nelson (1996) state that VP secretion and renal 
responsiveness to VP are normal in dogs with primary polydipsia, but they 
presented no data to substantiate this statement. Results of indirect approaches not 
involving VP measurements by Mulnix et al. (1976) also suggested the presence of 
a normal hypothalamic-neurohypophyseal system in dogs with primary polydipsia. 
However, Biewenga et al. (1987) described 6 dogs in which primary polydipsia 
was found to be associated with impaired VP release during hypertonic saline 
infusion. 
In an attempt to determine whether or not disturbed VP release in response 
to osmotic and non-osmotic stimulation occurs in dogs with primary polydipsia, we 
measured plasma VP concentrations during both water deprivation and hypertonic 
saline infusion in 4 dogs with primary polydipsia selected according to criteria not 
involving VP measurements. 
 
 
Materials and methods 
 
Routine laboratory examination 
Routine blood examination included measurement of packed cell volume, 
total and differential leukocyte counts, and the following measurements in plasma: 
Posm and urea, creatinine, glucose, sodium (Na), potassium, calcium, phosphate, 
alkaline phosphatase, bile acids and thyroxine concentrations. In 2 morning urine 
samples collected at home by the owners, the corticoid/creatinine (C/C) ratio was 
determined as described previously (Stolp et al. 1983, Rijnberk et al. 1988a). 
Urinalysis included determination of specific gravity (Usg) by refractometry, pH, 
concentrations of total protein, glucose, and hemoglobin, and sediment 
examination. 
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Analytical methods 
Plasma osmolality (reference range 295 - 320 mOsm/kg) and Uosm were 
determined in duplicate by freezing point depression (Cryostatic Osmometer 030, 
Gonotec GmbH, Berlin, Germany). Plasma VP concentration (reference range 1 - 6 
pmol/l) was measured with an antibody against arginine-vasopressin and the 
method of the kit as purchased from Nichols Institute (Wijchen, The Netherlands), 
and validated for the dog (Hellebrekers et al. 1987, Biewenga et al. 1991). The 
detection limit was 1 pmol/l and the intra- and interassay coefficients of variation 
were 6 and 10%, respectively. 
 
Serial measurements of Uosm 
Owners collected urine at 2-hour intervals during the day and at 4-hour 
intervals during the night for a period of 24 hours. In dog 3, urine samples were not 
collected at night. Urine osmolality was determined in all urine samples. 
 
Water deprivation test 
A water deprivation test was performed after a period of 12 hours in which 
food was withheld but water remained available ad libitum (Mulnix et al. 1976). At 
the start of the test, water was removed and the dog was weighed. A blood sample 
was drawn from the jugular vein for determination of Posm and plasma VP and Na 
concentrations. The bladder was emptied by catheterisation and Uosm was 
determined. Every 2 hours, the dog was weighed, the bladder was emptied by 
catheterisation, and blood was collected. The water deprivation test was concluded 
when (1) body weight loss was >5% or (2) Uosm increased to at least 1000 
mOsm/kg. The diagnosis of primary polydipsia was made when Uosm exceeded 
1000 mOsm/kg during water deprivation while Posm did not exceed the upper limit 
of the reference range. 
 
Hypertonic saline infusion 
Hypertonic saline infusion was performed at least 2 days after the water 
deprivation test. Food was withheld for 12 hours but water was available ad libitum 
until the start of the test. The VP response to hypertonic saline was investigated by 
intravenous infusion of 20% NaCl for 2 hours at a rate of 0.03 ml per kg body 
weight per minute. Samples for measurement of plasma VP concentration, 
collected in EDTA-coated tubes placed in ice, and for Posm were obtained from 
the jugular vein at 20-min intervals. Plasma osmolality was measured immediately 
after collection of samples. Plasma for measurement of VP was separated by 
centrifugation at 4°C and was stored at -20°C until assayed for VP. Nomograms for 
the relation between Posm and plasma VP concentration have been described 
previously (Biewenga et al. 1987). Briefly, reference values for basal Posm and 
plasma VP were obtained from the calculation of the inner 90% confidence 
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intervals of the 2.5 and 97.5 percentiles of values of 25 healthy dogs, aged 2 - 12 
years (8 Beagles, 4 Bouviers, 1 Boxer and 12 mongrels). In 11 of these dogs, VP 
measurements were performed during osmotic stimulation with hypertonic saline. 
The slope of the regression line was used to describe the sensitivity of the 
osmoregulatory system (reference range 0.24 - 2.47 pmol/l per mOsm/kg) and the 
intercept with the 5 pmol/l line provided a measure of its threshold value (reference 
range 276 - 309 mOsm/kg) (Biewenga et al. 1987). The ranges for the values 
observed in the 11 healthy dogs are presented in the figure depicting the relation of 
VP to Posm (Figure 3). 
 
 
Results 
 
Dog 1 
A 4-month-old male Jack Russell terrier weighing 5.5 kg was admitted to 
the Department of Clinical Sciences of Companion Animals of Utrecht University 
for evaluation of PUPD and urinating in the house for a few days. Physical 
examination and routine blood and urine examination disclosed no abnormalities 
except for a Usg of 1.010. 
During serial measurements of Uosm, the urine was well concentrated 
early in the morning, in the evening and at night, but not during the day (Figure 1). 
During the water deprivation test, Uosm was >1000 mOsm/kg within 4 hours 
(Figure 2). The initial values of both Posm (299 mOsm/kg) and plasma Na (143 
mmol/l, reference range 141 - 149 mmol/l) were at the lower limits of their 
respective reference ranges. A small weight loss (2.2%) and slight increases in 
Posm and plasma Na concentrations occurred, but plasma VP concentration 
remained low during water deprivation. The VP response to hypertonic saline 
infusion was abnormal, with extremely high plasma VP concentrations. The 
osmotic threshold for VP secretion was normal (306 mOsm/kg), whereas the 
sensitivity of the VP response was increased (6.4 pmol/l per mOsm/kg) (Figure 3, 
upper panel). 
Eight months later, the dog’s drinking behaviour had returned to normal 
according to the owners. The polyuria and urinating in the house had ceased. 
However, in 2 more urine samples collected by the owners, Uosm was 1804 
mOsm/kg in the morning and 345 mOsm/kg in the evening. At the time of writing, 
the dog was 3 years of age and its drinking behaviour and micturition pattern were 
virtually unchanged, and the owners had learned to live with this peculiarity. 
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Figure 1. Serial measurements of 
urine osmolality (Uosm) in 4 dogs 
with polyuria and polydipsia: dog 1 
(open diamond), dog 2 (closed circle), 
dog 3 (open triangle) and dog 4 
(closed square).  
Figure 2. Results of a water 
deprivation test in a 4-month-old Jack 
Russell terrier with polyuria and 
polydipsia (dog 1). Upper panel: 
plasma osmolality (Posm, closed 
diamond) and plasma sodium 
concentration (Na, open diamond). 
Lower panel: urine osmolality (Uosm, 
closed diamond) and plasma 
vasopressin concentration (VP, open 
diamond).  
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Figure 3. Relation between plasma 
vasopressin (VP) concentration and 
osmolality (Posm) in 4 dogs with 
polyuria and polydipsia. Upper panel: 
dog 1 (open diamond) and dog 2 (closed 
circle). Lower panel: dog 3 (open 
triangle) and dog 4 (closed square). The 
outlined area represents the range of 
responses to infusion of hypertonic 
saline in 11 healthy dogs (Biewenga et 
al. 1987). 
Figure 4. Results of a water deprivation test 
in a 15-month-old Bernese mountain dog 
with polyuria and polydipsia (dog 2). Upper 
panel: plasma osmolality (Posm, closed 
circle) and plasma sodium concentration 
(Na, open circle). Lower panel: urine 
osmolality (Uosm, closed circle) and 
plasma vasopressin concentration (VP, 
open circle). 
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Dog 2 
A 15-month-old female Bernese mountain dog weighing 34.0 kg was 
presented for evaluation of PUPD and urinating in the house for 4 weeks. Physical 
examination disclosed no abnormalities. Results of routine laboratory examinations 
were within reference ranges except for a low Usg (1.007). During serial 
measurements of Uosm, urine concentration fluctuated at low values of osmolality 
(Figure 1). After only 2 hours of water deprivation, Uosm was >1000 mOsm/kg 
(Figure 4). A small loss of weight (2.2%) occurred and Posm and plasma Na and 
VP concentrations remained relatively stable at the upper limit of their reference 
ranges. The VP response during hypertonic saline infusion was abnormal (Figure 3, 
upper panel). The threshold value was abnormally high at 333 mOsm/kg, and the 
sensitivity was abnormally high at 2.93 pmol/l per mOsm/kg.  
Six months later, the owners reported that all problems had disappeared. 
Their repeated attempts to collect urine samples were unsuccessful. 
 
Dog 3 
A 1.5-year-old male beagle dog weighing 9.0 kg was presented for 
evaluation of PUPD. The dog was a laboratory dog used for stress and behavioural 
research, but during the examinations for PUPD no other tests were performed. 
Physical examination disclosed no abnormalities. Routine laboratory examinations 
disclosed a low plasma Na concentration (139 mmol/l), a low Posm (294 
mOsm/kg), and a low Usg (1.008). During the day large fluctuations in Uosm 
occurred (Figure 1). During the water deprivation test, the dog produced well-
concentrated urine after 6 hours (Figure 5). A slight loss of weight (2.8%) 
occurred, but very small changes in Posm or plasma Na concentrations were 
detected, both of which were at the lower limit of their reference ranges. After a 
high initial value (16 pmol/l), plasma VP concentration remained below the limit of 
detection during the water deprivation test. The VP response to hypertonic saline 
infusion was abnormal (Figure 3, lower panel). The starting value (20 pmol/l) was 
abnormally high and an increased threshold value (325 mOsm/kg) was detected, 
whereas sensitivity was normal (0.60 pmol/l per mOsm/kg). 
 
Dog 4 
A 4-year-old female Rottweiler dog weighing 42.5 kg was referred for 
evaluation of PUPD. Physical examination and routine laboratory examination 
disclosed no abnormalities except for a low Usg (1.015). During the day, Uosm 
was very low (Figure 1). Urine was more concentrated at night and early in the 
morning, but high Uosm values were not detected. During the water deprivation 
test, Uosm increased steadily, and after 6 hours time a value >1000 mOsm/kg was 
obtained (Figure 6). The loss of weight was 3% and there was a small increase in 
Posm, but plasma Na concentration changed very little. Both Posm and plasma Na 
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concentration were at the upper limit of their reference ranges. Plasma VP 
concentration remained below the level of detection. The VP response to 
hypertonic saline infusion was abnormal (Figure 3, lower panel). The plasma VP 
concentration (28 pmol/l) was high before the gradual rise in response to the 
increasing hypertonicity. The threshold value was abnormally high (331 
mOsm/kg), whereas sensitivity was normal (0.81 pmol/l per mOsm/kg). 
Three months later, the owners reported that the situation was unchanged. 
In 2 evening urine samples, Uosm was 1014 and 1365 mOsm/kg, and in 2 morning 
urine samples Uosm was 552 and 648 mOsm/kg. 
 
 
Discussion 
 
In dogs 1 and 3, Uosm reached high values spontaneously during serial 
measurements. In dogs 2 and 4, Uosm also fluctuated, but on no occasion exceeded 
1000 mOsm/kg. The large fluctuations in Uosm observed during serial 
determinations in dogs 1 and 3 were very similar to those found in some healthy 
dogs without PUPD (Van Vonderen et al. 1997). Apparently, water intake in dogs 
1 and 3 exceeded the variation observed in healthy dogs to such an extent that the 
owners sought veterinary help. These observations also indicate that a water 
deprivation test is not needed in all polyuric dogs. When pronounced fluctuations 
are found in Uosm during serial measurents and some Uosm values are >1000 
mOsm/kg, the diagnosis of primary polydipsia seems justified. 
Basal Posm and plasma Na concentration were subnormal or at the lower 
limit of the reference ranges in dogs 1 and 3, whereas in dogs 2 and 4 Posm and 
plasma Na were at the upper limit of normal. This observation suggests that dogs 
diagnosed as having primary polydipsia may comprise two groups, as has been 
reported for humans with primary polydipsia: polydipsic patients with and without 
hyponatraemia (Goldman et al. 1996). 
During water deprivation, both plasma VP concentration and Posm are known to 
increase markedly in healthy dogs (Szczepanska-Sadowska et al. 1983, Wade et al. 
1983). According to Reeves and Andreoli (1992), a 2% increase in Posm or a 10% 
decrease in effective circulating volume can cause stimulation of osmo- and 
baroreceptors, respectively, leading to detectable increases in VP release. In dog 1, 
plasma VP concentration was low to undetectable until there was a slight increase 
at the end of the period of water deprivation. This response appeared to be the 
result of increases in Posm and plasma Na concentration, although the values 
remained within the reference range. In dog 2, plasma VP concentration remained 
around the upper limit of the reference range during water deprivation, which 
agrees  with the relatively high Posm and plasma Na concentration in this dog. This 
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observation suggests some peripheral resistance to the effect of VP, although water 
deprivation rapidly led to an increase in Uosm. Apparently in dogs 3 and 4, the 
changes in body weight and Posm during water deprivation were not sufficient to 
Figure 5. Results of a water deprivation 
test in a 1.5-year-old beagle dog with 
polyuria and polydipsia (dog 3). Upper 
panel: plasma osmolality (Posm, closed 
triangle) and plasma sodium concentration 
(Na, open triangle). Lower panel: urine 
osmolality (Uosm, closed triangle) and 
plasma vasopressin concentration (VP, 
open triangle).  
Figure 6. Results of a water deprivation 
test in a 4-year-old Rottweiler with 
polyuria and polydipsia (dog 4). Upper 
panel: plasma osmolality (Posm, closed 
square) and plasma sodium concentration 
(Na, open square). Lower panel: urine 
osmolality (Uosm, closed square) and 
plasma vasopressin concentration (VP, 
open square). 
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cause measurable VP concentrations. Despite the low plasma VP concentrations, 
Uosm increased to >1000 mOsm/kg in all dogs, which supports the findings of 
Hellebrekers et al. (1989) that production of highly concentrated urine can occur 
with relatively low plasma VP concentrations (<5 pmol/l). 
Current criteria for the diagnosis of primary polydipsia do not seem to 
encompass a uniform syndrome. There is heterogeneity not only in basal Posm and 
plasma Na concentration, but also in the course of Uosm throughout the day and 
Posm and plasma Na concentration during water deprivation. Dogs 1 and 3 both 
reached Uosm values of 1500 mOsm/kg or more spontaneously during serial 
measurements, whereas during water deprivation Posm and plasma Na 
concentrations remained at the lower limit or in the middle of their reference 
ranges. In dogs 2 and 4, however, Uosm did not exceed 1000 mOsm/kg during 
serial measurements, whereas during water deprivation both Posm and plasma Na 
concentration were at the upper limit of their reference ranges. Also, the VP 
response to hypertonic saline infusion was not uniform, an increased threshold 
value was found in 3 dogs, an increased sensitivity in 2 dogs, and an exaggerated 
response in 1 dog.  
As mentioned above, plasma VP concentrations were low or unmeasurable 
during water deprivation in all dogs, but were apparently still sufficient to result in 
an increase in Uosm to >1000 mOsm/kg. In contrast, the osmotic threshold for VP 
release calculated during hypertonic saline infusion was increased in dogs 2-4, 
which suggests that insufficient VP concentrations occurred at the Posm values 
reached during water deprivation. A delayed VP response to osmotic stimulation 
therefore was combined with an adequate VP concentration for urinary 
concentration during water deprivation in these dogs, suggesting adequate response 
only to the combined action of the osmo- and baroreceptors. 
The abnormal VP response to stimulation of the osmoreceptors may 
indicate a primary disturbance in osmoreceptor function and regulation of VP 
secretion. Polyuria and polydipsia thus could be a result of impaired VP release to 
osmotic stimulation, as demonstrated in the dogs with an increased threshold value 
during hypertonic saline infusion. Conversely, chronic overhydration might 
downregulate VP release in response to hypertonicity (Moses and Clayton 1993). 
In this situation polydipsia is primary and leads to decreases in Posm and 
consequently to low or absent VP release. Moses and Clayton (1993) have reported 
decreased sensitivity and an increased threshold value for the VP response to 
hypertonic saline infusion in humans with primary polydipsia. These observations 
in humans are supported by other studies in humans (Robertson and Athar 1976) 
and by studies in dogs (Quillen and Cowley 1983), in which it was found that 
hypervolaemia or hypertension lead to a shift in the relationship of plasma VP 
concentration to Posm. This phenomenon may be an explanation for the increased 
threshold value found in 3 of the dogs described here. 
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Another explanation for the observations in dogs 1 and 3 could be a mild 
form of the syndrome of inappropriate VP secretion (SIADH). In both dogs, Posm 
and plasma Na concentrations were relatively low, which in SIADH is caused by 
persistent VP release in the absence of hypovolaemia or hypotension (Rijnberk et 
al. 1988b). In dog 1, the VP response to osmotic stimulation was extremely high, 
whereas in dogs 3 and 4 the initial VP concentrations during the hypertonic saline 
test were high, as was the initial result in the water deprivation test of dog 3. The 
latter finding suggests bursts of VP release unrelated to an osmotic stimulus, as has 
been observed in SIADH (Rijnberk et al. 1988b). 
As already mentioned above, in dogs 2 and 4 the situation was different. 
Their basal Posm and plasma Na concentrations were not low. During water 
deprivation, their Posm and plasma Na concentrations tended to exceed the 
reference ranges. The responsiveness of VP secretion to hypertonic saline 
stimulation was delayed, although in dog 4 early in the test, VP concentration was 
high, apparently out of proportion to the rise in Posm. The latter may indicate 
occasional erratic VP release, as has been observed in humans with primary 
polydipsia (Zerbe and Robertson 1981). However, in healthy dogs the linear 
relationship of plasma VP to Posm can be irregular in some individuals (Meij et al. 
1997). This observation might be a reflection of the pulsatile character of VP 
release (Redekopp et al. 1986, Livesey et al. 1988).  
We have demonstrated that dogs fulfilling the commonly accepted criteria 
of primary polydipsia may exhibit abnormalities of VP release. These 
abnormalities may include episodes of hypersecretion as well as delayed responses 
to plasma hypertonicity. It is not clear whether these changes in VP release are the 
result or the cause of PUPD. 
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Abstract 
 
Common disorders of water homeostasis leading to polyuria include a 
variety of endocrine, metabolic and renal disturbances. After exclusion of most of 
these conditions, there may remain the diagnostic dilemma of differentiating 
between central diabetes insipidus, primary polydipsia, and nephrogenic 
abnormalities. Here, we report on 18 young dogs with polyuria, in most cases since 
puppyhood. The conditions were categorised according to the plasma vasopressin 
(VP) response to hypertonicity. 
The VP response to osmotic stimulation was tested by intravenous infusion 
(0.03 ml per kg body weight) of 20% NaCl for 2 hours. The slope of the regression 
line was used to describe the sensitivity of the osmoregulatory system and the 
intercept with the 5 pmol/l line provided a measure of the threshold value. In all 
dogs the VP response was abnormal. Three categories could be distinguished: (a) a 
hyperresponse (n=3), (b) a hyporesponse (n=4), and (c) a non-linear response with 
high VP values unrelated to increases in plasma osmolality (n=11).  
When these categories were considered together with the results of other 
diagnostic procedures (serial measurements of urine osmolality, water deprivation, 
and response to desmopressin administration) it appeared that the VP response to 
hypertonicity did not consistently distinguish between different clinical entities. In 
the 9 dogs with variations in urine osmolality compatible with primary polydipsia, 
hyper-, hypo-, and non-linear responses were observed. The VP peaks of the 11 
dogs with non-linear responses might represent the erratic secretory bursts known 
to occur in the syndrome of inappropriate VP release. However, the early peaks in 
particular might also reflect the pulsatile release pattern of VP, which may be either 
physiological or induced by the hypertonicity. 
The present data question the generally accepted notion that VP 
measurements during hypertonic saline infusion form the “gold standard” for the 
diagnostic interpretation of polyuria. There is a need for in-depth studies of the 
peripheral reflection in plasma of the pulsatile VP release in healthy and polyuric 
individuals, with and without provocation. 
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Introduction 
 
In healthy individuals, water homeostasis is accurately controlled, so that 
plasma osmolality (Posm) and its principal determinant, plasma sodium (Na), are 
maintained within a narrow range. This control is achieved by close integration of 
the antidiuretic action of vasopressin (VP), which regulates water excretion, and 
the sensation of thirst, which governs water intake (Robertson 1984, McKenna and 
Thompson 1998). Disturbances of the secretion and/or action of VP, or of the 
regulation of thirst and drinking behaviour, can cause profound abnormalities in Na 
and water homeostasis (McKenna and Thompson 1998). 
In humans, the capacity to concentrate urine develops progressively during 
infancy, and the adult capacity is reached at approximately 18 months of age 
(Poláček et al. 1965). In rats, urinary concentrating capacity increases in parallel 
with the expression of aquaporin-2, the VP-dependent renal water channel and 
reaches adult levels between 4 and 6 weeks of age (Yasui et al. 1996). It has been 
postulated that a low expression and/or deficiency of aquaporin-2 is a factor 
underlying the low urinary concentrating capacity of infants (Yasui et al. 1996, 
Robertson 2001). Also in dogs there is a gradual increase in concentrating ability 
during infancy (Horster and Valtin 1971).  
Polyuria and polydipsia (PUPD) occur in a wide variety of endocrine and 
metabolic disorders, and may result from either water diuresis or solute diuresis 
(Nichols 1992). Polyuria in infancy and childhood usually indicates an underlying 
neurological, renal or metabolic disorder (Leung et al. 1991, Cheetham and Baylis 
2002). Primary polydipsia is a less common disorder, but may be more prevalent in 
young children than previously recognised (Joshi et al. 1987, Horev and Cohen 
1994, Matsumoto et al. 2000, Cheetham and Baylis 2002). It is not always easy to 
distinguish between central diabetes insipidus, primary polydipsia and polyuria of 
renal origin (nephrogenic diabetes insipidus) as causes of polyuria in children 
(Cheetham and Baylis 2002). The most powerful diagnostic tool for differentiation 
of these conditions is the hypertonic saline infusion test, with measurement of 
Posm and plasma VP concentration (Diederich et al. 2001), although the 
interpretation of the test results may pose problems (Moses and Clayton 1993).  
In this context, the dog deserves attention because many polyuric 
syndromes are known to occur in this species. In puppies these may include 
conditions such as hepatoencephalopathy due to a congenital portosytemic shunt 
and congenital renal dysplasia (Meric 1995, Lees 1996, Sterczer et al. 1998, Greco 
2001). Following exclusion of these conditions there may remain the differential 
diagnostic dilemma, similar to that described above for children, i.e., the distinction 
between central diabetes insipidus, primary polydipsia and nephrogenic 
abnormalities (Nichols 1992, Belshaw 1995, Greco 2001). There are no reports 
documenting these conditions with VP measurements in a series of polyuric young 
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dogs. In a preliminary report on four cases we suggested that what is called 
primary polydipsia may comprise several conditions, including 
hyperresponsiveness of VP release (Van Vonderen et al. 1999). 
In this report, we describe our observations in 18 young dogs presented 
with polyuria, in most cases since puppyhood. The dogs were categorised 
according to their VP response to hypertonicity. Apart from this test, the protocol 
included serial measurements of urine osmolality (Uosm) during ad libitum water 
intake with and without desmopressin administration, and a water deprivation test. 
 
 
Materials and methods 
 
Dogs 
Thirteen male and 5 female (2 spayed) dogs with PUPD, ranging in age 
from 3 to 32 months (median: 8 months), were studied. Three mongrel dogs and 15 
pure-bred dogs comprising 12 different breeds were included. Dogs were included 
when the history, physical examination and routine laboratory examination did not 
adequately explain the PUPD.  
In 13 dogs the owners had noticed the PUPD at the first arrival of their pet 
at 8-10 weeks of age, and in dog 4 at 8 months of age. In dogs 1, 3 and 7, the 
PUPD was first noticed at 14, 6, and 8.5 months, respectively. In dog 13, a 
laboratory dog, the onset of the PUPD was unknown. The owners of 8 dogs also 
reported in-house micturition. 
In all dogs physical examination revealed no abnormalities. Results of 
routine blood and urinary examination were unremarkable in 15 dogs, except for 
Uosm, which was low in all cases. Plasma Na concentrations in dog 5 (135 
mmol/l), dog 12 (136 mmol/l) and dog 13 (139 mmol/l) were below the reference 
range (141-149 mmol/l), as well as Posm values (dog 5: 281 mOsm/kg; dog 12: 
293 mOsm/kg; dog 13: 294 mOsm/kg; reference range 295-320 mOsm/kg). 
 
Serial measurements of Uosm 
In 14 dogs serial measurements of Uosm, at 2-hour intervals during the day 
and at 4-hour intervals at night for 24 hours, were performed during ad libitum 
water intake (Van Vonderen et al. 1997). Subsequently, seven dogs were treated 
with desmopressin (MinrinR, Ferring B.V., Hoofddorp, The Netherlands), 1 drop at 
8-hour intervals in the conjunctival sac for 4 days, and serial measurements of 
Uosm were repeated on the fourth day. The variation in Uosm was judged by 
determination of the factor between the highest and the lowest Uosm. The response 
to desmopressin was expressed as the absolute increase and the percentage increase 
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in mean Uosm. In 4 dogs Uosm was measured in a single urine sample before and 
after desmopressin administration, and in 3 dogs the response to desmopressin was 
tested at the end of the water deprivation test. The response to desmopressin was 
classified into 3 categories, namely, small (<25% increase in Uosm), medium (25-
75% increase), and large (>75% increase). 
 
Water deprivation test 
A water deprivation test was performed in all dogs, as described previously 
by Mulnix et al. (1976). Briefly, after an overnight fast the water bowl was 
removed, the dog was weighed, and basal urine and blood samples were collected 
for the determination of Uosm, Posm, and plasma VP and Na concentrations. This 
protocol was repeated every 2 hours until Uosm had increased to at least 1000 
mOsm/kg or had reached a plateau of 3 similar values. The water deprivation test 
was also terminated when body weight loss was >5%. Maximum urinary 
concentrating ability was divided into 4 categories: low (<500 mOsm/kg), low-to-
medium (500 to 750 mOsm/kg), medium-to-high (>750 to 1000 mOsm/kg), and 
high (>1000 mOsm/kg). 
 
Hypertonic saline infusion 
The VP response to osmotic stimulation was tested in all dogs by 
intravenous infusion of 20% NaCl for 2 hours at a rate of 0.03 ml per kg body 
weight per minute (Biewenga et al. 1987). Blood samples for the measurement of 
plasma VP concentration, collected in EDTA-coated tubes pre-chilled in ice, and 
for Posm were obtained from the jugular vein at 20-min intervals. Plasma 
osmolality was measured immediately after the collection of samples. Plasma for 
measurement of VP was separated by centrifugation at 4°C and was stored at -20°C 
until assayed. Nomograms for the relation between Posm and plasma VP have been 
described previously (Biewenga et al. 1987). The slope of the regression line was 
used to describe the sensitivity of the osmoregulatory system (reference range 0.24-
2.47 pmol/l per mOsm/kg), and the intercept with the 5 pmol/l line provided a 
measure of its threshold value (reference range 276-309 mOsm/kg). If the 
correlation coefficient of the regression line was less than 0.8, VP peaks were 
excluded from the regression analysis, and the VP response was termed non-linear 
(dogs 8-18).  
 
Vasopressin assay 
Vasopressin was extracted from plasma by the addition of 5.2 ml 96% 
ethanol (4°C) to 0.8 ml plasma, and incubation by end-over-end rotation for 30 min 
at 4°C. After centrifugation for 30 min at 5000xg and 4°C, the supernatant was 
collected and dried overnight using a speedvac vacuum concentrator. Extracts were 
dissolved in 0.8 ml assay buffer. The recovery of VP amounted to a mean value of 
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75 ± 1%. Vasopressin concentrations were measured by radioimmunoassay 
(Nichols Institute, Wijchen, The Netherlands), validated for the dog by measuring a 
serial dilution of an extract of canine plasma with a high VP concentration that 
resulted in a curve parallel to the standard curve. The detection limit was 1 pmol/l. 
The intra-assay coefficient of variation was 12% at 8 pmol/l, and the inter-assay 
coefficient of variation was 20% at 1.5 and 4 pmol/l, and 10% at 8.5 pmol/l. 
 
 
 
Table 1. Laboratory data collected during hypertonic saline infusion in 18 young polyuric 
dogs, categorised according to the plasma vasopressin (VP) response to hypertonicity. 
 
VP response Sex Age Osmotic Sensitivity Plasma VP VP peak Correlation coefficient
threshold S-E values values incl. VP excl. VP 
pmol/l per peaks peaks
months mOsm/kg mOsm/kg              pmol/l
Hyper-
response
dog 1 f 15 333 2.93 7-80 0.97 nd
dog 2 m 5 309 2.73 22-114 0.94 nd
dog 3 m 6 306 6.36 1-239 0.94 nd
Hypo-
response
dog 4 m 10 ns ns 1-0 ns nd
dog 5 f 4 318 0.42 1-16 0.98 nd
dog 6 m 8 321 0.21 1-12 0.93 nd
dog 7 fc 9 317 0.25 2-12 0.89 nd
Non-linear 
 response
dog 8 m 26 309 1.90 1-77 96 0.16 0.94
dog 9 m 8 314 0.68 1-35 34 0.67 0.98
dog 10 fc 32 ns ns 1-6 68/16 0.41 ns
dog 11 m 12 324 0.19 0.4-8 6.3 0.79 0.92
dog 12 m 4 318 0.13 2-8 14 0.22 0.95
dog 13 m 18 325 0.60 1-19 20 0.21 0.92
dog 14 m 8 324 0.37 1-15 10 0.73 0.95
dog 15 m 7 307 0.51 4-22 19 0.61 0.91
dog 16 m 25 299 0.22 5-15 20 0.25 0.91
dog 17 m 3 337 0.44 6-14 14 0.25 0.99
dog 18 f 3.5 314 0.58 27-24 115/32 0.47 0.99
Reference values 276-309 0.24-2.47 (1)
(1) Biewenga et al . (1987)
f=female; fc=female castrate; m=male; S-E value=start-to-end value; ns= not significant; nd= not done  
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Results 
 
Vasopressin hyperresponse 
Dogs 1-3 had a very high VP response to hypertonic saline infusion 
compared to the reference range obtained in healthy adult dogs (Table 1, Figure 1, r 
= 0.94 - 0.97). The osmotic threshold for VP secretion was increased in dog 1, 
whereas the sensitivity of the VP response was increased in all three dogs (Table 
1).  
In dog 1 Uosm varied by a factor of 2.2 during the day (Table 2). In dog 3 
Uosm varied considerably, with a factor of 7.4 between the highest and lowest 
Uosm value. In this dog Uosm reached values of >1000 mOsm/kg during basal 
serial measurements. In dog 1 the desmopressin response was not measured 
because high Uosm values were reached during water deprivation. The response to 
desmopressin in dog 2 was large. In dog 3 desmopressin was administered at the 
end of the water deprivation test and the response was small (Table 2). 
In dogs 1 and 3, Uosm exceeded 1000 mOsm/kg during water deprivation, 
with hardly any weight loss or increase in Posm and plasma Na concentration 
(Table 3). During water deprivation, dog 2 had a low-to-medium concentrating 
ability, with a large weight loss (8.2%), but hardly any increase in Posm. Plasma 
VP concentrations during water deprivation in dogs 1 and 3 varied at a low level 
(≤7 pmol/l). 
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Figure 1. Plasma vasopressin concentration during hypertonic saline infusion in a 6-month-
old Jack Russell terrier (dog 3) with polyuria and polydipsia, illustrating 
hyperresponsiveness. The outlined area represents the range of responses to infusion of 
hypertonic saline in 11 healthy dogs (Biewenga et al. 1987). VP = vasopressin; Posm = 
plasma osmolality. 
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Table 2. Laboratory data collected during serial measurements of urine 
osmolality (Uosm) in 18 young polyuric dogs, categorised according to the 
plasma vasopressin (VP) response to hypertonicity. 
 
VP response Minimum Maximum (Mean) Factor Desmopressin response
basal basal basal Absolute Percentage
Uosm Uosm Uosm (1) increase increase
mOsm/kg mOsm/kg
Hyper-
response
dog 1 371 823 496 2.2 nd nd
dog 2 nd nd 510 (1) nd 450 88 *
dog 3 223 1658 1168 7.4 249 17 **
Hypo-
response
dog 4 nd nd 113 (1) nd 639 565*
dog 5 467 836 682 1.8 0 0 *
dog 6 119 346 202 2.9 195 97
dog 7 390 1257 767 3.2 346 45
Non-linear 
 response
dog 8 88 1387 695 15.8 439 63
dog 9 87 308 141 3.5 188 133
dog 10 140 695 286 5.0 97 34
dog 11 266 1489 741 5.6 nd nd
dog 12 68 679 217 10.0 131 60
dog 13 157 1468 1044 9.4 108 10 **
dog 14 159 1482 975 9.3 nd nd
dog 15 229 503 379 2.2 nd nd
dog 16 nd nd nd nd 15 2 **
dog 17 nd nd 338 (1) nd 77 23 *
dog 18 169 308 237 1.8 93 39
(1) In dogs 2, 4, and 17 the starting point for measurement of desmopressin response 
in a single urine sample (dog 5: 445 mOsm/kg)
nd=not done; * measured in a single urine sample; ** measured after water deprivation  
 
 
Vasopressin hyporesponse 
In dogs 4-7 the VP response during hypertonic saline infusion was low, 
with no significant response in dog 4, and low values in dogs 5-7 (Table 1, Figure 
2, r = 0.89 – 0.98). The osmotic threshold for VP secretion was increased in dogs 
5-7, and the sensitivity of the VP response was decreased in dog 6 (Table 1).  
In dogs 5-7 Uosm varied during the day by a factor of 1.8-3.2 (Table 2). In 
dog 7 Uosm reached values of >1000 mOsm/kg during basal serial measurements. 
The response to desmopressin was large in dogs 4 and 6, medium in dog 7, and 
absent in dog 5 (Table 2).  
Chapter 6 
 
98 
Urine concentration during water deprivation in dogs 5 and 6 was low-to-
medium, with a moderate weight loss (2.7-4.1%), and a variable increase in Posm 
(+5 to +11 mOsm/kg) and plasma Na concentration (+1 to +5 mmol/l) (Table 3). 
Dog 4 had a poor concentrating ability during water deprivation, with a large 
weight loss (6.2%) and a large increase in Posm (+12 mOsm/kg). In dog 7, Uosm 
almost reached the level of 1000 mOsm/kg during water deprivation. This was 
associated with a large weight loss and a considerable increase in Posm. In dog 6 
plasma VP concentrations during water deprivation varied at a low level (≤3 
pmol/l).  
 
 
Table 3. Laboratory data collected during water deprivation in 18 young 
polyuric dogs, categorised according to the plasma vasopressin (VP) response to 
hypertonicity. 
 
VP response Maximum Weight Posm Plasma Na Plasma VP VP peak
Uosm loss S-E values S-E values S-E values values
mOsm/kg % mOsm/kg mmol/l              pmol/l
Hyper-
response
dog 1 1397 2.2 310-311 148-151 4-7
dog 2 713 8.2 300-302 nd nd
dog 3 1436 2.2 299-301 143-147 1-3
Hypo-
response
dog 4 463 6.2 296-308 nd nd
dog 5 557 2.7 291-296 141-142 nd
dog 6 539 4.1 305-316 144-149 1-3
dog 7 937 6.5 307-314 147-150 nd
Non-linear 
 response
dog 8 1293 5.2 306-321 146-151 2-29 13
dog 9 834 2.1 308-309 146-145 3-1
dog 10 623 2.0 303-306 142-144 1-2
dog 11 nd nd nd nd nd
dog 12 420 6.4 293-302 136-144 1-3
dog 13 1107 3.4 297-298 141-142 <1 16
dog 14 nd nd nd nd nd
dog 15 1620 2.0 306-312 143-149 nd
dog 16 900 2.9 314-314 144-148 nd
dog 17 1008 4.8 304-314 143-150 4-6 23
dog 18 333 7.2 315-324 146-150 7-16 44/42/26
Reference values 295-320 141-149
Uosm=urine osmolality; Posm=plasma osmolality; Na=plasma sodium concentration
S-E value=start-to-end value; nd=not done  
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Non-linear VP response 
During hypertonic saline infusion in dogs 8-18 abrupt VP rises occurred 
unrelated to the gradual increase in Posm (Table 1, Figure 3, r = 0.16 – 0.79). 
Omission of these peak values from the regression analysis improved the 
correlation coefficients to 0.91 – 0.99, while the remaining VP response in dog 10 
was not significant. The osmotic threshold was increased in dogs 9,11-14, and 17-
18, and the sensitivity was decreased in dogs 11,12, and 16 (Table 1). 
Figure 2. Plasma vasopressin 
concentration during hypertonic 
saline infusion in a 8-month-old 
Flatcoated Retriever (dog 6) with 
polyuria and polydipsia, illustrating 
hyporesponsiveness. See also legend 
to Figure 1. 
 
Figure 3. Plasma vasopressin 
concentrations during hypertonic 
saline infusion in a 26-month-old 
Maltese (dog 8, uninterrupted line 
and closed diamond), and a 3.5-
month-old Scottish terrier (dog 18, 
dotted line and open diamond) with 
polyuria and polydipsia, illustrating 
peak responses unrelated to the 
gradual rise in plasma osmolality. 
See also legend to Figure 1. 
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Serial measurements of Uosm revealed a large variation in Uosm during 
the day, with Uosm differing by a factor of 5 or more in 6 out of 11 dogs (Table 2). 
In 4 dogs (no 8,11,13,14) Uosm reached values of >1000 mOsm/kg. The response 
to desmopressin was small in 3 dogs (no 13, 16, 17), medium in 4 dogs (no 8, 10, 
12, 18), and large in 1 dog (no 9). In the 3 remaining dogs high Uosm values 
occurred spontaneously during basal serial measurements and/or water deprivation, 
and therefore desmopressin was not administered (Table 2). 
During the water deprivation test, Uosm exceeded 1000 mOsm/kg in dogs 
8,13,15 and 17. These dogs showed a variable weight loss (2.0- 5.2%) and increase 
1400 mOsm/kg, and the water deprivation test was discontinued. Urinary 
concentrating ability during water deprivation was medium-to-high in dogs 9 and 
16, low-to-medium in dog 10, and low in dogs 12 and 18. In the 2 dogs with a low 
concentrating ability, weight loss was large (6.4 and 7.2%) and there was a large 
increase in Posm (+9 mOsm/kg) and plasma Na concentration (+4 and +8 mmol/l). 
In the dog with low-to-medium concentrating ability, weight loss (2%) and the 
absolute increase in Posm (+3 mOsm/ kg) were small, as they were in the dogs 
with medium-to-high concentrating ability (weight loss 2.1 and 2.9% and increase 
in Posm 0 and +1 mOsm/kg). In 3 dogs plasma VP concentrations varied at a low 
level during water deprivation (≤3 pmol/l). In 4 dogs high VP peaks occurred, 
ranging from 13 to 44 pmol/l. 
 
 
Discussion 
 
In agreement with the general belief that the VP response to hypertonic 
saline infusion is the most powerful tool in the differential diagnosis of PUPD 
(Diederich et al. 2001), we categorised our group of 18 young dogs with PUPD on 
the basis of these results. All dogs had an abnormal VP response to osmotic 
stimulation, in that there was either a hyperresponse with increased sensitivity, a 
hyporesponse, or a non-linear response with VP peaks unrelated to increases in 
Posm. In addition, there were abnormalities in the threshold value of the VP 
response.  
In the three hyperresponsive dogs, plasma VP concentrations reached high 
values with an increased threshold value in one dog and an increased sensitivity in 
all three dogs, when compared to the reference values (Biewenga et al. 1987). This 
increased VP response could be a form of the syndrome of inappropriate VP 
release (SIADH), in which plasma VP levels may be abnormally high in relation to 
Posm (Rijnberk et al. 1988), although the increased threshold value does not fit in 
in Posm (+1 to + 15 mOsm/kg) (Table 3).  In  dogs  11  and  14,  initial  Uosm  was  above  
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with this theory. The increased sensitivity may also be seen as a compensation 
mechanism for the slow start (i.e. increased threshold) of the VP response system. 
An alternative explanation for the VP results in the hyperresponsive dogs could be 
an alteration in the responsiveness of the hypothalamo-neurohypophyseal system 
due to chronic dehydration and overhydration (Moses and Scheinman 1993). 
During chronic dehydration upregulation of VP release occurs, which is associated 
with a higher sensitivity of the VP response (Moses and Scheinman 1993), or a 
lower osmotic threshold for VP secretion (Robertson and Athar 1976). In dogs, 
short-term hypovolaemia is also known to lead to a shift in the relationship 
between plasma VP and Posm, i.e., a decreased osmotic threshold and an increased 
sensitivity (Quillen and Cowley 1983). In another study Quillen et al. (1984) 
demonstrated that chronically altered volume states do not affect the VP response 
to increases in Posm. Nevertheless, we cannot rule out the possibility that 
hypovolaemia due to polyuria may have affected the VP response to osmotic 
stimulation in the three hyperresponsive dogs. The polyuria in these dogs could 
also have been due to VP resistance at the level of the kidneys, e.g. a disorder of 
the VP receptor or the renal water channel aquaporin-2, leading to an increased VP 
response (Moses and Scheinman 1993, Robertson 1995). However, the strong 
Uosm fluctuations with high values and the response to desmopressin 
administration argue against a causative abnormality at the kidney level. 
In four dogs there was a hyporesponse in VP release during hypertonic 
saline infusion, which was characterised by an increased threshold value and a low 
sensitivity. At least in two of these dogs the diagnosis partial diabetes insipidus was 
supported by the good response to desmopressin administration. One dog 
concentrated its urine spontaneously to >1000 mOsm/kg during serial Uosm 
measurements. Downregulation of the VP response due to overhydration caused by 
primary polydipsia seems the most likely explanation in this dog (Moses and 
Clayton 1993). In the remaining dog the diminished VP response was accompanied 
by hyponatraemia and hypo-osmolality under basal conditions. A form of SIADH 
with low VP concentrations, due to production of a different antidiuretic substance 
or due to VP receptor upregulation (Kern et al. 1986, Sugama et al. 1992), cannot 
be ruled out in this dog. 
In 11 dogs unexpected high VP peaks unrelated to increases in Posm 
occurred during hypertonic saline infusion. After elimination of the peaks, in all 
but two dogs the remaining VP response was abnormal with regard to the threshold 
value and/or sensitivity. In an earlier study, we described similar VP responses in 
dogs with PUPD (Van Vonderen et al. 1999). These high VP values might reflect 
the erratic bursts of VP release which are known to occur in SIADH (Robertson et 
al. 1976, Rijnberk et al. 1988). Nevertheless, initially dog 8 responded well to 
desmopressin treatment, which was started before the results of the VP 
measurements were available. During treatment, hyponatraemia and hypo-
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osmolality developed, associated with episodes of restless behaviour and tremor. 
The desmopressin dose was reduced, Posm and plasma Na concentration returned 
to within their reference ranges, and the neurological signs disappeared. Apparently 
in this dog, the ongoing VP release due to the SIADH, in combination with the 
desmopressin therapy, caused hyponatraemia to the extent that neurological signs 
developed. In two other dogs the concurrence of hyponatraemia with high VP 
values make SIADH with desensitisation of renal VP receptors a likely cause of the 
PUPD. 
In the dogs with a non-linear VP response, there was a wide range of VP 
responses to increases in Posm, with strong individual variations in threshold value 
and sensitivity of the response. This is very similar to what has been found in 
healthy humans (Robertson et al. 1976) and dogs (Meij et al. 1997), although in 
some publications the impression of a linear response is created because data are 
presented as idealised curves or as single dots not related to the individual studied. 
The present non-linear responses might reflect spontaneous (patho)physiological 
variations in plasma VP concentrations. Several studies have demonstrated 
episodic VP secretion (Weitzman et al. 1977, Hammer and Engell 1982, Livesey et 
al. 1988). The observed peaks might also be a reflection of the pulsatile character 
of VP release and not a pathological condition. 
Considering all dogs, thus irrespective of categorisation according to VP 
measurements during hypertonic saline infusion, it appears that similar changes 
occurred in all these categories. For example, nine dogs (no 1,3,7-8,11,13-15,17) 
concentrated well spontaneously during basal serial measurements and/or during 
water deprivation, which complies with the diagnosis of primary polydipsia. In 
accordance with our previous report (Van Vonderen et al. 1999), we found 
different abnormalities in VP release in our dogs with so-called primary polydipsia. 
Whether or not these abnormalities are consequence or cause in the development of 
PUPD is not clear. Primary polydipsia is the only disorder of water metabolism in 
which drinking is the primary response, and the polyuria is a compensatory 
response. In humans, primary polydipsia can be divided into two categories: (1) 
psychogenic polydipsia (schizophrenia, neurosis), in which a generalised cognitive 
defect leads to excessive fluid intake, and (2) dipsogenic diabetes insipidus, in 
which there is an abnormality in the thirst mechanism (Robertson 1995). In 
psychogenic polydipsia, VP release may be suppressed by the low Posm caused by 
overhydration (Robertson 1995), but the occurrence of SIADH in schizophrenic 
patients with psychogenic polydipsia has also been described (Delva et al. 1990), 
as well as a defective thirst osmoregulation (Goldman et al. 1988). Intermittent 
hyponatraemia has been reported as a feature of psychogenic polydipsia (Vieweg et 
al. 1988), which fits in with the observations in dog 13. In dipsogenic diabetes 
insipidus, the osmotic thirst threshold is decreased, with or without associated 
abnormalities in VP osmoregulation (Robertson 1984, 1987, Thompson et al. 
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1991). Normally, drinking leads to an early satiation of thirst and to a complete 
cessation of VP secretion before Posm or plasma volume change (Thrasher et al. 
1981, Geelen et al. 1984, Salata et al. 1987, Appelgren et al. 1991). In dipsogenic 
diabetes insipidus, patients drink more than healthy controls in response to an 
increase in Posm, and drinking fails to suppress thirst (Thompson et al. 1991). It is 
entirely possible that dogs with primary polydipsia have abnormalities in the thirst 
mechanism in addition to the described abnormalities in VP release. 
What remains is the group of dogs with an inadequate concentrating ability 
during water deprivation. Similar to the situation in the dogs with primary 
polydipsia these dogs were present in all three categories of VP responses. In view 
of the response to desmopressin administration a (partial) VP deficiency seems 
likely in four of these dogs. In 2 of the latter dogs there were also sudden high VP 
values, but these peaks may have been too short to have sufficient effect on urine 
concentration. In one dog, insufficient urine concentration during dehydration in 
combination with an inadequate response to desmopressin administration may be 
explained by insensitivity to VP. Upregulation of VP release (as a result of 
dehydration) may have caused the sudden high VP values during water deprivation 
and hypertonic saline infusion in this dog. The other dogs with a diminished 
concentrating ability have been discussed above. 
Thus in all three categories there were dogs with strong spontaneous 
fluctuations in Uosm and dogs with inadequate urinary concentrating capacity. It 
seems that the VP response to hypertonicity does not consistently distinguish 
between different clinical entities. This may in part be due to the relatively 
infrequent sampling. The observed non-linear (or erratic) responses compiled in the 
third category may in part represent spontaneous peaks in VP concentrations, 
whereby it is not clear whether this should be interpreted as a spontaneous 
(patho)physiological event or as due to the hypertonic stimulus. The present data 
question the generally accepted notion that VP measurements during hypertonic 
saline infusion are the “gold standard” for the diagnostic interpretation of polyuria. 
There is a need for in-depth studies of the peripheral reflection in plasma of the 
pulsatile VP release in healthy and polyuric individuals, with and without 
provocation. Although the pulsatile nature of VP release has been known for 
several years, this phenomenon is not commonly considered when the results of VP 
measurements in response to hypertonicity are interpreted. 
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Abstract 
 
Measurement of plasma osmolality (Posm) and plasma vasopressin (VP) 
concentration in response to hypertonicity is regarded as the “gold standard” for the 
assessment of VP release in polyuric conditions. Yet the interpretation of the VP 
curve as a function of Posm may be hampered by the occurrence of VP pulses. To 
determine whether VP is secreted in a pulsatile fashion in the dog and whether 
stimulation of VP release changes the secretion pattern of VP, we investigated the 
secretion pattern of VP by blood sampling at 2-min intervals for 2 hours under 
basal conditions, after 12 hours of water deprivation, and during osmotic 
stimulation with hypertonic saline (20%) in 8 healthy dogs. Volume and electrolyte 
losses due to blood sampling were substituted by intravenous infusion of Ringer’s 
lactate. The secretion pattern of VP was analysed by means of the Pulsar 
programme. 
Vasopressin was secreted in a pulsatile fashion with a wide variation in 
number of VP pulses, VP pulse duration, and VP pulse amplitude and height. After 
water deprivation, total and basal VP secretion, the number of significant VP 
pulses, as well as the pulse characteristics did not differ from the basal situation. 
During osmotic stimulation, there was a large increase in both basal and pulsatile 
VP secretion. The number of VP pulses and the VP pulse height and amplitude 
were significantly increased compared to the basal and water-deprived state. The 
VP pulse amplitude correlated significantly with the basal plasma VP concentration 
during osmotic stimulation. 
It is concluded that VP is secreted in a pulsatile manner in healthy dogs. 
The basal and pulsatile VP secretion increases during osmoreceptor-mediated 
stimulation. The VP pulses may occur to the magnitude that they may be 
interpreted as erratic bursts, when occurring in the hypertonic saline infusion test. 
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Introduction 
 
The release of vasopressin (VP), like that of other pituitary hormones, is 
the integrated result of intrinsically controlled episodic secretion and 
environmental factors. Vasopressin is secreted in a pulsatile pattern in humans 
(Hammer and Engell 1982, Wood et al. 1994), although there is some controversy 
about whether pulsatile VP secretion occurs under basal conditions, i.e., without 
stimulating factors such as activity, posture changes and osmotic stimulation. Some 
studies on the ultradian rhythm of VP reported only minimal changes in plasma VP 
concentrations in recumbent subjects (Luboshitzky et al. 1978, Lavie et al. 1980), 
whereas others demonstrated episodic VP secretion during bed rest and sleep, 
although considerably less than during daytime activity (Katz et al. 1979). The 
pattern of VP secretion varies considerably both inter-individually and intra-
individually (Rubin et al. 1975, 1978). In well-hydrated humans the amplitude of 
plasma VP pulses may be 2-6 times higher than the basal plasma VP level (Uhlich 
et al. 1975, Lavie et al. 1977, Hammer and Engell 1982, Wood et al. 1994). The 
pulsatile secretion pattern of VP in humans is superimposed on a circadian rhythm 
that may vary with the sleep-wake cycle (Nadal 1996, Forsling et al. 1998).  
The fluctuations in plasma VP concentrations have also been addressed in 
animal studies. A circadian VP rhythm has been found in several species, including 
the dog (Gordon and Lavie 1985). The pulsatile secretion pattern of VP has been 
most elegantly studied in the horse by measurements in the pituitary effluent, both 
under basal conditions and during osmotic stimulation (Redekopp et al. 1986, 
Irvine et al. 1989). In these studies it became clear that the detection of hormone 
pulses is highly dependent upon the intensity of the sampling regimen (Alexander 
et al. 1994). Episodic secretion of VP has also been documented in sheep (Engler 
et al. 1989), cats (Coleman and Reppert 1985), and rats (Ohno 1981). 
Studies on episodic VP release in dogs are limited. Bie et al. (1982) found 
a few unexpectedly high plasma VP values in some euhydrated anaesthetized dogs, 
and significantly more during osmotic stimulation. Weitzman et al. (1977) studied 
VP release in dogs during intravenous water loading, dehydration and osmotic 
stimulation. During both water loading and minimal dehydration plasma VP levels 
remained low. Episodic VP release occurred in response to severe dehydration and 
osmotic stimulation, with a tendency for larger VP peaks in animals with higher 
baseline VP values. Unfortunately, in the latter study VP measurements were not 
performed under basal conditions and sampling took place for less than 1 hour. 
In earlier studies, we reported the occurrence of unexpectedly high plasma 
VP concentrations during hypertonic saline infusion in dogs with polyuria (Van 
Vonderen et al. 1999, 2003). In these dogs it was not clear whether these high VP 
values had to be regarded as pathological or as the result of the physiological 
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pulsatile secretion pattern of VP. Hypertonic saline infusion with measurement of 
plasma osmolality (Posm) and plasma VP concentration is regarded as a very 
powerful diagnostic tool for the differentiation of polyuric conditions in both 
humans and dogs (Biewenga et al. 1987, Diederich et al. 2001). In this test, 
hypertonic saline is infused and blood is collected for VP measurements at 20-
minute intervals for 2 hours (Zerbe and Robertson 1981). The plasma VP 
concentrations are plotted as a function of Posm. In principle, the interpretation of 
the curves thus obtained may be hampered by the infrequent sampling and the 
occurrence of VP pulses. However, so far there are no reports on the possible 
interference of VP pulses with the (linear) Posm-plasma VP relationship during 
hypertonic saline infusion.  
To determine whether VP is secreted in a pulsatile fashion in the dog and 
whether stimulation of VP release changes the secretion pattern of VP, we 
investigated VP secretion in 8 healthy dogs by blood sampling at 2-min intervals 
for 2 hours under basal conditions, after water deprivation, and during osmotic 
stimulation with hypertonic saline.  
 
 
Materials and methods 
 
Dogs 
Eight healthy castrated female dogs (2 cross-breds and 6 beagle dogs), with 
ages ranging from 1 to 8 years (median 5 years), were studied. All dogs were 
accustomed to the laboratory environment and experimental procedures. The dogs 
were housed singly or in pairs in indoor-outdoor runs, fed on a standard 
commercial dog food once daily, and given water ad libitum.  
 
Studies 
Studies were conducted in a random order and were at least 4 weeks apart. 
Food was withheld for 12 hours before all studies. 
Study 1: Secretion pattern of VP under basal conditions. Water remained 
available until the start of the study. Blood samples for measurement of plasma VP 
concentration were collected from the jugular vein every 2 min for 2 hours. In 
addition, every hour blood was collected for the measurement of Posm. To 
compensate for the blood withdrawn, the dogs received a continuous infusion of 
Ringer’s lactate (RL) in the cephalic vein, with a total volume equal to that 
withdrawn. 
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Study 2: Secretion pattern of VP after 12 hours of water deprivation. The 
protocol for this study was identical to that of study 1, with the exception that the 
blood sampling started after 12 hours of water deprivation. 
Study 3: Secretion pattern of VP during hypertonic saline infusion. Saline 
solution (20%) was infused intravenously at a rate of 0.03 ml/kg body weight/min 
for 1 hour. In addition, the dogs received RL to compensate for the blood 
withdrawn. The infusion volumes in the first hour (20% NaCl and RL) and the 
second hour (RL) were the same. Blood samples were collected as above, except 
that samples for measurement of Posm were collected every 20 min. 
 
Vasopressin determination 
Blood samples for plasma VP measurement were collected in EDTA-
coated tubes pre-chilled in ice. Plasma was obtained by centrifugation at 4°C and 
stored at –20°C until assayed. Vasopressin was extracted by the addition of 5.2 ml 
96% ethanol (4°C) to 0.8 ml plasma, and incubation by end-over-end rotation for 
30 min at 4°C. After centrifugation for 30 min at 5000xg and 4°C, the supernatant 
was collected and dried overnight using a speedvac vacuum concentrator. Extracts 
were dissolved in 0.8 ml assay buffer. The recovery of VP amounted to a mean 
value of 75 ±1%. Vasopressin concentrations were measured by radioimmunoassay 
(Nichols Institute, Wijchen, The Netherlands), validated for the dog by measuring a 
serial dilution of an extract of canine plasma with a high VP concentration that 
resulted in a curve parallel to the standard curve. The detection limit was 1 pmol/l. 
The intra-assay coefficient of variation was 12% at 8 pmol/l, and the inter-assay 
coefficient of variation was 20% at 1.5 and 4 pmol/l, and 10% at 8.5 pmol/l. 
 
Data analysis 
The secretion pattern of VP was analysed by means of the Pulsar 
programme developed by Merriam and Wachter (1982). The programme identifies 
secretory pulses by height and duration from a smoothed baseline, using the assay 
standard deviation (SD) as a scale factor. The cut-off parameters G1-G5 of the 
Pulsar programme were set at 3.98, 2.40, 1.68, 1.24 and 0.93 times the assay SD as 
criteria for accepting pulses 1, 2, 3, 4, and 5 points wide, respectively. The 
smoothing time, a window used to calculate a running mean value omitting pulses, 
was set at 1.5 hours. The splitting cut-off parameter was set at 0.5 and the weight 
assigned to pulses was 0.05. The A, B, and C values of the Pulsar programme, used 
to calculate the variance of the assay, were set at A=0.01, B=12.5 and C=37. Data 
below the detection limit of the VP assay were set at 1.0 pmol/l. The values 
extracted from the Pulsar analyses included the mean of the smoothed baseline (as 
a measure of the mean basal plasma VP concentration), the overall mean, the total 
number of pulses, the mean pulse duration, the mean pulse amplitude, the mean 
pulse height, and the area under the curve (AUC). The AUC was calculated above 
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the zero level as a measure of the total amount of VP secreted. The AUC above the 
baseline was used as a measure of the amount of VP secreted in pulses, while the 
AUC under the baseline was used as a measure of the basal secretion of VP.  
The distribution of the data extracted from the Pulsar programme was 
tested using the Kolmogorov-Smirnov and the Shapiro-Wilk tests. The mean basal 
plasma VP concentration, the VP pulse duration, and Posm were normally 
distributed. Changes in these variables were further evaluated by analysis of 
variance (ANOVA) for repeated measurements. Subsequently, multiple 
comparisons were performed for data with significant differences (P<0.05) using 
the Student-Newman-Keuls test. These values are presented as mean ± SEM. The 
overall mean plasma VP concentration, the number of VP pulses, the VP pulse 
amplitude, the VP pulse height, and the AUC values were not normally distributed. 
For these variables differences between studies were analysed with the Friedman 
test and multiple comparisons were conducted using the Student-Newman-Keuls 
test. These values are expressed as median and range. Differences in AUC between 
the first and second hour of the studies were compared using the Wilcoxon signed 
ranks test. Differences in mean Posm between the first and second hour of study 3 
between the basal plasma VP concentration and the pulse amplitude was examined 
by linear regression analysis. P<0.05 was considered significant. 
 
Ethics of experimentation 
The studies were approved by the Ethics Committee of the Faculty of 
Veterinary Medicine, Utrecht University. 
 
 
Results 
 
Study 1 
Vasopressin was secreted in a pulsatile fashion (Figure 1). The mean basal 
plasma VP concentration was 3.2 ± 0.3 pmol/l. The AUC above the zero line varied 
between 3.0 and 20.4 pmol/l • 2 h, with a median value of 7.1 pmol/l • 2 h. The 
median AUC above the baseline was 1.2 pmol/l • 2 h (range 0.13 – 11.8 pmol/l • 2 
h). The median AUC under the baseline was 6.1 pmol/l • 2 h (range 2.6 – 8.8 
pmol/l • 2 h). The median of the overall mean plasma VP concentration was 3.6 
pmol/l, and varied between 1.4 and 10.1 pmol/l. The number of VP pulses ranged 
from 0 to 5 during the period of blood sampling, with a median value of 2. The 
mean VP pulse duration was 5 ± 2 min. The median of the mean VP pulse 
amplitude  was  7.3 pmol/l (range 4.4 – 81.3 pmol/l), and  the  median  of  the mean 
were compared using a paired Students t-test. The significance of the relationship 
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Figure 1. Basal plasma vasopressin (VP) concentrations in blood samples collected every 2 
min for 2 hours. Volume and electrolyte losses due to blood sampling were substituted by 
intravenous infusion of Ringer’s lactate. Upper panel: a 6-year-old beagle dog, middle 
panel: a 5-year-old beagle dog, lower panel: a 2-year-old beagle dog. (Note differences in 
scale of y-axis.) 
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VP pulse height was 10.9 pmol/l (range 7.0 – 86.1 pmol/l). Maximum VP pulse 
height was 143 pmol/l.  
There was a small but significant decrease in Posm during the study (305 ± 
1 ⇒ 303 ± 1 mOsm/kg). There were no significant differences in the AUC above 
the zero line, the AUC above the baseline, and the AUC under the baseline 
between the first and the second hour of sampling. After omission of one extreme 
value, there was no significant correlation between VP pulse amplitude and basal 
plasma VP concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Plasma vasopressin (VP) concentrations after 12 hours of water deprivation in 
blood samples collected every 2 min for 2 hours. Volume and electrolyte losses due to 
blood sampling were substituted by intravenous infusion of Ringer’s lactate. Upper panel: a 
6-year-old beagle dog (same dog as in Figure 1), lower panel: a 5-year-old beagle dog 
(same dog as in Figure 1). 
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Study 2 
After 12 hours of water deprivation VP was secreted in a pulsatile fashion 
similar to that in study 1 (Figure 2). The mean basal plasma VP concentration after 
water deprivation was 3.4 ± 0.7 pmol/l. The AUC above the zero line varied 
between 3.5 and 16.1 pmol/l • 2 h, with a median value of 6.6 pmol/l • 2 h. The 
median AUC above the baseline was 0.43 pmol/l • 2 h (range 0.12 – 2.8 pmol/l • 2 
h). The median AUC under the baseline was 5.7 pmol/l • 2 h (range 3.0 – 15 pmol/l 
• 2 h). The median of the overall mean plasma VP concentration was 3.3 pmol/l, 
with a range of 1.7 – 8.2 pmol/l. The number of VP pulses in study 2 varied 
between 0 and 6, with a median of 1. The mean VP pulse duration was 6 ± 2 min. 
The median of the mean VP pulse amplitude was 8.2 pmol/l (range 2.3 - 10.6 
pmol/l), and the median of the mean VP pulse height was 12.2 pmol/l (range of 4.6 
– 16.3 pmol/l). Maximum VP pulse height was 42 pmol/l.  
There was a small but significant decrease in Posm during the study (310 ± 
3 ⇒ 307 ± 3 mOsm/kg). There were no significant differences in the AUC above 
the zero line, the AUC above the baseline, and the AUC under the baseline 
between the first and the second hour of sampling. The correlation between VP 
pulse amplitude and basal plasma VP concentration was not significant.  
There was no significant difference in Posm between studies 1 and 2. 
There were also no significant differences in the basal plasma VP concentration, 
the AUC above the zero line, the AUC above the baseline, the AUC under the 
baseline, and the overall mean plasma VP concentration between studies 1 and 2. 
Also with regard to the number of significant VP pulses and the pulse 
characteristics there were no significant differences between studies 1 and 2.  
 
Study 3 
The pulsatile secretion pattern of VP during osmotic stimulation was more 
pronounced than in studies 1 and 2 (Figure 3). The mean basal plasma VP 
concentration in study 3 was 15.3 ± 3.4 pmol/l. The AUC above the zero line 
varied between 9.3 and 206.4 pmol/l • 2 h, with a median value of 55.1 pmol/l • 2 
h. The median AUC above the baseline was 24.1 pmol/l • 2 h (range 2.0 – 136.1 
pmol/l • 2 h). The median AUC under the baseline was 25.8 pmol/l • 2 h (range 6.9 
– 70.3 pmol/l • 2 h). The median of the overall mean plasma VP concentration was 
27.5 pmol/l (range 4.6 – 104.1 pmol/l). The number of VP pulses varied between 2 
and 14, with a median of 10. The mean VP pulse duration was 5 ± 0.5 min. The 
median of the mean VP pulse amplitude was 66.2 pmol/l (range 10.8 – 159.9 
pmol/l), and the median of the mean VP pulse height was 78.6 pmol/l (range 20.0 – 
197.9 pmol/l). Maximum VP pulse height was 683 pmol/l.  
Plasma osmolality increased significantly during the first hour of the study 
(309 ± 1 ⇒ 330 ± 1 mOsm/kg). During the second hour of sampling Posm 
decreased  significantly to  325 ± 1 mOsm/kg, which  was still  significantly higher 
Chapter 7 
 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Plasma vasopressin (VP) concentrations in blood samples collected every 2 min 
for 2 hours during osmotic stimulation. Hypertonic saline (20% NaCl 0.03 ml/kg/min) was 
infused for 1 hour. Volume and electrolyte losses due to blood sampling were substituted 
by intravenous infusion of Ringer’s lactate. Upper panel: a 6-year-old beagle dog (same 
dog as in Figures 1 and 2), lower panel: a 5-year-old beagle dog (same dog as in Figures 1 
and 2). (Note differences in scale of y-axis, also as compared to Figures 1 and 2.) 
 
 
than at the start of the measurements. The mean Posm during the second hour (326 
± 2 mOsm/kg) was significantly higher than the mean Posm during the first hour 
(320 ± 1 mOsm/kg). In the second hour the median AUC above the zero line (37.7 
pmol/l • h, range 4.5 – 172.6 pmol/l • h) and the median AUC under the baseline 
(16.5 pmol/l • h, range 4.3 – 56.6 pmol/l • h) were significantly higher than in the 
first hour (17.5 pmol/l • h, range 4.3 – 42.5 pmol/l • h, and 9.4 pmol/l • h, range 2.6 
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– 13.7 pmol/l • h, respectively). The median AUC above the baseline in the second 
hour (17.7 pmol/l • h, range 0.2 – 116 pmol/l • h) was also higher than in the first 
hour of the study (6.4 pmol/l • h, range 0 – 33.5 pmol/l • h), but this difference did 
not reach statistical significance. There was a significant positive correlation 
between VP pulse amplitude and basal plasma VP concentration (r=0.65).  
The basal plasma VP concentration, the AUC above the zero line, the AUC 
above the baseline, the AUC under the baseline, as well as the overall mean plasma 
VP concentration were significantly higher during osmotic stimulation than in 
studies 1 and 2. There was no significant difference in VP pulse duration between 
studies 1-3. The number of VP pulses, the VP pulse amplitude, and the VP pulse 
height were significantly higher in study 3 than in studies 1 and 2. 
 
 
Discussion 
 
The level of the mean basal plasma VP concentration measured under basal 
conditions was consistent with the reference range of VP (1-6 pmol/l) reported 
earlier in dogs (Biewenga et al. 1987, Hellebrekers et al. 1987). In both the 
hydrated state (study 1) and after 12 hours of water deprivation (study 2), basal and 
total plasma VP secretion did not change during the 2 hours of blood sampling. 
Thus, it seems justified to assume that the volume and electrolyte losses due to 
blood sampling were adequately substituted. Plasma osmolality, basal and total VP 
secretion, as well as VP pulse characteristics in study 2 were not significantly 
different from those in study 1. This indicates that water deprivation for 12 hours 
does not change the secretion pattern of VP in healthy dogs. Basal and total VP 
secretion in study 3 were significantly higher than those under basal conditions and 
after water deprivation. Thus, in agreement with other studies (Wang and Goetz 
1985, Robertson and Ganguly 1986), osmotic stimulation proved to be a very 
strong stimulus for VP secretion.  
In study 1 significant VP pulses were recognised by the Pulsar programme, 
indicating that, even under basal conditions, VP is secreted in a pulsatile fashion in 
the dog. The pulsatile secretion pattern of VP was characterised by large individual 
variations in number of VP pulses, VP pulse amplitude, VP pulse height and VP 
pulse duration. Studies on the pulsatile secretion pattern of VP under basal 
conditions have not been reported before in dogs. In an earlier study, plasma VP 
levels remained relatively constant in dogs with minimal dehydration, while 
significant VP pulses with variable amplitude and timing were found in dogs with 
severe dehydration (Weitzman et al. 1977). We did not find that water deprivation 
altered the number of VP pulses and the VP pulse characteristics. Apparently, VP 
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pulsatile secretory activity is not influenced by mild dehydration to the extent that 
it leads to detectable changes when sampled at 2-min intervals. During osmotic 
stimulation, the amount of VP secreted in pulses increased considerably, with an 
increase in number, amplitude and height of the VP pulses. Weitzman et al. (1977) 
have reported higher VP pulses in dogs with higher baseline VP levels during 
severe dehydration and osmotic stimulation. Although we could not confirm a 
difference in total VP secreted in pulses between the first and second hour of blood 
sampling in study 3, there was indeed a significant increase in VP pulse amplitude 
with increasing basal plasma VP concentration. 
The half-life of endogenous VP has been reported to vary between 2 and 5 
min in dogs, and between 5 and 15 min in humans (Wilson et al. 1981, Vilhardt 
1990, Robinson and Verbalis 2003). Weitzman and Fisher (1978) determined the 
existence of two exponential components in the disappearance curve of synthetic 
VP after pulse injection. The first component resembled distribution over the total 
plasma volume (half-life 1.4 min), while the second component corresponded to 
VP clearance (half-life 4.1 min). Occasionally, we observed a much faster decline 
in plasma VP concentration following large pulses. Katz et al. (1979) reported a 
similar discrepancy between VP pulse decline and hormone half-life, and 
suggested that VP half-life in the basal state may differ from that during 
stimulation.  
The secretion of VP is primarily controlled by osmoreceptors located in the 
anterior hypothalamus near the cell bodies of the VP-synthesising magnocellular 
neurons (Robertson 1985, Wang and Goetz 1985, Robertson and Ganguly 1986). In 
addition, baroreceptors situated in the heart, aorta, and carotid arteries may mediate 
haemodynamic influences to the neurohypophyseal system. Functionally, the two 
control systems are integrated in such a way that osmoregulation is altered but not 
disrupted by haemodynamic influences (Robertson and Ganguly 1986). An 
increase in Posm by as little as 1% may increase plasma VP, whereas blood 
volume and pressure must decrease by more than 10% to 15% to stimulate VP 
release (Robinson and Verbalis 2003). In the present study, volume loss was 
substituted and Posm decreased only minimally. Therefore, osmo- and/or 
baroreceptor-mediated VP stimulation will not have contributed to the occurrence 
of significant VP pulses in the basal state. As dehydration was minimal after 12 
hours, the same probably accounts for study 2. The increase in VP pulse height and 
amplitude and the increase in total number of VP pulses upon infusion of 
hypertonic saline can solely be attributed to the stimulation of osmoreceptors. 
Other important stimuli of VP release are nausea (Rowe et al. 1979), 
hypoglycaemia (Baylis and Heath 1977, Ellis et al. 1990), hypoxia/hypercapnia 
(Raff et al. 1983), pain (Kendler et al. 1978), and stress (Jørgensen et al. 2002). 
The presence of hypoglycaemia, hypoxia or hypercapnia does not seem to have 
played a role in our studies. All dogs were accustomed to the laboratory 
Chapter 7 
 
122 
environment and handling, and catheters had been inserted prior to the studies. 
Nausea, however, cannot be completely excluded during hypertonic stimulation. In 
previous studies, we observed nausea in some dogs during the last 15 min of a 2-
hour-infusion of hypertonic saline. As in our study 3 no signs of nausea were 
observed and hypertonic saline was only infused for one hour, it is unlikely that 
nausea played a role in stimulating VP release.  
Our studies in healthy dogs were initiated because of uncertainty about the 
possible confounding role of spontaneous VP pulses in the test that is regarded as 
the “gold standard” for the assessment of VP release in polyuric conditions, i.e. 
hypertonic saline infusion with measurements of Posm and plasma VP 
concentrations (Biewenga et al. 1987, Diederich et al. 2001). The results of our 
study demonstrate that in healthy dogs VP pulses may occur of a height that would 
lead to high points outside the nomogram for the (linear) relation between Posm 
and plasma VP concentration (Zerbe et al. 1980). Such VP pulses may erroneously 
be interpreted as erratic, and consequently, a false-positive diagnosis of the 
syndrome of inappropriate antidiuresis could be made. The present observations 
may explain, in part, the non-linear VP response to osmotic stimulation observed 
previously in polyuric dogs (Van Vonderen et al. 1999, 2003). In some of these 
dogs, VP peaks occurred that did not seem to relate to the gradual rise in Posm 
following hypertonic saline infusion. However, a pathological origin of the VP 
peaks in these polyuric dogs cannot be excluded.  
In conclusion, in healthy dogs VP is secreted in a pulsatile fashion. Basal 
and pulsatile VP secretion increase during osmoreceptor-mediated stimulation. The 
magnitude of the VP pulses may be sufficient for the pulses to be considered as 
erratic bursts when occurring during the hypertonic saline infusion test, a test used 
to assess VP release in polyuric conditions.  
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Abstract 
 
Water conservation by the kidney is mediated by both short- and long-term 
regulation of aquaporin-2 (AQP2), the vasopressin (VP)-dependent water channel 
in the apical membrane and the intracellular vesicles of the collecting duct cells. In 
humans, the urinary AQP2 (U-AQP2) excretion closely parallels changes in VP 
action and has been proposed as a marker for collecting duct responsiveness to VP. 
This report describes the development of a radioimmunoassay for the measurement 
of U-AQP2 excretion in dogs. Urinary AQP2 measurements were performed in 
states of high and low VP exposure. In addition, the localisation of AQP2 in the 
canine kidney was investigated by immunohistochemistry. 
Basal U-AQP2 excretion was highly variable among healthy dogs. Two 
hours after oral water loading, the mean U-AQP2/creatinine ratio decreased 
significantly from 231 ± 30  x 10-9 to 60 ± 15 x 10-9, while the median plasma VP 
concentration decreased from 4.2 pmol/l (range 2.2 – 4.8 pmol/l) to 1.2 pmol/l 
(range 1.0 – 1.9 pmol/l). Subsequent intravenous administration of desmopressin 
led to a significantly increased mean U-AQP2/creatinine ratio of 258 ± 56 x 10-9. 
Desmopressin administration via the conjunctival sac did not result in a significant 
change in the U-AQP2/creatinine ratio. Two hours of intravenous hypertonic saline 
infusion (20% NaCl, 0.03 ml/kg body weight/min) significantly increased the mean 
U-AQP2/creatinine ratio from 86 ± 6 x 10-9 to 145 ± 23 x 10-9, while the median 
plasma VP concentration increased significantly from 2.2 pmol/l (range 1.1 – 6.3 
pmol/l) to 17.1 pmol/l (range 8.4 – 67 pmol/l). Immunohistochemistry revealed 
extensive labeling for AQP2 exclusively in the kidney collecting duct cells. The 
AQP2 labeling was distributed throughout the cytoplasm, but predominantly 
localised in the apical and subapical region.  
As in humans, U-AQP2 excretion in dogs closely reflects changes in VP 
exposure, elicited by water loading, hypertonic saline infusion, and intravenous 
desmopressin administration. Urinary AQP2 excretion may become a diagnostic 
tool in dogs for the differentiation of polyuric conditions such as (partial) central or 
nephrogenic diabetes insipidus, primary polydipsia, and inappropriate VP release. 
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Introduction 
 
Aquaporin-2 (AQP2) has been characterised as the major vasopressin 
(VP)-regulated water channel and is predominantly localised in the apical 
membrane and intracellular vesicles of the kidney collecting duct principal cells 
(Nielsen et al. 1993, 1995). Water conservation by the kidney is mediated by both 
short- and long-term regulation of AQP2 (Wen et al. 1999). Upon binding of VP to 
its V2-receptor in the basolateral membrane of collecting duct cells, a chain of 
signalling events is initiated, resulting in the translocation of AQP2 from an 
intracellular reservoir to the apical plasma membrane and an increased passage of 
water within a few minutes (Nielsen et al. 1993, 1995, Marples et al. 1995a). After 
VP withdrawal, AQP2 is redistributed into the cell by endocytosis and water 
permeability decreases (Nielsen et al. 1995). Chronic VP exposure (>24 h) leads to 
increased expression of AQP2 and, consequently, maximal water permeability of 
the collecting duct epithelium (DiGiovanni et al. 1994, Hozawa et al. 1996, 
Kishore et al. 1996).  
Studies of urinary AQP2 (U-AQP2) excretion in rats indicate that 3% of 
total kidney AQP2 is excreted into the urine by a selective apical pathway (Rai et 
al. 1997, Wen et al. 1999). Of the AQP2 excreted into the urine, 35% - 45% is 
glycosylated (Baumgarten et al. 1998) and 40% is associated with small vesicles 
and larger membrane fragments (Kanno et al. 1995, Deen et al. 1996, Wen et al. 
1999). In humans and rats, U-AQP2 excretion closely parallels changes in VP 
action, and thus has been proposed as a marker for collecting duct responsiveness 
to VP (Elliot et al. 1996, Mitsuma et al. 1998, Wen et al. 1999, Pedersen et al. 
2001). Indeed, U-AQP2 excretion decreases during water loading and increases 
during water deprivation, osmotic stimulation with hypertonic saline, and 
administration of the VP-analogue desmopressin (Elliot et al. 1996, Saito et al. 
1997, Wen et al. 1999, Pedersen et al. 2001). 
A defective function and/or regulation of AQP2 plays a key role in several 
disorders of water homeostasis (Wen et al. 1999, King and Yasui 2002). In 
hereditary nephrogenic diabetes insipidus, mutations in the AQP2 gene may lead to 
impaired routing of AQP2 to the apical membrane or to misfolding of the protein. 
The molecule is retained in the endoplasmic reticulum and is subsequently 
degraded (Deen et al. 1994, Marr et al. 2002). Animal models of acquired 
nephrogenic diabetes insipidus are based on downregulation of AQP2 as a result of 
long-term lithium treatment, hypokalaemia, and hypercalcaemia (Marples et al. 
1995b, 1996, Wang et al. 2002). Saito et al. (1998, 2001) demonstrated an 
exaggerated U-AQP2 excretion in humans with the syndrome of inappropriate VP 
release (SIADH), and concluded that U-AQP2 is a potent marker for VP excess. In 
addition, U-AQP2 excretion may contribute in the differentiation of polyuric 
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conditions such as central diabetes insipidus, nephrogenic diabetes insipidus, and 
primary polydipsia in humans (Kanno et al. 1995, Saito et al. 1997, Mitsuma et al. 
1998, Saito et al. 1999, Matsumoto et al. 2000). 
Much more so than in other species, polyuria is a feature of disease in the 
dog. In several endocrine diseases such as hyperadrenocorticism, hyperthyroidism, 
and hyperparathyroidism, polyuria is the dominating symptom (Biewenga et al. 
1991, Rijnberk 1996, Van Vonderen et al. 2003a). After exclusion of these 
conditions, there remains a group of largely unresolved polyurias. Particularly the 
differentiation between primary polydipsia, SIADH, partial central diabetes 
insipidus, and partial nephrogenic diabetes insipidus may pose problems (Van 
Vonderen et al. 1999, 2003b). As in humans, U-AQP2 excretion may be of value in 
the differentiation of polyuric conditions. 
Studies on the presence and function of AQPs in dogs are scarce. Two 
studies have demonstrated a large similarity between the cDNA and amino acid 
sequences of AQP1 and the N-terminal part of AQP2 of dogs, humans, and rats 
(Madsen et al. 1997, Higa et al. 2000). Urinary AQP2 excretion has not been 
measured before in dogs, and there is no commercially available test for U-AQP2 
in animals (Cohen and Post 2002). In this report, we describe the development of a 
radioimmunoassay for the measurement of U-AQP2 excretion in dogs. To validate 
the assay, U-AQP2 excretion was measured in healthy dogs under basal conditions, 
after water loading, during hypertonic saline infusion, and after desmopressin 
administration. In addition, the immunohistochemical localisation of AQP2 in the 
canine kidney is described. 
 
 
Materials and methods 
 
Dogs 
All dogs were accustomed to the laboratory environment, and handling 
such as collection of blood samples. The dogs were housed singly or in pairs in 
indoor-outdoor runs, fed on a standard commercial dog food once daily, and given 
water ad libitum. Food was withheld for 12 hours before all studies, while water 
remained available until the start of the measurements. 
 
Studies 
Study 1: Desmopressin administration in the conjunctival sac. Six healthy 
beagle dogs (2 male dogs and 4 neutered female dogs), aged 4 to 11 years (median: 
7 years), were studied. Four urine samples for the measurement of urine osmolality 
(Uosm), urinary creatinine concentration (Ucreat), and U-AQP2 concentration 
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were collected via catheterisation at hourly intervals. After the first 2 basal urine 
samples (h-1/h0), 2 drops of desmopressin (MinrinR, Ferring B.V., Hoofddorp, The 
Netherlands) were administered in the conjunctival sac. Urine sampling was 
continued for 2 hours after desmopressin administration (h1/h2). 
Study 2: Hypertonic saline infusion. The group of dogs studied was the 
same as in study 1. Four urine samples for the measurement of Uosm, Ucreat, and 
U-AQP2 were collected via catheterisation at hourly intervals. After the first 2 
basal urine samples (h-1/h0), 20% NaCl was infused intravenously at a rate of 0.03 
ml/kg body weight/min for 2 hours (Biewenga et al. 1987). Blood samples for the 
measurement of plasma VP concentration and plasma osmolality (Posm) were 
collected every 20 min, starting 40 min before the hypertonic saline infusion (9 
samples). Urine sampling was continued every hour during the hypertonic saline 
infusion (h1/h2). 
Study 3: Water loading and intravenous desmopressin administration. Four 
healthy male beagle dogs, all of them 4 years of age, were studied. A total of 8 
urine samples for the measurement of Uosm, Ucreat, and U-AQP2 were collected 
via catheterisation. The first 4 urine samples were collected at hourly intervals. 
After 2 basal urine samples (h-1/h0), the dogs were given an oral water load (42 
ml/kg), and 2 additional urine samples were collected (h1/h2). Next, 0.3 µg 
desmopressin per kg body weight was administered intravenously in 100 ml 0.9% 
NaCl over a period of 20 min. After the start of the desmopressin infusion, urine 
samples were collected at 30-min intervals (h2.5/h3/h3.5/h4). Samples for 
measurement of Posm, and plasma concentrations of VP, sodium (Na), and total 
protein (TP) were collected at the same times as the urine samples during basal 
sampling and water loading. 
 
Plasma VP determination 
Blood samples for plasma VP measurement were collected in EDTA-
coated  tubes  pre-chilled  in  ice,  separated by centrifugation at 4°C, and stored at 
-20°C until assayed. Vasopressin was extracted from plasma by the addition of 5.2 
ml 96% ethanol (4°C) to 0.8 ml plasma, and incubation by end-over-end rotation 
for 30 min at 4°C. Next, the tubes were centrifuged for 30 min at 5000xg and 4°C. 
Supernatants were dried overnight using a speedvac vacuum concentrator. Extracts 
were dissolved in 0.8 ml assay buffer. The recovery of VP amounted to a mean 
value of 75 ± 1%. Vasopressin concentrations were measured by 
radioimmunoassay (Nichols Institute, Wijchen, The Netherlands), validated for the 
dog by measuring a serial dilution of an extract of canine plasma with a high VP 
concentration that resulted in a curve parallel to the standard curve. The detection 
limit was 1 pmol/l. Data below the detection limit of the VP assay were set at 1.0 
pmol/l. The intra-assay coefficient of variation was 15% at 7 pmol/l, and the inter-
assay coefficient of variation was 20% at 1.5 and 4 pmol/l, and 10% at 8.5 pmol/l. 
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Urinary AQP-2 determination 
Samples for measurement of U-AQP2 were placed on ice immediately 
after collection, separated from debris by centrifugation at 4°C (10 min at 3000xg), 
and stored at –20°C. All samples were analysed within 10 days. The AQP2 
antibody was a generous gift from Dr. M.A. Knepper, National Heart, Lung, and 
Blood Institute, National Institutes of Health (Bethesda, Maryland, USA). The 
AQP2 antibody had been raised in rabbits against a BSA-linked synthetic peptide 
corresponding to the 15 carboxy-terminal amino acids of rat AQP2 (DiGiovanni et 
al. 1994). The synthetic rat AQP2 peptide was purchased from Alpha Diagnostic 
International (San Antonio, TX, USA) and provided with an N-terminal tyrosin for 
labeling. Iodination of tyrosin-linked AQP2 was performed by the chloramine T 
method. To 1 µg of AQP2 (dissolved in destilled water at 1 µg/5 µl), 3 µl 125I- (11.1 
MBq) (Amersham Pharmacia Biotech, Buckinghamshire, UK), 5 µl 10 mM HCl, 
10 µl 0.5 M sodium phosphate (pH 7.4), and 10 µl choramine T (1 mg/ml) were 
added. After 1 min the reaction was stopped by addition of 10 µl sodium 
metabisulphite (2 mg/ml). 125I-labeled AQP2 was separated from free 125I- on a 
sephadex G25 column (Amersham Pharmacia Biotech, Uppsala, Sweden). The 
assay buffer consisted of 63 mM sodium phosphate (pH 7.4), 13 mM sodium 
EDTA, 0.05% (v/v) Tween-20, 2% (v/v) Trasylol, and 0.25% (w/v) BSA. 
The mixture of 100 µl of standard or urine sample, 100 µl of antibody 
(final dilution 1:6000), and 100 µl of tracer was incubated for 24 h at 4°C. After 
incubation with the second antibody (100 µl of Sac-cel Anti-rabbitR, IDS Boldon, 
Tyne & Wear, UK) for 30 min at 4°C, and subsequent centrifugation (10 min, 4°C, 
5000xg), the precipitate (bound fraction) was counted in a gamma counter for 1 
min. All samples were analysed in duplicate. A standard curve was made with the 
concentrations 0.1 - 100 ng/ml of the synthetic AQP2 peptide. Serial dilution 
curves of canine urine samples paralleled that of the standard. The detection limit 
was 0.05 ng/ml. The intra-assay coefficient of variation was 7.2% at 7.3 ng/ml, and 
the inter-assay coefficient of variation was 8.3% at 1.7 ng/ml, and 5.3% at 6.8 
ng/ml. The U-AQP2 concentrations were converted to pmol/ml using the molecular 
weight of the synthetic AQP2 peptide (M=1858). In addition to the U-AQP2 
concentration, the U-AQP2/creatinine ratio is reported.  
 
Immunohistochemistry 
The immunohistochemical localisation of AQP2 in the canine kidney was 
studied using both the avidin-biotin-peroxidase complex (ABC) technique and 
immunofluorescence. Control sections were stained according to the same protocol 
with omission of the primary antibody. For the ABC technique, tissue samples 
fixed in 10% buffered formalin were processed by conventional methods, 
embedded in paraffin wax, and sectioned at 5 µm. After deparaffination and 
blockage of endogenous peroxidase activity, sections were incubated with the 
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AQP2 antibody (1:800) at room temperature for 60 min. Next, they were incubated 
with goat biotinylated anti-rabbit IgG (1:1600, 30 min) and treated with the ABC 
standard kit for 45 min (Vector, Amsterdam, The Netherlands). The peroxidase 
activity was “visualised” with 0.5% 3.3’-diaminobenzidine tetrahydrochloride 
(DAB, Sigma-Aldrich Chemie BV, St. Louis, USA) and H2O2 0.3% in 0.05 M 
Tris-HCl. All sections were counterstained with Mayer’s haematoxylin for 1 min. 
Immunofluorescense microscopy was performed on 5-µm cryosections of 
the canine kidney. Sections were dried (room air) for 10 min, and then fixed in cold 
aceton for an additional 10 min. The sections were then washed in PBS (3 x 5 min) 
and incubated for 30 min at 37ºC with the AQP2 antibody described above at a 
1:100 dilution. After washing, the sections were incubated with a fluorescein-
conjugated secondary antibody (swine anti-rabbit 1:100). Final washing was done 
in PBS (2 min) and destilled water. 
 
Data analysis 
In all studies, changes in U-AQP2 concentration and U-AQP2/creatinine 
ratio were assessed by analysis of variance (ANOVA) for repeated measurements. 
Subsequently, multiple comparisons were performed for data with significant 
differences (P<0.05) using the Student-Newman-Keuls test. Values are presented 
as mean ± SEM and range. The mean of the first two urine samples (h-1/h0) was 
used to calculate basal Ucreat (study 2), basal U-AQP2 concentration, basal U-
AQP2/creatinine ratio, and basal Uosm (all studies). In study 3, urine data after 
desmopressin administration were pooled for analysis, because one dog produced 
insufficient urine in the second hour. In study 2, the mean of the first three blood 
samples was used to calculate the basal plasma VP concentration. In study 3, the 
mean of the first two blood samples was used to calculate basal Posm and basal 
plasma concentrations of Na, VP, and TP. Differences in Uosm (studies 1-3), 
Ucreat (study 2), Posm (studies 2-3), and plasma concentrations of Na and TP 
(study 3) were assessed by ANOVA for repeated measurements and the Student-
Newman-Keuls test for multiple comparisons. Values are presented as mean ± 
SEM. Because of the pulsatile nature of VP secretion (Van Vonderen et al. 2003c), 
differences in plasma VP concentrations in studies 2 and 3 were analysed with the 
non-parametric Friedman test and multiple comparisons were conducted using the 
Student-Newman-Keuls test. These data are presented as median and range. 
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Results 
 
Study 1 
The mean basal U-AQP2 concentration was 1.28 ± 0.33 pmol/ml (range 
0.04 – 2.82 pmol/ml) and the mean basal U-AQP2/creatinine ratio was 125 ± 20 x 
10-9 (range 18 – 219 x 10-9). After desmopressin administration in the conjunctival 
sac, mean Uosm increased from 723 ± 138 mOsm/kg to 1021 ± 188 mOsm/kg (h1) 
and 1292 ± 108 mOsm/kg (h2). The mean Uosm 2 hours after desmopressin 
administration (h2) was significantly higher than the basal value. The mean U-
AQP2 concentration increased significantly to 2.05 ± 0.47 pmol/ml (range 0.06 – 
3.64 pmol/ml, h1) and 2.22 ± 0.47 pmol/ml (range 1.21 – 4.37 pmol/ml, h2). The 
mean U-AQP2/creatinine ratio did not change significantly, with values of 117 ± 
29 x 10-9 (range 21 – 224 x 10-9, h1) and 109 ± 20 x 10-9 (range 65 – 201 x 10-9, 
h2).  
 
Study 2 
The mean basal U-AQP2 concentration was 1.45 ± 0.32 pmol/ml (range 
0.53 – 4.34 pmol/ml) and the mean basal U-AQP2/creatinine ratio was 86 ± 6 x  
10-9 (range 59 – 136 x 10-9). During hypertonic saline infusion, the mean Uosm did 
not change significantly, while the mean Ucreat decreased significantly. Parallel 
with Ucreat, the mean U-AQP2 concentration decreased significantly to 0.54 ± 
0.11 pmol/ml (range 0.13 – 0.83 pmol/ml, h1) and to 0.24 ± 0.05 pmol/ml (range 
0.10 – 0.45 pmol/ml, h2). The mean Posm increased significantly from 303 ± 1 
mOsm/kg (basal) to 336 ± 2 mOsm/kg (h2), while the median plasma VP 
concentration increased significantly from 2.2 pmol/l (basal, range 1.1 – 6.3 
pmol/l) to 17.1 pmol/l (h2, range 8.4 – 67 pmol/l) (Figure 1). The mean U-
AQP2/creatinine ratio increased to 108 ± 18 x 10-9 (range 55 – 181 x 10-9, h1) and 
145 ± 23 x 10-9 (range 87 – 233 x 10-9, h2) (Figure 1). The mean U-
AQP2/creatinine ratio after 2 hours of osmotic stimulation (h2) was significantly 
higher than the basal value.  
 
Study 3 
The mean basal U-AQP2 concentration was 3.62 ± 1.03 pmol/ml (range 
0.76 – 8.06 pmol/ml), and the mean basal U-AQP2/creatinine ratio was 231 ± 30 x 
10-9 (range 125 – 482 x 10-9). After water loading, the mean basal Uosm (909 ± 157 
mOsm/kg) decreased significantly to 416 ± 252 mOsm/kg (h1) and 59 ± 6 
mOsm/kg (h2). In addition there were significant decreases in the mean basal Posm 
(309 ± 1 mOsm/kg) to 293 ± 1 mOsm/kg (h1) and 296 ± 2 mOsm/kg (h2), the 
mean basal plasma Na concentration (147 ± 1 mmol/l) to 140 ± 1 mmol/l (h1) and 
141 ± 1 mmol/l (h2), and the mean basal plasma TP concentration (60 ± 1 g/l) to 55 
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Figure 1. Plasma osmolality 
(Posm), plasma vasopressin (VP) 
concentration, and urinary 
aquaporin-2/creatinine (U-AQP2/ 
creat) ratio in 6 healthy beagle dogs 
under basal conditions and during 2 
hours of intravenous osmotic 
stimulation with 20% NaCl 
infusion. Means ± SEM are shown. 
(a = significant difference from the 
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± 1 g/l (h1) and 57 ± 1 g/l (h2). The median plasma VP concentration (4.2 pmol/l, 
range 2.2 – 4.8 pmol/l) decreased to 1.8 pmol/l (range 1.0 – 5.1 pmol/l, h1) and 1.2 
pmol/l (range 1.0 – 1.9 pmol/l, h2) (Figure 2). The mean U-AQP2 concentration 
decreased significantly to 1.0 ± 0.55 pmol/ml (range 0.09 – 2.6 pmol/ml, h1) and 
Figure 2. Plasma vasopressin (VP) 
concentration, plasma osmolality (Posm), 
and urinary aquaporin-2/creatinine (U-
AQP2/creat) ratio in 4 healthy dogs under 
basal conditions (0), 1 and 2 hours after 
oral water loading (1 and 2), and after 
intravenous desmopressin administration 
(3). Means ± SEM are shown. (a = 
significant difference from the basal 
value; b = significant difference from h2) 
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0.05 ± 0.01 pmol/ml (range 0.03 – 0.08 pmol/ml, h2). The mean U-
AQP2/creatinine ratio decreased to 160 ± 30 x 10-9 (range 86 – 228 x 10-9, h1) and 
60 ± 15 x 10-9 (range 31 – 94 x 10-9, h2) (Figure 2). The mean U-AQP2/creatinine 
ratio 2 hours after water loading (h2) was significantly lower than the basal value.  
After desmopressin administration, the mean Uosm significantly increased 
to 836 ± 135 mOsm/kg compared to values 1 and 2 hours after water loading. The 
mean U-AQP2 concentration increased significantly to 3.12 ± 0.6 pmol/ml (range 
1.54 – 4.48 pmol/ml) after desmopressin compared to its concentration 1 and 2 
hours after water loading. The mean U-AQP2/creatinine ratio after desmopressin 
administration (258 ± 56 x 10-9, range 158 – 417 x 10-9) was significantly higher 
than that 2 hours after water loading (Figure 2). 
 
Immunohistochemistry 
Immunohistochemistry revealed extensive labeling for AQP2 exclusively 
in the kidney collecting duct (Figure 3). The AQP2 labeling was distributed 
throughout the cytoplasm, but predominantly localised in the apical and subapical 
region. Control sections revealed no labeling. Results obtained with the ABC and 
immunofluorescence techniques were similar.  
 
 
Discussion 
 
Immunohistochemistry revealed exclusive AQP2 labeling of collecting duct cells 
in the canine kidney. This pattern of labeling is identical to that described earlier in 
the human and rat kidney (Nielsen et al. 1993, Sasaki et al. 1994). The subcellular 
distribution of AQP2 depends on the presence or absence of VP. Prior to VP 
exposure, AQP2 labeling is predominantly localised in intracellular vesicles in 
apical, central, and basal parts of the cells, but also in the apical plasma membrane 
(Nielsen et al. 1993, 1995). After VP exposure, the AQP2 labeling of the apical 
membrane increases markedly, and the vesicles are located mainly in the subapical 
region. Following VP washout, there is a decrease in labeling of the apical plasma 
membrane relative to the intracellular vesicles, and the labeled vesicles are 
distributed throughout the cells. We found AQP2 labeling to be distributed 
predominantly in the apical and subapical region of the canine collecting duct cells, 
which is in accordance with some VP exposure. The results also indicate that the 
rat AQP2 antibody specifically recognises canine AQP2, so that what is measured 
as U-AQP2 can be regarded as derived from renal AQP2. 
There was a large individual variation in basal U-AQP2 excretion, 
expressed as the U-AQP2/creatinine ratio, as has also been found in humans (Elliot  
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et al. 1996, Rai et al. 1997, Saito et al. 1997). This variation may in part be due to 
differences in basal hydration state, plasma VP concentration, or kidney collecting 
duct sensitivity (Elliot et al. 1996, Rai et al. 1997). The levels of U-AQP2 
excretion in dogs seem to be of a similar magnitude compared to those described in 
humans (Saito et al. 1998, 1999, 2001), although the studies are not fully 
comparable due to differences in radioimmunoassay and antibody.  
Urinary AQP2 excretion in dogs closely reflected changes in exposure of 
the collecting duct to VP, elicited by water loading, hypertonic saline infusion, and 
intravenous desmopressin administration. Water loading leads to retrieval of AQP2 
from the apical membrane of kidney collecting duct cells to the intracellular 
vesicles, and thus to decreased water permeability (Marples et al. 1995a). In 
humans and rats, U-AQP2 excretion decreases up to threefold depending on water 
load volume and preceding water deprivation (Kanno et al. 1995, Elliot et al. 1996, 
Saito et al. 1997, Wen et al. 1999). In agreement with these findings, we found a 
decrease in U-AQP2 excretion in our dogs, to 26% of the basal level, 2 hours after 
water loading. 
Figure 3. Immunohistochemical 
localisation of aquaporin-2 in 5-µm 
sections of a canine kidney. Upper 
panel: cortex, lower panel: papilla. 
Labeling was exclusively seen in the 
collecting duct cells, mainly in the 
apical and subapical region. 
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Stimulation by endogenous and exogenous VP results in the translocation of AQP2 
from the intracellular vesicles to the apical membrane of kidney collecting duct 
cells and to an increase in water permeability (Nielsen et al. 1993, DiGiovanni et 
al. 1994, Marples et al. 1995a, Nielsen et al. 1995). It has been established that 
thirst (in rats and humans) and osmotic stimulation by hypertonic saline infusion 
(in humans) increase U-AQP2 excretion (Kanno et al. 1995, Elliot et al. 1996, 
Saito et al. 1997, Wen et al. 1999, Pedersen et al. 2001). Our findings of an 
increased U-AQP2 excretion during hypertonic saline infusion are in accordance 
with these observations. Also our observations in dogs after intravenous 
desmopressin administration agree with the desmopressin-induced increase in U-
AQP2 excretion found in humans and rats (Kanno et al. 1995, Saito et al. 1997, 
Wen et al. 1999). However, in study 1 U-AQP2 excretion did not increase 
significantly after conjunctival administration of desmopressin. These dogs had a 
relatively high Uosm indicative of mild antidiuresis, at the start of the study, which 
limits the potential response to desmopressin (Marples et al. 1995a). Prior water 
loading, as in study 3, might have led to a significant response in U-AQP2 
excretion after desmopressin administration via the conjuctival sac.  
Urinary AQP2 excretion has been proposed as a reliable marker for 
collecting duct responsiveness to VP in various physiological states of water 
homeostasis as well as disorders of water homeostasis in humans (Kanno et al. 
1995, Elliot et al. 1996, Saito et al. 1997, 1998, Mitsuma et al. 1998, Saito et al. 
1999, Matsumoto et al. 2000, Pedersen et al. 2001, Saito et al. 2001). Also in dogs 
U-AQP2 excretion parallels changes in VP exposure, as demonstrated by the 
responses to oral water loading, osmotic stimulation, and intravenous desmopressin 
administration. As in humans, U-AQP2 excretion may be of use as a diagnostic 
tool in canine polyuria, for the differentiation of (partial) central diabetes insipidus, 
(partial) nephrogenic diabetes insipidus, primary polydipsia, and SIADH. In earlier 
studies we found that interpretation of VP measurements during osmotic 
stimulation still leaves unresolved issues in the differentiation of these polyuric 
conditions (Van Vonderen et al. 1999, 2003b). In these situations, measurement of 
AQP2 excretion may be of value. Moreover, compared to VP measurements, the 
easier sample collection and the less time-consuming radioimmunoassay without 
extraction might make U-AQP2 measurement a more convenient and practical tool 
for diagnostic purposes. 
 
 
 
 
Chapter 8 
 
141 
Acknowledgements 
 
The authors would like to thank Dr. M.A. Knepper (NIH, Bethesda, 
Maryland, USA) for donating the AQP2 antibody, and Mr. H. van Engelen, Miss I. 
van der Heijden and Mr. R. Molenbeek for their excellent technical assistance. The 
morphological examination of the kidney immunohistochemistry by Dr. ir. T. van 
Haeften is highly appreciated. 
Chapter 8 
 
142 
References 
 
 
Baumgarten R, van de Pol MHJ, Wetzels JFM, van Os CH, Deen PMT. Glycosylation is 
not essential for vasopressin-dependent routing of aquaporin-2 in transfected Madin-Darby 
canine kidney cells. J Am Soc Nephrol 1998; 9: 1553-1559. 
 
Biewenga WJ, van den Brom WE, Mol JA. Vasopressin in polyuric syndromes in the dog. 
Front Horm Res 1987; 17: 139-148. 
 
Biewenga WJ, Rijnberk A, Mol JA. Osmoregulation of systemic vasopressin release during 
long-term glucocorticoid excess: A study in dogs with hyperadrenocorticism. Acta 
Endocrinol 1991; 124: 583-588. 
 
Cohen M, Post GS. Water transport in the kidney and nephrogenic diabetes insipidus. J Vet 
Intern Med 2002; 16: 510-517. 
 
Deen PMT, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, van Os CH, van 
Oost BA. Requirement of human renal water channel aquaporin-2 for vasopressin-
dependent concentration of urine. Science 1994; 264: 92-95. 
 
Deen PMT, van Aubel RAMH, van Lieburg AF, van Os CH. Urinary content of aquaporin 
1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol 1996; 7: 836-841. 
 
DiGiovanni SR, Nielsen S, Christensen EI, Knepper MA. Regulation of collecting duct 
water channel expression by vasopressin in Brattleboro rat. Proc Nat Acad Sci USA 1994; 
91: 8984-8988. 
 
Elliot S, Goldsmith P, Knepper MA, Haughey M, Olson B. Urinary excretion of aquaporin-
2 in humans: a potential marker of collecting duct responsiveness to vasopressin. J Am Soc 
Nephrol 1996; 7: 403-409. 
 
Higa K, Ochiai H, Fujise H. Molecular cloning and expression of aquaporin-1 (AQP1) in 
dog kidney and erythroblasts. Biochim Biophys Acta 2000; 1463: 374-382. 
 
Hozawa S, Holtzman EJ, Ausiello DA. cAMP motifs regulating transcription in the 
aquaporin 2 gene. Am J Physiol 1996; 270: C1695-C1702. 
 
Kanno K, Sasaki S, Hirata Y, Ishikawa S-E, Fushimi K, Nakanishi S, Bichet DG, Marumo 
F. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995; 
332: 1540-1545. 
 
King LS, Yasui M. Aquaporins and disease: lessons from mice to humans. Trends 
Endocrinol Metab 2002; 13: 355-360. 
Chapter 8 
 
143 
Kishore BK, Terris JM, Knepper MA. Quantitation of aquaporin-2 abundance in 
microdissected collecting ducts: axial distribution and control by AVP. Am J Physiol 1996; 
271: F62-F70. 
 
Madsen O, Deen PMT, Pesole G, Saccone C, de Jong WW. Molecular evolution of 
mammalian aquaporin-2: further evidence that elephant shrew and aardvark join the 
Paenungulate clade. Mol Biol Evol 1997; 14: 363-371. 
 
Marples D, Knepper MA, Christensen EI, Nielsen S. Redistribution of aquaporin-2 water 
channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J 
Physiol 1995a; 269: C655-C664. 
 
Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced 
downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin 
Invest 1995b; 95: 1838-1845. 
 
Marples D, Frøkiær J, Dørup J, Knepper MA, Nielsen S. Hypokalemia-induced 
downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. 
J Clin Invest 1996; 97: 1960-1968. 
 
Marr N, Bichet DG, Hoefs S, Savelkoul PJM, Konings IBM, De Mattia F, Graat MPJ, 
Arthus M-F, Lonergan M, Fujiwara TM, Knoers NVAM, Landau D, Balfe WJ, Oksche A, 
Rosenthal W, Müller D, van Os CH, Deen PMT. Cell-biologic and functional analyses of 
five new aquaporin-2 missense mutations that cause recessive nephrogenic diabetes 
insipidus. J Am Soc Nephrol 2002; 13: 2267-2277.  
 
Matsumoto T, Takeya M, Takuwa S, Hiquchi E, Fujimatsu A, Maeshiro H, Ito Y, Kanno K, 
Sasaki S, Kato H. Suppressed urinary excretion of aquaporin-2 in an infant with primary 
polydipsia. Pediatr Nephrol 2000; 14: 48-52. 
 
Mitsuma T, Takagi J, Otake K, Kayama M, Mori Y, Adachi K, Nogimori T, Sakai J, 
Hirooka Y. Radioimmunoassay for aquaporin-2. Endocr Regul 1998; 32: 141-144. 
 
Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW. Cellular and 
subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc 
Nat Acad Sci USA 1993; 90: 11663-11667. 
 
Nielsen S, Chou C-L, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin 
increases water permeability of kidney collecting duct by inducing translocation of 
aquaporin-CD water channels to plasma membrane. Proc Nat Acad Sci USA 1995; 92: 
1013-1017. 
 
Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and 
hypertonic  saline  infusion  on  urinary  AQP2  excretion  in healthy humans. Am J Physiol  
Chapter 8 
 
144 
Renal Physiol 2001; 280: F860-F867. 
 
Rai T, Sekine K, Kanno K, Hata K, Miura M, Mizushima A, Marumo F, Sasaki S. Urinary 
excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 1997; 
8: 1357-1362. 
 
Rijnberk A. Thyroids. In: Rijnberk A, ed. Clinical Endocrinology of Dogs and Cats. 
Kluwer Academic Publishers: Dordrecht; 1996: 35-59. 
 
Saito T, Ishikawa S-E, Sasaki S, Nakamura T, Rokkaku K, Kawakami A, Honda K, 
Marumo F, Saito T. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes 
insipidus. J Clin Endocrinol Metab 1997; 82: 1823-1827. 
 
Saito T, Ishikawa S-E, Ando F, Okada N, Nakamura T, Kusaka I, Higashiyama M, 
Nagasaka S, Saito T. Exaggerated urinary excretion of aquaporin-2 in the pathological state 
of impaired water excretion dependent upon arginine vasopressin. J Clin Endocrinol Metab 
1998; 83: 4034-4040. 
 
Saito T, Ishikawa S-E, Ito T, Oda H, Ando F, Higashiyama M, Nagasaka S, Hieda M, Saito 
T. Urinary excretion of aquaporin-2 water channel differentiates psychogenic polydipsia 
from central diabetes insipidus. J Clin Endocrinol Metab 1999; 84: 2235-2237. 
 
Saito T, Higashiyama M, Nakamura T, Kusaka I, Nagasaka S, Saito T, Ishikawa S-E. 
Urinary excretion of the aquaporin-2 water channel exaggerated in pathological states of 
impaired water excretion. Clin Endocrinol 2001; 55: 217-221. 
 
Van Vonderen IK, Kooistra HS, Timmermans-Sprang EPM, Rijnberk A. Disturbed 
vasopressin release in 4 dogs with so-called primary polydipsia. J Vet Intern Med 1999; 13: 
419-425. 
 
Van Vonderen IK, Kooistra HS, Peeters ME, Rijnberk A, van den Ingh TSGAM. 
Parathyroid hormone immunohistochemistry in dogs with primary and secondary 
hyperparathyroidism: The question of adenoma and primary hyperplasia. J Comp Pathol 
2003a; 129: 61-69. 
 
Van Vonderen IK, Kooistra HS, Timmermans-Sprang EPM, Meij BP, Rijnberk A. 
Vasopressin response to osmotic stimulation in 18 young dogs with polyuria and 
polydipsia; Vasopressin responsiveness to hypertonicity still the “gold standard”? 
Submitted, 2003b. 
 
Van Vonderen IK, Wolfswinkel J, Oosterlaken-Dijksterhuis MA, Rijnberk A, Kooistra HS. 
Pulsatile secretion pattern of vasopressin under basal conditions, after water deprivation, 
and during osmotic stimulation in dogs. Submitted, 2003c. 
 
Chapter 8 
 
145 
Wang W, Li C, Kwon T-H, Knepper MA, Frøkiær J, Nielsen S. AQP3, p-AQP2, and AQP2 
expression is reduced in polyuric rats with hypercalcemia: prevention by cAMP-PDE 
inhibitors. Am J Physiol Renal Physiol 2002; 283: F1313-F1325. 
 
Wen H, Frøkiær J, Kwon T-H, Nielsen S. Urinary excretion of aquaporin-2 in rat is 
mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 1999; 10: 1416-
1429. 
 
 146 
 147 
 
 
 
 
Chapter 9 
 
 
 
Summarising discussion and conclusions 
 148 
 
Summarising discussion and conclusions 
 
149 
Summarising discussion and conclusions 
 
It is generally accepted that there is a high degree of individual biologic 
variability in urine specific gravity (Usg) and urine osmolality (Uosm) of urine 
samples obtained at different times of the day from the same dog (Chew and 
DiBartola 1989, Finco 1989). Therefore, basing the assessment of urinary 
concentrating ability on a single urine sample may be misleading, and a second 
sample or a series of samples should be obtained to confirm any abnormality 
(Chew and DiBartola 1989). However, few studies have investigated the normal 
range of these variables in healthy dogs. The observations in 89 healthy dogs 
described in Chapter 3 indicate that the ranges of Usg (1.006 - >1.050) and Uosm 
(161 – 2830 mOsm/kg) values are much larger than previously thought. Urine 
concentration was significantly higher in the morning than in the evening, and was 
not related to gender. Urinary concentrating ability decreased significantly with 
age, which could not be ascribed to an associated increase in glucocorticoid 
production. In parallel to the situation in other species, the impaired urine 
concentration during aging may be caused by an age-associated reduction in renal 
responsiveness to vasopressin (VP) (Geelen and Corman 1992), or to a decline in 
glomerular filtration rate (Lindeman et al. 1960). 
In addition to the large interindividual variation in Uosm, in some dogs 
Uosm varied widely during the day with the intraindividual coefficient of variation 
approaching the interindividual coefficient of variation. Two- to three-fold 
increases or decreases in Uosm often occurred within two hours. Possible factors 
underlying the fluctuation in Uosm during the day may be the effect of activity and 
feeding on drinking behaviour (O’Connor 1975, Meyer et al. 1994). Stimulation of 
oropharyngeal receptors leads to an early satiation of thirst (Thrasher et al. 1981), 
but apparently this does not prevent some dogs from drinking excessive amounts of 
water, although not to an extent that the owners perceived the dogs to have 
polyuria and polydipsia (PUPD). The results of the study reported in Chapter 3 
lead to the conclusion that whenever the suspicion of PUPD arises, urine samples 
should be collected every two hours to measure Uosm, and this approach may 
prevent the need for further studies.  
  
 The results of the study reported in Chapter 4 demonstrate that VP release 
is impaired in dogs with secondary polycythaemia due to renal neoplasm. During 
hypertonic saline infusion, the osmotic threshold of VP release was markedly 
increased and the sensitivity of the response was low. Polyuria and polydipsia are 
an important clinical feature of secondary polycythaemia in dogs (Peterson and 
Randolph 1983, Campbell 1990). The increase in red blood cell mass leads to 
hyperviscosity of the blood and to an increased blood volume (Peterson and 
Randolph 1983, Campbell 1990), and these factors may stimulate the atrial and 
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carotid bifurcation baroreceptors controlling VP release. It is indeed well known 
that hypervolaemia impairs the VP response to osmotic stimulation in humans and 
dogs, resulting in an increased threshold and a decreased sensitivity of the 
osmoregulatory VP response (Robertson and Athar 1976, Quillen and Cowley 
1983). In addition, the increased blood volume in secondary polycythaemia may 
lead to an increased release of atrial natriuretic peptide due to the atrial stretch. 
Atrial natriuretic peptide not only inhibits the renal responsiveness to VP, but may 
also impair VP release (Dillingham and Anderson 1986, Iitake et al. 1986). 
Therefore, both the hypervolaemia per se and the resulting increase in atrial 
natriuretic peptide may underlie the impaired osmoregulation of VP release in dogs 
with secondary polycythaemia. The results of the study indicate that, in secondary 
polycythaemia, the associated polyuria is at least in part the result of impaired VP 
release.  
  
 Primary polydipsia is characterised by a marked increase in water intake 
that cannot be explained as a compensatory mechanism for excessive fluid loss 
(Dunn 1990). Therefore, there is no urinary concentrating defect, and the diagnosis 
can be made when Uosm exceeds 1000 mOsm/kg during water deprivation, while 
plasma osmolality (Posm) remains below the upper limit of its reference range. The 
results of the study described in Chapter 5 indicate that some of the dogs fulfilling 
the criteria of primary polydipsia produced concentrated urine spontaneously 
during the day. Serial measurements of Uosm (collected every 2 hours for 24 
hours, with an interval of 4 hours during the night) demonstrated large fluctuations 
in Uosm in these dogs with some Uosm values exceeding 1000 mOsm/kg. This 
pattern of Uosm was very similar to that of some healthy pet dogs without noticed 
PUPD described in Chapter 3. Apparently, the water intake in the dogs with 
primary polydipsia exceeded the variation observed in healthy dogs to such an 
extent that the owners sought veterinary help. Based on the results of the studies 
described in Chapters 3 and 5, it can be concluded that a water deprivation test 
need not be performed in all polyuric dogs. When pronounced fluctuations are 
found in Uosm during serial measurements and some Uosm values exceed 1000 
mOsm/kg, the diagnosis of primary polydipsia seems justified.  
 Dogs fulfilling the criteria of primary polydipsia do not seem to encompass 
a uniform syndrome. In the dogs that produced concentrated urine spontaneously 
during the day, Posm and plasma sodium (Na) concentration remained at the lower 
limit or the middle of their reference ranges. Other dogs only reached the limit of 
1000 mOsm/kg during water deprivation, while both Posm and plasma Na 
concentration were at the upper level of their reference ranges. These observations 
suggest that dogs diagnosed as having primary polydipsia may comprise two 
groups, as has been reported for humans with primary polydipsia: polydipsic 
patients with and without hyponatraemia (Goldman et al. 1996). Apart from this 
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heterogeneity, also the VP response to osmotic stimulation was not uniform, albeit 
abnormal in all dogs. These abnormalities included episodes of hypersecretion, as 
well as delayed responses to plasma hypertonicity. In several dogs initial high 
plasma VP levels were found during water deprivation and/or osmotic stimulation. 
These findings may represent bursts of VP release, similar to those that occur in the 
syndrome of inappropriate VP secretion (SIADH) (Rijnberk et al. 1988), or they 
may reflect the (normal) pulsatile character of VP release. The disturbed VP 
response to osmotic stimulation in dogs with primary polydipsia may be interpreted 
as a primary disturbance in the regulation of VP secretion, although it might also 
be the result of overhydration caused by a primary abnormality in drinking 
behaviour. 
 
 Common disorders of water homeostasis leading to polyuria include a 
variety of endocrine, metabolic, and renal disturbances. After exclusion of most of 
these conditions, there may remain the diagnostic dilemma of differentiating 
between central diabetes insipidus, primary polydipsia, and nephrogenic 
abnormalities (Nichols 1992, Greco 2001). The most powerful diagnostic tool for 
differentiation of these conditions is the hypertonic saline infusion test, with 
measurement of Posm and plasma VP concentration (Diederich et al. 2001). The 
study described in Chapter 6 reports on eighteen young polyuric dogs categorised 
according to the plasma VP response to hypertonic saline infusion. In all dogs the 
VP response was abnormal. Three categories could be distinguished: (a) a 
hyperresponse, (b) a hyporesponse, and (c) a non-linear response with high VP 
values unrelated to increases in Posm. Similar to the situation in the polyuric dogs 
described in Chapter 5, the VP peaks (up to 150 pmol/l) of the dogs with a non-
linear response might represent the erratic secretory bursts known to occur in 
SIADH. However, the early peaks, in particular, could also reflect a pulsatile 
release pattern of VP, which may be either physiological or induced by the 
beginning increase in tonicity. In accordance with the results of the study described 
in Chapter 5, (seemingly) abnormal VP responses to hypertonicity were found in 
the dogs with variations in Uosm compatible with primary polydipsia. When the 
three categories of VP response were considered together with the results of other 
diagnostic procedures (serial measurements of Uosm, water deprivation, and 
response to desmopressin administration), it appeared that the VP response to 
hypertonicity did not consistently distinguish between the different clinical 
conditions. In all three categories, there were dogs with an inadequate 
concentrating ability and dogs diagnosed as having primary polydipsia. Thus, the 
data presented in Chapter 6 question the generally accepted notion that VP 
measurements during hypertonic saline infusion are the “gold standard” for the 
diagnosis of polyuric conditions. 
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The results of the study described in Chapter 7 indicate that in dogs VP is 
secreted in a pulsatile fashion with a wide variation in the number of VP pulses, VP 
pulse duration, and VP pulse amplitude and height. Episodic VP secretion during 
severe dehydration and osmotic stimulation has been reported earlier in dogs 
(Weitzman et al. 1977), but Chapter 7 describes the first report documenting the 
pulsatile secretion of VP under basal conditions. By means of the Pulsar 
programme developed by Merriam and Wachter (1982), secretory pulses were 
identified by their height and duration from a smoothed baseline, using the assay 
standard deviation as a scale factor. Thus, apart from pulse characteristics and total 
VP secretion, basal VP secretion and pulsatile VP secretion could be determined. 
After twelve hours of water deprivation, total and basal VP secretion, the number 
of significant VP pulses, as well as the pulse characteristics did not differ from 
those under basal conditions. Apparently, VP secretory activity is not influenced by 
mild dehydration to the extent that changes in VP secretion could be detected in 
samples collected at 2-min intervals. During osmotic stimulation with hypertonic 
saline, there was a large increase in both basal and pulsatile VP secretion. The 
number of VP pulses and the VP pulse height and amplitude were significantly 
increased compared to the basal and water-deprived state. As volume loss due to 
blood sampling was substituted, and the presence of other stimuli on VP release, 
such as nausea, was unlikely, the increase in VP pulsatile secretion upon infusion 
of hypertonic saline can solely be attributed to the stimulation of osmoreceptors.  
The pulsatile secretion pattern of VP in dogs may explain part of the non-
linear VP responses to osmotic stimulation, as observed in the polyuric dogs 
described in Chapters 5 and 6. In some of these dogs VP peaks occurred that did 
not seem to relate to the gradual rise in Posm in response to the hypertonic saline 
infusion. In addition, in some cases the plasma VP concentration at the start of 
osmotic stimulation or water deprivation was high. A pathological origin of the VP 
peaks in these polyuric dogs cannot be excluded. The results reported in Chapter 7 
demonstrate that in healthy dogs VP pulses can occur of a height that would lead to 
high points outside the nomogram for the (linear) relation between Posm and 
plasma VP concentrations (Zerbe et al. 1980). Such VP pulses may erroneously be 
interpreted as erratic, and consequently, a false positive diagnosis of SIADH could 
be made. Thus, apart from the finding that the VP response to hypertonicity did not 
consistently distinguish between different clinical entities, as reported in Chapter 
6, the results of the study reported in Chapter 7 indicate that the occurrence of 
spontaneous VP pulses may severely hamper the interpretation of the curve 
describing the relationship between Posm and plasma VP concentration during 
osmotic stimulation. 
 
Chapter 8 is the first report to describe the development of a 
radioimmunoassay for the measurement of urinary aquaporin-2 (U-AQP2) 
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excretion in dogs. Aquaporin-2, the VP-regulated water channel, is localised in the 
apical membrane and the intracellular vesicles of the kidney collecting duct cells 
(Nielsen et al. 1993). Studies in rats revealed that 3% of total kidney AQP2 is 
excreted into the urine by a selective apical pathway (Rai et al. 1997). Basal U-
AQP2 excretion in healthy dogs, expressed as the U-AQP2/creatinine ratio, varied 
similarly to the large individual variation in U-AQP2 excretion found in humans 
(Saito et al. 1997). This variation may in part be due to differences in basal 
hydration state, plasma VP concentration, or kidney collecting duct sensitivity (Rai 
et al. 1997). The levels of U-AQP2 excretion in dogs seem to be of a similar 
magnitude compared to those described in humans (Saito et al. 2001). Urinary 
AQP2 excretion in dogs closely reflected changes in the collecting duct exposure to 
VP elicited by water loading, hypertonic saline infusion, and intravenous 
desmopressin administration. After oral water loading, U-AQP2 excretion 
decreased significantly, whereas stimulation by endogenous and exogenous VP 
resulted in a significant increase in U-AQP2 excretion, which is in accordance with 
earlier studies in humans (Saito et al. 1997, Pedersen et al. 2001). 
Immunohistochemistry of canine kidney tissue demonstrated extensive labeling for 
AQP2 predominantly in the apical and subapical region of the collecting duct cells, 
consistent with the localisation of the VP-regulated water channel in the 
intracellular vesicles (Nielsen et al. 1993).  
Urinary AQP2 excretion has been proposed as a reliable marker for 
collecting duct responsiveness to VP in various physiological states of water 
homeostasis as well as disorders of water homeostasis in humans. In water 
retention disorders, U-AQP2 excretion is exaggerated (Saito et al. 2001), whereas 
downregulation of AQP2 is found in hereditary and acquired nephrogenic diabetes 
insipidus (Deen et al. 1994, Wang et al. 2002). Urinary AQP2 excretion may 
contribute to the differentiation of polyuric conditions such as central diabetes 
insipidus, nephrogenic diabetes insipidus, and primary polydipsia (Kanno et al. 
1995). Also in dogs, U-AQP2 excretion seems to parallel changes in VP action, as 
demonstrated by the responses to oral water loading, osmotic stimulation, and 
intravenous desmopressin administration. As in humans, U-AQP2 excretion may 
be of use as a diagnostic tool in canine polyuria, for the differentiation of (partial) 
central diabetes insipidus, (partial) nephrogenic diabetes insipidus, primary 
polydipsia, and SIADH. As described in Chapters 5-7, the interpretation of VP 
measurements during osmotic stimulation still leaves unresolved issues regarding 
the differentiation of these polyuric conditions. Particularly in this dilemma, 
measurements of U-AQP2 excretion may be helpful. 
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The following conclusions can be drawn: 
• Because of the wide spontaneous fluctuations in Uosm occurring in healthy 
dogs, documentation of polyuria cannot be based on the measurement of 
Uosm in a single urine sample. 
• Measurement of Uosm at 2-hour intervals may allow the diagnosis of 
primary polydipsia, thereby avoiding further clinical studies. 
• Polyuria in dogs with secondary polycythaemia due to renal neoplasm is 
associated with an impaired osmoregulation of VP release. 
• In dogs supposedly having primary polydipsia a wide variation in VP 
responses to hypertonic stimulation can be found. 
• As the VP response to hypertonic saline infusion does not consistently 
distinguish between some forms of polyuria, it is questionable whether VP 
measurements during osmotic stimulation are the “gold standard” for 
differentiation of canine polyuria. 
• In the dog, VP is secreted in a pulsatile fashion with a wide variation in the 
number of VP pulses, VP pulse duration, and VP pulse amplitude and 
height. 
• Mild dehydration does not influence VP pulsatile secretion, whereas 
osmotic stimulation significantly increases basal and pulsatile VP release 
in the dog. 
• The occurrence of spontaneous VP pulses may severely hamper the 
interpretation of the curve describing the relationship between Posm and 
plasma VP concentration during osmotic stimulation. 
• In healthy dogs, U-AQP2 excretion closely reflects changes in collecting 
duct exposure to VP. 
• Measurement of U-AQP2 excretion in polyuric dogs may be helpful in the 
differentiation of (partial) central diabetes insipidus, (partial) nephrogenic 
diabetes insipidus, primary polydipsia, and SIADH. 
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In de laatste decennia is de indruk ontstaan dat er een grote intraindividuele 
variatie bestaat van het soortelijk gewicht (Usg) en de osmolaliteit (Uosm) van 
urinemonsters verzameld op verschillende momenten van de dag bij dezelfde hond 
(Chew en DiBartola 1989, Finco 1989). Het gebruik van één urinemonster om het 
concentrerend vermogen van de nieren te beoordelen kan dan ook misleidend zijn. 
Onderzoek van enkele urinemonsters kan nodig zijn om een afwijking vast te 
stellen (Chew en DiBartola 1989). Er zijn echter maar weinig rapportages over 
deze variabelen bij gezonde honden. De waarnemingen bij 89 gezonde honden, 
zoals beschreven in Hoofdstuk 3 tonen aan dat de variaties van Usg (1.006 - 
>1.050) en van Uosm (161 – 2830 mOsm/kg) veel groter zijn dan tot voor kort 
werd aangenomen. De concentratie van de urine was ’s ochtends significant hoger 
dan ’s avonds, en was niet gerelateerd aan het geslacht. Er was een significante 
afname van de urineconcentratie met de leeftijd, hetgeen niet verklaard kon worden 
door een toename in glucocorticoidproductie. Evenals bij de mens en de rat kan de 
daling van de urineconcentratie met de leeftijd wellicht verklaard worden door een  
afname van de gevoeligheid van de nieren voor vasopressine (VP) (Geelen en 
Corman 1992), of een afname van de glomerulaire filtratiesnelheid (Lindeman et 
al. 1960).  
Naast de ruime interindividuele variatie van de Uosm, was er bij sommige 
honden ook een grote fluctuatie van de Uosm tijdens de dag, waarbij de 
intraindividuele variatiecoëfficiënt overeenkwam met de interindividuele 
variatiecoëfficiënt. Twee- tot drievoudige toe- of afnamen van de Uosm traden 
vaak binnen een tijdsbestek van twee uur op. De fluctuatie in Uosm kan wellicht 
verklaard worden door het effect van lichaamsbeweging en voeding op het 
drinkgedrag (O’Connor 1975, Meyer et al. 1994). Stimulatie van orofaryngeale 
receptoren geeft normaliter in een vroeg stadium verzadiging van de dorstbehoefte 
(Thrasher et al. 1981). Blijkbaar kan dit niet voorkomen dat sommige honden grote 
hoeveelheden water drinken, al leidde dit niet tot voor de eigenaar merkbare 
polyurie en polydipsie (PUPD). De bevindingen beschreven in Hoofdstuk 3 
hebben tot een andere diagnostische aanpak geleid van patiënten verdacht van 
PUPD. Verzameling van urinemonsters met een interval van twee uur voor de 
bepaling van Uosm kan bij sommige honden verder onderzoek voorkomen. 
 
De resultaten van het onderzoek beschreven in Hoofdstuk 4 laten een 
verminderde VP-afgifte zien bij honden met secundaire polycythemie als gevolg 
van een niertumor. Tijdens osmotische stimulatie met een hypertoon zoutinfuus 
was de drempelwaarde van de VP-afgifte verhoogd en de sensitiviteit van de 
respons laag. Polyurie en polydipsie zijn belangrijke klinische symptomen van 
secundaire polycythemie bij de hond (Peterson en Randolph 1983, Campbell 
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1990). De toegenomen massa van de rode bloedcellen leidt tot een stijging van de 
viscositeit van het bloed en een toegenomen bloedvolume (Peterson en Randolph 
1983, Campbell 1990), hetgeen de baroreceptoren die de VP-afgifte beïnvloeden 
kan stimuleren. Het is inderdaad bekend dat een toegenomen bloedvolume de VP-
respons op osmotische stimulatie vermindert, resulterend in een hogere drempel en 
een lagere sensitiviteit van de VP-afgifte (Robertson en Athar 1976, Quillen en 
Cowley 1983). Daarnaast kan het toegenomen bloedvolume bij secundaire 
polycythemie ook leiden tot een stijging van de afgifte van het atriale natriuretische 
peptide. Dit peptide remt niet alleen de gevoeligheid van de nieren voor VP, maar 
kan ook de VP-afgifte verzwakken (Dillingham en Anderson 1986, Iitake et al. 
1986). Zowel het toegenomen bloedvolume, als de resulterende toename in het 
atriale natriuretische peptide kunnen dus de gestoorde osmoregulatie van de VP-
afgifte bij honden met secundaire polycythemie verklaren.  
 
Primaire polydipsie wordt gekenmerkt door een toename van de 
wateropname, die niet gerelateerd is aan een verhoogd vochtverlies (Dunn 1990). 
Derhalve is er geen defect in het concentrerend vermogen van de nieren, en kan de 
diagnose gesteld worden wanneer Uosm >1000 mOsm/kg bedraagt tijdens 
wateronthouding, terwijl de plasma osmolaliteit (Posm) binnen het referentiegebied 
blijft. De resultaten van het onderzoek beschreven in Hoofdstuk 5 laten zien dat 
sommige honden met kenmerken van primaire polydipsie spontaan kunnen 
concentreren. Tijdens een dagcurve van Uosm (elke 2 uur gemeten gedurende de 
dag, en ’s nachts met een interval van 4 uur) treden er bij deze honden grote 
fluctuaties op van de Uosm, met op sommige momenten een Uosm >1000 
mOsm/kg. Dit patroon van Uosm is vergelijkbaar met dat van enkele gezonde 
honden zonder merkbare PUPD (Hoofdstuk 3). Blijkbaar varieert de wateropname 
bij honden met primaire polydipsie sterker dan bij sommige gezonde honden. Op 
basis van de resultaten van de onderzoeken beschreven in Hoofdstukken 3 en 5 
kan geconcludeerd worden dat een dorstproef niet noodzakelijk is bij alle honden 
met polyurie. Wanneer er grote fluctuaties in Uosm optreden tijdens een dagcurve, 
en sommige waarden van Uosm >1000 mOsm/kg bedragen, lijkt de diagnose 
primaire polydipsie gerechtvaardigd. 
Honden die voldoen aan de criteria van primaire polydipsie vertonen geen 
uniform beeld. Bij de honden die spontaan een goede urineconcentratie bereikten 
tijdens de dag, bleven Posm en de plasma natrium concentratie ([Na+]) bij de 
ondergrens of in het midden van het referentiegebied. Andere honden daarentegen 
bereikten pas een Uosm van 1000 mOsm/kg tijdens wateronthouding, terwijl zowel 
Posm als [Na+] zich bij de bovengrens van de referentiegebied bevonden. Deze 
waarnemingen suggereren een tweedeling bij de groep honden met primaire 
polydipsie, zoals al eerder beschreven bij de mens: polydipsie met en zonder lage 
[Na+] (Goldman et al. 1996). Daarnaast was ook de VP-afgifte tijdens hypertoon 
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zoutinfuus niet uniform bij honden met primaire polydipsie, hoewel er een 
afwijking was bij alle honden. Naast een vertraagde VP-afgifte tijdens osmotische 
stimulatie, kwamen er ook episoden met hypersecretie voor. Bij sommige honden 
waren de initiële plasma-VP-concentraties tijdens wateronthouding en/of 
osmotische stimulatie hoog. Deze hoge waarden kunnen passen bij de plotselinge 
uitstoot van VP zoals bekend van het syndroom van onaangepaste VP-afgifte 
(SIADH) (Rijnberk et al. 1988), of ze kunnen passen bij een pulsatiele afgifte van 
VP. De afwijkende VP-afgifte tijdens osmotische stimulatie bij honden met een 
beeld passend bij primaire polydipsie kan geïnterpreteerd worden als een primaire 
afwijking van de regulatie van de VP-afgifte, maar kan ook het gevolg zijn van 
overhydratie passend bij een primaire afwijking in het drinkgedrag.  
 
Verstoringen van de waterhomeostase leidend tot polyurie omvatten een 
groot scala aan endocriene, metabole en renale afwijkingen. Na het uitsluiten van 
het merendeel van deze oorzaken, resteert het diagnostische dilemma van het 
onderscheid tussen centrale diabetes insipidus, primaire polydipsie en nefrogene 
afwijkingen (Nichols 1992, Greco 2001). Het belangrijkste diagnostische 
hulpmiddel hierbij is de zoutbelasting, waarbij zowel Posm als plasma-VP-
concentraties worden gemeten (Diederich et al. 2001). Hoofdstuk 6 beschrijft 18 
jonge honden met polyurie, ingedeeld in categorieën aan de hand van de plasma-
VP-respons tijdens zoutbelasting. De VP-afgifte was bij alle honden afwijkend, 
waarbij er drie categorieën werden onderscheiden: (a) een hyperrespons, (b) een 
hyporespons, en (c) een non-lineaire respons met hoge VP-waarden los van 
stijgingen van de Posm. Vergelijkbaar met de situatie bij de honden met polyurie 
beschreven in Hoofdstuk 5, kunnen de hoge VP-waarden (tot 150 pmol/l) van de 
honden met een non-lineaire respons passen bij de grillige VP-afgifte zoals die 
bekend is van SIADH. In het bijzonder de vroege VP-pieken kunnen een 
afspiegeling zijn van een pulsatiel afgiftepatroon van VP, dat zowel fysiologisch 
kan zijn alsook geïnduceerd door de beginnende osmotische stimulatie. In 
overeenstemming met de resultaten van het onderzoek beschreven in Hoofdstuk 5, 
was de VP-afgifte tijdens osmotische stimulatie afwijkend bij de honden met 
variaties in Uosm passend bij primaire polydipsie. Bij het beoordelen van de 
samenhang tussen de VP-respons en de resultaten van de andere diagnostische 
testen (dagcurve, dorstproef, en de respons op desmopressine toediening), bleek dat 
de VP-respons tijdens osmotische stimulatie niet altijd onderscheid kon maken 
tussen verschillende klinische afwijkingen waarbij polyurie optreedt. In alle drie 
categorieën bevonden zich honden met onvoldoende concentrerend vermogen en 
honden met primaire polydipsie. Dit doet de vraag rijzen of VP-bepalingen tijdens 
hypertoon zoutinfuus wel de “gouden standaard” vormen voor de diagnostiek van 
polyurie bij de hond. 
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De resultaten van het onderzoek beschreven in Hoofdstuk 7 laten zien dat 
VP bij de hond pulsatiel wordt afgegeven, met een grote variatie in het aantal 
pulsen, de pulsduur, de pulshoogte en de pulsamplitude. Het voorkomen van VP-
pieken tijdens dehydratie en osmotische stimulatie was al eerder gerapporteerd bij 
de hond (Weitzman et al. 1977), maar de pulsatiele afgifte van VP onder basale 
omstandigheden was niet eerder beschreven. Met behulp van het Pulsar programma 
(Merriam en Wachter 1982) werden significante pulsen geïdentificeerd aan de hand 
van pulsduur en pulshoogte vanaf een berekende basaallijn. Naast de totale VP-
afgifte en de pulskarakteristieken, konden ook de basale VP-afgifte en de pulsatiele 
VP-afgifte worden bepaald. Na twaalf uur wateronthouding waren de totale VP-
afgifte, de basale VP-afgifte, het aantal significante VP-pulsen en de 
pulskarakteristieken identiek aan de basale situatie. Blijkbaar wordt het VP-
afgiftepatroon niet zodanig beïnvloed door milde dehydratie dat er veranderingen 
worden gevonden wanneer met een interval van 2 minuten VP wordt gemeten. 
Tijdens osmotische stimulatie met hypertoon zout was er een duidelijke toename 
van de basale en de pulsatiele VP-afgifte. Het aantal VP-pulsen en de VP-
pulshoogte en –amplitude waren significant hoger dan onder basale 
omstandigheden en tijdens wateronthouding. Aangezien het vochtverlies tijdens 
bloedafname gesubstitueerd werd, en de aanwezigheid van andere stimulerende 
factoren zoals misselijkheid onwaarschijnlijk lijkt, kan de toename van de 
pulsatiele afgifte van VP tijdens hypertoon zoutinfuus worden toegeschreven aan 
de stimulatie van osmoreceptoren. 
Het pulsatiele afgiftepatroon van VP bij de hond verklaart (voor een deel) 
de non-lineaire VP-afgifte tijdens osmotische stimulatie bij de honden met polyurie 
beschreven in Hoofdstukken 5 en 6. Bij sommige van deze honden werden VP-
pieken gemeten die niet proportioneel gerelateerd waren aan stijgingen van de 
Posm. Daarnaast was in sommige gevallen de initiële plasma-VP-concentratie 
voorafgaand aan wateronthouding of osmotische stimulatie al vrij hoog. 
Desalniettemin kan een pathologische oorzaak van deze VP-pieken niet geheel 
worden uitgesloten. De resultaten beschreven in Hoofdstuk 7 laten zien dat bij 
gezonde honden VP-pulsen kunnen voorkomen die buiten het nomogram vallen dat 
de (lineaire) relatie tussen Posm en plasma-VP-concentratie beschrijft (Zerbe et al. 
1980). Zulke VP-pulsen kunnen abusievelijk worden aangezien voor de grillige 
afgifte zoals bekend bij SIADH, waarmee een foutieve diagnose gesteld zou 
worden. Naast de bevinding dat de VP-respons tijdens osmotische stimulatie niet 
altijd onderscheid kan maken tussen verschillende klinische afwijkingen waarbij 
polyurie optreedt, zoals beschreven in Hoofdstuk 6, blijkt uit het onderzoek 
beschreven in Hoofdstuk 7 ook dat het voorkomen van spontane VP-pulsen de 
interpretatie van de resultaten van de zoutbelasting ernstig kan bemoeilijken. 
 
Samenvatting en conclusies 
 
165 
Hoofdstuk 8 beschrijft de ontwikkeling van een radioimmunoassay voor 
de bepaling van de uitscheiding van aquaporine-2 (AQP2) in hondenurine. 
Aquaporine-2, het VP-gereguleerde waterkanaal, bevindt zich in de apicale 
membraan en de intracellulaire vesikels van de verzamelbuiscellen in de nieren 
(Nielsen et al. 1993). Onderzoek bij ratten heeft aangetoond dat 3% van de totale 
hoeveelheid AQP2 in de nieren met de urine wordt uitgescheiden via een selectief 
apicaal pad (Rai et al. 1997). De basale uitscheiding van AQP2 in de urine van 
gezonde honden, uitgedrukt als de AQP2/kreatinine ratio, vertoonde dezelfde grote 
individuele variatie als de AQP2-uitscheiding bij mensen (Saito et al. 1997). Deze 
variatie berust waarschijnlijk op verschillen in basale hydratatiestatus, plasma-VP-
concentraties en/of gevoeligheid van de nieren voor VP (Rai et al. 1997). De totale 
hoeveelheid AQP2 in de urine van de hond en de mens is van een vergelijkbaar 
niveau (Saito et al. 2001). De uitscheiding van AQP2 met de urine bij gezonde 
honden bleek een goede afspiegeling te zijn van de respons van de verzamelbuizen 
op VP, zowel bij waterbelasting als bij hypertoon zoutinfuus en intraveneuze 
desmopressine-toediening. Na orale waterbelasting nam de uitscheiding van AQP2 
met de urine significant af, terwijl stimulatie door middel van endogeen en exogeen 
VP leidde tot een significante toename van de uitscheiding van AQP2. Deze 
bevindingen komen overeen met de resultaten van eerdere studies bij mensen 
(Saito et al. 1997, Pedersen et al. 2001). Bij immunohistochemisch onderzoek van 
nierweefsel van de hond werd uitgebreide AQP2-kleuring in het cytoplasma van de 
verzamelbuiscellen gevonden, passend bij de localisatie van AQP2 in de 
intracellulaire vesikels (Nielsen et al. 1993).  
De uitscheiding van AQP2 met de urine lijkt een betrouwbare afspiegeling 
te zijn van de respons van de verzamelbuizen op VP tijdens fysiologische 
omstandigheden en bij stoornissen van de waterhomeostase bij mensen. Bij 
ziektebeelden waarbij vocht wordt vastgehouden is de uitscheiding van AQP2 met 
de urine verhoogd (Saito et al. 2001), terwijl verminderde uitscheiding van AQP2 
met de urine wordt gevonden bij erfelijke en verkregen vormen van nefrogene 
diabetes insipidus waarbij de nieren minder gevoelig zijn voor VP (Deen et al. 
1994, Wang et al. 2002). Daarnaast kan de uitscheiding van AQP2 met de urine 
ook bijdragen aan het onderscheid tussen diverse vormen van polyurie bij de mens, 
zoals bijvoorbeeld centrale diabetes insipidus, nefrogene diabetes insipidus en 
primaire polydipsie (Kanno et al. 1995). Ook bij de hond lijkt de uitscheiding van 
AQP2 met de urine een goede afspiegeling te zijn van de reactie van de 
verzamelbuizen op VP, zoals in dit onderzoek aangetoond aan de hand van de 
reacties op waterbelasting, osmotische stimulatie en intraveneuze 
desmopressinetoediening. Vergelijkbaar met de situatie bij mensen zou de bepaling 
van de uitscheiding van AQP2 met de urine wellicht waardevol kunnen zijn voor 
de diagnostiek van polyurie bij de hond, en dan vooral voor het onderscheid tussen 
(partiële) centrale diabetes insipidus, (partiële) nefrogene diabetes insipidus, 
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primaire polydipsie en SIADH. Zoals beschreven in Hoofdstukken 5-7, resteren er 
in diverse gevallen na interpretatie van de plasma-VP-concentraties tijdens 
osmotische stimulatie nog vragen. Voor de beantwoording van deze vragen zou de 
AQP2-uitscheiding met de urine van nut kunnen zijn.  
 
 
De volgende conclusies kunnen worden getrokken: 
• Aangezien er bij gezonde honden spontaan grote fluctuaties kunnen 
optreden in de Uosm, kan de documentatie van polyurie niet gebaseerd 
worden op de meting van Uosm in één enkel urinemonster.  
• Wanneer de Uosm elke 2 uur wordt gemeten tijdens een dagcurve kan in 
sommige gevallen de diagnose primaire polydipsie al worden gesteld, en is 
verder onderzoek niet nodig. 
• Polyurie bij honden met secundaire polycythemie als gevolg van een 
niertumor gaat gepaard met een afwijkende osmoregulatie van de VP-
afgifte. 
• Bij honden met kenmerken van primaire polydipsie kunnen verschillende 
afwijkingen van de VP-afgifte tijdens osmotische stimulatie worden 
gevonden. 
• Aangezien de VP-respons tijdens osmotische stimulatie niet altijd 
onderscheid kan maken tussen verschillende klinische afwijkingen waarbij 
polyurie optreedt, is het twijfelachtig of VP-bepalingen tijdens hypertoon 
zoutinfuus als de “gouden standaard” beschouwd kunnen worden voor de 
diagnostiek van polyurie bij de hond. 
• Bij de hond wordt VP in een pulsatiel patroon afgegeven met een grote 
variatie in het aantal pulsen, de pulsduur, de pulshoogte en de 
pulsamplitude. 
• Milde dehydratie beïnvloedt het pulsatiele afgiftepatroon van VP bij de 
hond niet, terwijl osmotische stimulatie leidt tot een significante toename 
van de basale en pulsatiele VP-afgifte. 
• Het voorkomen van spontane VP-pulsen kan de interpretatie van de curve, 
die het verband tussen de Posm en de plasma-VP-concentratie tijdens 
osmotische stimulatie beschrijft, bemoeilijken. 
• Bij gezonde honden is de uitscheiding van AQP2 met de urine een goede 
afspiegeling van de reactie van de verzamelbuizen op VP. 
• Bepaling van de AQP2-uitscheiding met de urine bij honden met polyurie 
kan waardevol zijn voor het onderscheid tussen (partiële) centrale diabetes 
insipidus, (partiële) nefrogene diabetes insipidus, primaire polydipsie en 
SIADH. 
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Dit proefschrift is mede tot stand gekomen dankzij de inzet, de adviezen en 
de steun van vele mensen. Op deze plaats wil ik graag eerst iedereen die op 
enigerlei wijze heeft bijgedragen aan dit proefschrift hartelijk bedanken voor hun 
inspanningen! Een aantal mensen wil ik graag apart bedanken. 
Allereerst mijn promotor, Prof. dr. A. Rijnberk. Beste Ad, jouw geweldige 
belangstelling en inzet voor zowel endocrinologie als onderzoek hebben mij 
geïnspireerd als dierenarts en als onderzoeker! Wat in 1994 begon als een 
“Excellent tracé” onderzoek, is uiteindelijk uitgegroeid tot het huidige proefschrift. 
Ik wil je graag bedanken voor al je adviezen en je ondersteuning bij het schrijven 
van wetenschappelijke artikelen, en je uitstekende begeleiding van mijn onderzoek. 
Daarnaast ben ik je zeer erkentelijk voor het vertrouwen dat je in mij hebt gesteld 
door mij aan dit promotie-onderzoek te laten beginnen. 
Mijn co-promotor Dr. H.S. Kooistra. Beste Hans, met jouw grote 
enthousiasme en inzet heb je mij enorm gesteund tijdens het schrijven van dit 
proefschrift. Op alle uren van de dag kon ik bij je aankloppen voor advies en “een 
paar” vraagjes. Ik heb de samenwerking met jou bijzonder gewaardeerd, en ik wil 
je graag bedanken voor je voortreffelijke begeleiding en steun tijdens alle 
verschillende facetten van dit promotieonderzoek. 
Mijn co-promotor Dr. ir. J.A. Mol. Beste Jan, onder jouw deskundige 
leiding heb ik veel tijd doorgebracht in het biochemisch laboratorium, waar ik de 
techniek van de vasopressine radioimmunoassay heb geleerd, en we er uiteindelijk 
in geslaagd zijn de aquaporine-2 assay te ontwikkelen. “Monnikenwerk” heb je mij 
eens toevertrouwd, maar uiteindelijk is het ons toch gelukt om alle vasopressine 
metingen te verrichten! 
Mijn paranimf, Mevr. S.C. Renes. Beste Suus, onze vriendschap gaat al 
heel lang terug. Na afloop van de middelbare school filosofeerden we of we elkaar 
over 10 jaar nog zouden kennen, maar inmiddels zijn er veel meer jaren verstreken 
en is onze vriendschap alleen maar gegroeid. Hoewel we elkaar door de komst van 
een aantal kleine wereldwondertjes minder vaak zien dan we zouden willen, 
merken we bij elk gesprek dat de golflengte nog wel ‘goed’ zit! Ik wil je graag 
bedanken voor je vriendschap, en je bereidheid paranimf te zijn op de tweede 
verjaardag van Saskia! 
Mijn paranimf, Drs. A. Kummeling. Beste Anne, we hebben tegelijkertijd 
het “Excellent tracé” doorlopen en vervolgens zijn we ook tegelijk ingestroomd als 
roulant bij de Hoofdafdeling Geneeskunde van Gezelschapsdieren. Ondanks de 
drukke dagen was er altijd wel even tijd voor een kopje thee op de kamer, of een 
korte wandeling met Eilish. Ik heb altijd enorm genoten van onze gezamenlijke 
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overpeinzingen ten aanzien van onze wensen en ideeën voor de (nabije) toekomst. 
Ik ben blij jou als vriendin te mogen hebben!  
Mevr. J. Wolfswinkel en mevr. E.P.M. Timmermans-Sprang. Beste 
Jeannette en Elpetra, samen hebben we heel wat uren doorgebracht in het 
biochemisch laboratorium. Elpetra, je hebt mij met veel geduld de techniek van de 
vasopressine assay bijgebracht, en Jeannette, jij hebt mij begeleid bij de 
ontwikkeling van de aquaporine-2 assay. Dat deze assays niet zomaar vanzelf 
wilden lukken, bleek wel uit onze vele overlegmomenten, waar ik met veel plezier 
naar terugkijk! Ik wil jullie graag bedanken voor jullie grote inzet en het 
enthousiasme waarmee jullie mij begeleid hebben. Daarnaast heb ik de 
belangstelling en de gezelligheid van alle andere medewerkers van het biochemisch 
laboratorium enorm gewaardeerd. 
Dr. M.A. Oosterlaken-Dijksterhuis. Beste Marja, samen met Jeannette 
hebben we heel was brainstorm sessies gehad over de diverse problemen van de 
radioimmunoassays, die we uiteindelijk samen hebben opgelost. Bedankt voor al je 
hulp en gezelligheid. 
Dr. B.E. Belshaw. Beste Bruce, met veel geduld en altijd op heel korte 
termijn heb je mijn manuscripten gecorrigeerd. Hartelijk dank! 
De medewerkers van het klinisch-chemisch en het hematologisch 
laboratorium. Jullie hebben vele bepalingen voor mij verricht, en ik wil jullie graag 
allemaal bedanken voor de snelle en uiterst bekwame wijze waarop dit is gebeurd. 
 De heer H.G.H. van Engelen. Beste Harry, ik wil je graag bedanken voor je 
grote inzet en het enthousiasme waarmee je mij hebt geholpen met mijn 
experimenten. Ik kijk hier met veel plezier naar terug! 
De dierverzorgers en dierverplegers van de Hoofdafdeling Geneeskunde 
van Gezelschapsdieren. Vele malen hebben jullie mij bijgestaan tijdens de diverse 
studies en testen. De hulp die ik daarbij van jullie kreeg was onmisbaar voor het tot 
stand komen van dit proefschrift. Bedankt voor jullie grote inzet!  
De heer J. Fama. Beste Joop, je hebt mij geweldig geholpen met de 
afwerking van foto’s en afbeeldingen, ook al was het vaak kort dag. Bedankt voor 
je hulp. 
In de loop der jaren heb ik heel wat kamergenoten gehad: Anne, Gert, 
Ingrid, Erik, Frank, Marianna, Monique, Edgar, Bouvien, Sacha, Polona, Yvette, 
Linda, en Bart. Ik wil jullie, en ook alle andere sio’s en aio’s graag bedanken voor 
alle leuke en gezellige momenten die we met elkaar hebben gedeeld! 
Tot slot, degenen aan wie dit proefschrift is opgedragen. Mijn 
schoonouders, Miep en Arnold, jullie hebben mij vol liefde opgenomen in de 
familie, en zijn altijd vol belangstelling geweest voor het onderzoek waar ik mij 
mee bezig hield.  
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Mams en Paps, Marit en Oma, met recht hebben jullie laten zien dat je op 
je familie altijd onvoorwaardelijk kan bouwen. Zonder jullie altijd aanwezige steun 
en vertrouwen zou het mij niet zijn gelukt zover te komen!  
En natuurlijk Ron en Jesse: Jesse, jouw komst heeft ons onbeschrijfelijk 
veel geluk gebracht, en dat wordt nog dagelijks meer. Er is geen betere manier om 
te relativeren, dan de wereld eens door jouw ogen te bekijken. Ron, mijn 
allergrootste steunpilaar, naast alle, vaak dagelijkse hulp, bijvoorbeeld met 
computers die weer eens niet deden wat van ze verwacht werd, ben ik je bijzonder 
dankbaar voor je liefde en steun, en al het geluk dat wij samen mogen delen.  
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De schrijfster van dit proefschrift werd op 19 maart 1972 geboren in 
Amsterdam. De lagere school werd doorlopen aan de ‘International Community 
School’ in Zürich, Zwitserland. De middelbare schoolopleiding werd gestart aan 
het ‘Freies Gymnasium’ in dezelfde stad, en vervolgens voltooid aan het Christelijk 
Gymnasium te Utrecht (1984-1990). In 1990 startte de schrijfster met de studie 
diergeneeskunde aan de Faculteit der Diergeneeskunde van de Universiteit Utrecht. 
Tijdens deze studie nam ze in 1994 deel aan het ‘Excellent tracé’, waarbij ze 
gedurende 1 jaar onderzoek heeft verricht bij de Hoofdafdeling Geneeskunde van 
Gezelschapsdieren naar de achtergronden van polyurie bij de hond, afgerond met 
het diploma ‘Master of Veterinary Research’. De studie diergeneeskunde werd in 
1998 ‘cum laude’ voltooid. Hierna werd schrijfster aangesteld bij de Hoofdafdeling 
Geneeskunde van Gezelschapsdieren voor een algemene klinische roulatie (1998-
1999). Aansluitend volgde een klinische roulatie gericht op de interne geneeskunde 
van gezelschapsdieren bij dezelfde hoofdafdeling (1999-2000). Van 2001 tot 2003 
heeft ze promotieonderzoek verricht naar de rol van vasopressine bij honden met 
polyurie. De schrijfster is in 2001 getrouwd met Ron Geerars en in 2002 moeder 
geworden van Jesse Michael. 
 
 
The author of this thesis was born in Amsterdam, The Netherlands, on 
March 19th 1972. After primary school education at the International Community 
School in Zurich, Switzerland, secondary school education was received at the 
‘Freies Gymnasium’ in Zurich and at the ‘Christelijk Gymnasium’ in Utrecht, The 
Netherlands (1984-1990). In 1990 the author started to study veterinary medicine at 
the Faculty of Veterinary Medicine of Utrecht University. In 1994 she was invited 
to participate in the Faculty’s ‘Excellent track’ research programme. At the 
Department of Clinical Sciences of Companion Animals she investigated 
mechanisms underlying canine polyuria for 1 year, and received the MVSc degree. 
After graduating as a DVM with honours, the author completed a clinical 
internship in companion animal medicine (1998-1999), and thereafter she 
concentrated on internal medicine of companion animals at the same department 
(1999-2000). From 2001 to 2003 the author performed her PhD research on the 
role of vasopressin in canine polyuria. In 2001 the author married to Ron Geerars 
and in 2002 she became mother of Jesse Michael. 
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